ChEMBL ID,Receptor,Species,Purchasable,No. records,Assay type,Min.,Average,Max.,Unit,Mol. weight,Rot. Bonds,H don,H acc,LogP,Smiles,,,,,
CHEMBL4847536,187775,0,None,416,2,Human,11,pEC50,=,11,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,368,7,5,5,2.6,CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028449,187775,0,None,416,2,Human,11,pEC50,=,11,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,368,7,5,5,2.6,CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4871708,187819,0,None,245,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028726,187819,0,None,245,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4873082,187842,0,None,316,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL5028871,187842,0,None,316,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL4848793,187777,0,None,173,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,368,7,5,5,2.6,CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028458,187777,0,None,173,2,Human,10.9,pEC50,=,10.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,368,7,5,5,2.6,CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4854569,187758,0,None,104,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028293,187758,0,None,104,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
156010908,177607,0,None,2238,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4634131,177607,0,None,2238,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651173,177607,0,None,2238,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4865710,187824,0,None,1479,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL5028744,187824,0,None,1479,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL4848018,187780,0,None,389,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028489,187780,0,None,389,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4848704,187763,0,None,120,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028319,187763,0,None,120,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4862449,187821,0,None,47,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028738,187821,0,None,47,2,Human,10.8,pEC50,=,10.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4854261,187729,0,None,131,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,7,5,5,3,CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028104,187729,0,None,131,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,7,5,5,3,CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4860454,187731,0,None,2454,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL5028117,187731,0,None,2454,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL4868938,187788,0,None,95,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028525,187788,0,None,95,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4855974,187722,0,None,134,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL5028040,187722,0,None,134,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,380,7,4,4,3.6,Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
11504295,2853,35,None,1047,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1021/acs.jmedchem.0c01195
4814,2853,35,None,1047,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1021/acs.jmedchem.0c01195
7543,2853,35,None,1047,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1021/acs.jmedchem.0c01195
CHEMBL605846,2853,35,None,1047,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1021/acs.jmedchem.0c01195
DB09080,2853,35,None,1047,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1021/acs.jmedchem.0c01195
9957764,88193,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,503,11,6,6,3.6,COc1ccccc1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
CHEMBL236039,88193,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,503,11,6,6,3.6,COc1ccccc1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
11259765,85498,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,462,11,5,5,3.4,CC(C)(Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.04.081
CHEMBL230486,85498,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,462,11,5,5,3.4,CC(C)(Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.04.081
11621158,16489,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,575,12,6,7,3.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(O)cc2Cl)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1242943,16489,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,575,12,6,7,3.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(O)cc2Cl)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
155517986,169491,0,None,478630,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4445289,169491,0,None,478630,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
155517986,169491,0,None,478630,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4445289,169491,0,None,478630,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4863282,187804,0,None,120,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL5028641,187804,0,None,120,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL4872480,187831,0,None,199,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,374,7,4,4,2.8,O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
CHEMBL5028793,187831,0,None,199,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,374,7,4,4,2.8,O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
44434130,88196,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,487,10,5,5,3.9,C[C@H](Cc1ccc2[nH]c(C(=O)N(C)Cc3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL236041,88196,0,None,-,1,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,487,10,5,5,3.9,C[C@H](Cc1ccc2[nH]c(C(=O)N(C)Cc3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL4857267,187760,0,None,91,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028301,187760,0,None,91,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4868585,187817,0,None,26,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028721,187817,0,None,26,2,Human,10.7,pEC50,=,10.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,400,7,4,4,3.9,CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
11455274,16511,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,525,12,5,6,3.3,CC(C)(Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243189,16511,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,525,12,5,6,3.3,CC(C)(Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL4868684,187838,0,None,131,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,370,7,4,4,3,CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028836,187838,0,None,131,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,370,7,4,4,3,CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
156014115,177564,0,None,58,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4635163,177564,0,None,58,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4650951,177564,0,None,58,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
11214499,85500,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,516,11,5,5,4.3,C[C@H](Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm1005989
CHEMBL230490,85500,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,516,11,5,5,4.3,C[C@H](Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm1005989
CHEMBL4846631,187712,0,None,181,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,356,7,4,4,2.6,O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
CHEMBL5027923,187712,0,None,181,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,356,7,4,4,2.6,O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
156015148,177559,0,None,208,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4646881,177559,0,None,208,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4650929,177559,0,None,208,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4863847,187797,0,None,288,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL5028596,187797,0,None,288,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
11249243,16508,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,511,12,5,6,2.9,C[C@H](Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243158,16508,0,None,-,1,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,511,12,5,6,2.9,C[C@H](Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
156015482,177525,0,None,204,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4641262,177525,0,None,204,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4650664,177525,0,None,204,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4868763,187791,0,None,371,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,370,7,4,4,3,CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028547,187791,0,None,371,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,370,7,4,4,3,CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4872653,187827,0,None,2754,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,406,7,4,4,3.5,O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
CHEMBL5028764,187827,0,None,2754,2,Human,10.6,pEC50,=,10.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,406,7,4,4,3.5,O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
CHEMBL4848617,187732,0,None,64,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028119,187732,0,None,64,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,8,4,5,2.9,COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
156014817,177578,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4642770,177578,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4650993,177578,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccccc1CCC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4848775,187772,0,None,251,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL5028422,187772,0,None,251,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,396,8,4,5,3.3,COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
156013777,177622,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4636255,177622,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651241,177622,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1cccc(O)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
10390417,167055,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,480,10,6,7,3,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3nccs3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL430361,167055,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,480,10,6,7,3,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3nccs3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
49864395,15429,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,400,7,4,6,3.1,O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1,10.1016/j.bmcl.2010.06.136
CHEMBL1221680,15429,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,400,7,4,6,3.1,O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1,10.1016/j.bmcl.2010.06.136
11477877,16534,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,517,12,5,6,3.3,C[C@H](Cc1cccc(CC(=O)NCC2CCCCC2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243348,16534,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,517,12,5,6,3.3,C[C@H](Cc1cccc(CC(=O)NCC2CCCCC2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
13121366,176729,0,None,457,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,370,7,4,5,2.8,CC(C)(CCc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4638864,176729,0,None,457,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,370,7,4,5,2.8,CC(C)(CCc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4853372,187733,0,None,190,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028127,187733,0,None,190,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL4860764,187753,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028269,187753,0,None,134,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
156014962,177523,0,None,229,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4645203,177523,0,None,229,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4650644,177523,0,None,229,2,Human,10.5,pEC50,=,10.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
155536314,171459,0,None,6025,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4473515,171459,0,None,6025,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
155536314,171459,0,None,6025,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4473515,171459,0,None,6025,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4866766,187798,0,None,616,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,7,5,5,3,CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028602,187798,0,None,616,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,382,7,5,5,3,CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
44434126,88195,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,519,11,6,6,4.3,CSc1ccccc1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
CHEMBL236040,88195,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,519,11,6,6,4.3,CSc1ccccc1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
10027868,144225,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,474,10,6,6,2.9,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccccn3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL391006,144225,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,474,10,6,6,2.9,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccccn3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL4865833,187787,0,None,275,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL5028523,187787,0,None,275,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,366,7,4,4,3.2,Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL4870623,187825,0,None,380,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
CHEMBL5028756,187825,0,None,380,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2021.113697
156014983,177604,0,None,724,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4644638,177604,0,None,724,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651152,177604,0,None,724,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,386,7,5,6,2.5,CC(C)(CCc1ccc(O)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
11261001,16512,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,525,13,5,6,2.9,C[C@H](Cc1cccc(CC(=O)NCCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243190,16512,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,525,13,5,6,2.9,C[C@H](Cc1cccc(CC(=O)NCCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
11489605,16519,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,541,13,5,7,2.9,COc1ccccc1CNC(=O)Cc1cccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
CHEMBL1243256,16519,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,541,13,5,7,2.9,COc1ccccc1CNC(=O)Cc1cccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
155533625,171161,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4469364,171161,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,366,7,4,4,3.3,CC(C)(CCc1ccccc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
155564766,174766,0,None,181,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
CHEMBL4577508,174766,0,None,181,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
11489574,16516,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,539,14,5,6,3.3,C[C@H](Cc1cccc(CC(=O)NCCCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243222,16516,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,539,14,5,6,3.3,C[C@H](Cc1cccc(CC(=O)NCCCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
155536813,171490,0,None,263,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4473790,171490,0,None,263,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4865514,187834,0,None,794,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,442,10,4,7,2.9,COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC,10.1016/j.ejmech.2021.113697
CHEMBL5028807,187834,0,None,794,2,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,442,10,4,7,2.9,COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC,10.1016/j.ejmech.2021.113697
2419,3377,76,None,17,6,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2019.115178
5152,3377,76,None,17,6,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2019.115178
559,3377,76,None,17,6,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2019.115178
CHEMBL1263,3377,76,None,17,6,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2019.115178
DB00938,3377,76,None,17,6,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2019.115178
11699773,16503,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,569,12,6,7,3.6,Cc1cc(O)cc(C)c1CNC(=O)Cc1cccc(CC(C)(C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
CHEMBL1243101,16503,0,None,-,1,Human,10.4,pEC50,=,10.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,569,12,6,7,3.6,Cc1cc(O)cc(C)c1CNC(=O)Cc1cccc(CC(C)(C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
CHEMBL4874945,187848,0,None,346,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,356,7,4,4,2.6,O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
CHEMBL5028930,187848,0,None,346,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,356,7,4,4,2.6,O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2021.113697
11398811,16522,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,555,14,5,7,3.3,CCOc1ccccc1CNC(=O)Cc1cccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
CHEMBL1243285,16522,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,555,14,5,7,3.3,CCOc1ccccc1CNC(=O)Cc1cccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
155543358,174052,0,None,102,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4561253,174052,0,None,102,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
156015401,177545,0,None,251,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4645694,177545,0,None,251,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4650809,177545,0,None,251,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1cccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
156015798,177552,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4649233,177552,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4650858,177552,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,400,8,4,6,2.8,COc1ccc(CCC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
44434125,145444,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,473,10,6,5,3.6,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL391946,145444,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,473,10,6,5,3.6,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
155557083,173820,0,None,724,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4556022,173820,0,None,724,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,5,5,2.2,O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
10389119,88240,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,451,10,6,5,3.2,C[C@H](Cc1ccc2[nH]c(C(=O)NCC3CCC3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL236251,88240,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,451,10,6,5,3.2,C[C@H](Cc1ccc2[nH]c(C(=O)NCC3CCC3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
155564340,174701,0,None,263,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,493,11,5,5,4.9,CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C,10.1016/j.bmc.2018.10.043
CHEMBL4576089,174701,0,None,263,2,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,493,11,5,5,4.9,CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C,10.1016/j.bmc.2018.10.043
44434127,88094,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,509,10,6,5,3.8,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3c(F)cccc3F)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL235612,88094,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,509,10,6,5,3.8,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3c(F)cccc3F)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
3466,4047,36,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,10.1021/jm1005989
37990,4047,36,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,10.1021/jm1005989
CHEMBL1243407,4047,36,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,10.1021/jm1005989
1499,2038,40,None,-72,36,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2019.115178
3779,2038,40,None,-72,36,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2019.115178
536,2038,40,None,-72,36,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2019.115178
CHEMBL434,2038,40,None,-72,36,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2019.115178
DB01064,2038,40,None,-72,36,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2019.115178
11376125,16527,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,539,12,5,6,3.5,Cc1ccc(CNC(=O)Cc2cccc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)c2)cc1C,10.1021/jm1005989
CHEMBL1243317,16527,0,None,-,1,Human,10.3,pEC50,=,10.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,539,12,5,6,3.5,Cc1ccc(CNC(=O)Cc2cccc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)c2)cc1C,10.1021/jm1005989
CHEMBL4859591,187748,0,None,295,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028241,187748,0,None,295,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
10324803,89079,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,533,12,6,7,3.6,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
CHEMBL237501,89079,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,533,12,6,7,3.6,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2[nH]1,10.1016/j.bmcl.2007.09.031
10390752,145589,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,487,10,6,5,4.1,C[C@H](Cc1ccc2[nH]c(C(=O)N[C@H](C)c3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL392056,145589,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,487,10,6,5,4.1,C[C@H](Cc1ccc2[nH]c(C(=O)N[C@H](C)c3ccccc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
16049087,63686,0,None,125,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,448,13,4,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807817,63686,0,None,125,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,448,13,4,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
9892481,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.095
CHEMBL1940832,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.095
90645347,111925,0,None,7,3,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,578,12,6,7,5.6,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298987,111925,0,None,7,3,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,578,12,6,7,5.6,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
9892481,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL1940832,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
9892481,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940832,69816,8,None,-3,4,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
11420492,154525,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,492,10,5,5,3.8,C[C@H](Cc1cccc(CC(=O)NC23CC4CC(CC(C4)C2)C3)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm1005989
CHEMBL402501,154525,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,492,10,5,5,3.8,C[C@H](Cc1cccc(CC(=O)NC23CC4CC(CC(C4)C2)C3)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm1005989
155564079,174688,0,None,97,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,442,8,4,4,4.9,CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4575759,174688,0,None,97,2,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,442,8,4,4,4.9,CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
11456127,16533,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,593,12,5,6,4.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243347,16533,0,None,-,1,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,593,12,5,6,4.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
2419,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.09.031
5152,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.09.031
559,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.09.031
CHEMBL1263,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.09.031
DB00938,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.09.031
2419,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.04.081
5152,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.04.081
559,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.04.081
CHEMBL1263,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.04.081
DB00938,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2007.04.081
2419,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm1005989
5152,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm1005989
559,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm1005989
CHEMBL1263,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm1005989
DB00938,3377,76,None,17,6,Human,10.2,pEC50,=,10.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm1005989
CHEMBL4847767,187762,0,None,61,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
CHEMBL5028315,187762,0,None,61,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,4,3.5,CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2021.113697
155548071,173027,0,None,131,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,338,7,4,4,2.5,O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4536813,173027,0,None,131,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,338,7,4,4,2.5,O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
155567283,175247,0,None,588,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.bmc.2018.10.043
CHEMBL4588479,175247,0,None,588,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,368,8,4,5,2.5,COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.bmc.2018.10.043
155548668,173060,0,None,-,1,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,478,8,4,4,5.1,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4537644,173060,0,None,-,1,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,478,8,4,4,5.1,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
2419,3377,76,None,17,6,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2018.10.043
5152,3377,76,None,17,6,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2018.10.043
559,3377,76,None,17,6,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2018.10.043
CHEMBL1263,3377,76,None,17,6,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2018.10.043
DB00938,3377,76,None,17,6,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2018.10.043
16049088,63687,0,None,100,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,448,13,4,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807818,63687,0,None,100,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,448,13,4,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
16049028,63688,0,None,50,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,462,14,4,7,3.7,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807819,63688,0,None,50,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,462,14,4,7,3.7,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
11592062,111869,0,None,25,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1,10.1016/j.bmcl.2014.04.095
CHEMBL3298325,111869,0,None,25,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1,10.1016/j.bmcl.2014.04.095
11169365,111924,0,None,22,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,502,11,6,7,4,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298986,111924,0,None,22,3,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,502,11,6,7,4,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
155513474,169024,0,None,83,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,478,8,4,4,5.1,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4438531,169024,0,None,83,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,478,8,4,4,5.1,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4867311,187816,0,None,120226,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,428,10,4,7,2.5,COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC,10.1016/j.ejmech.2021.113697
CHEMBL5028718,187816,0,None,120226,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,428,10,4,7,2.5,COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC,10.1016/j.ejmech.2021.113697
11504295,2853,35,None,1047,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1016/j.ejmech.2021.113697
4814,2853,35,None,1047,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1016/j.ejmech.2021.113697
7543,2853,35,None,1047,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1016/j.ejmech.2021.113697
CHEMBL605846,2853,35,None,1047,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1016/j.ejmech.2021.113697
DB09080,2853,35,None,1047,2,Human,10.1,pEC50,=,10.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,10.1016/j.ejmech.2021.113697
11707090,16499,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,609,12,6,7,4.3,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)c(O)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243068,16499,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,609,12,6,7,4.3,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)c(O)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL4873280,187829,0,None,316,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
CHEMBL5028767,187829,0,None,316,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,352,7,4,4,2.8,Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2021.113697
11247541,85452,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,434,11,5,5,2.6,O=C(Cc1cccc(CCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NCc1ccccc1,10.1016/j.bmcl.2007.04.081
CHEMBL230203,85452,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,434,11,5,5,2.6,O=C(Cc1cccc(CCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NCc1ccccc1,10.1016/j.bmcl.2007.04.081
44425580,85499,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,448,11,5,5,3,C[C@H](Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.04.081
CHEMBL230487,85499,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMPAgonistactivityathumanrecombinantbeta-2adrenoceptorexpressedinCHOcellsassessedaselevationofcAMP,ChEMBL,448,11,5,5,3,C[C@H](Cc1cccc(CC(=O)NCc2ccccc2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.04.081
12065,618,15,None,6,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,10.1016/j.bmcl.2009.10.013
45483813,618,15,None,6,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,10.1016/j.bmcl.2009.10.013
CHEMBL579394,618,15,None,6,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,10.1016/j.bmcl.2009.10.013
13345218,192899,0,None,8,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,372,6,5,6,2.1,CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL568272,192899,0,None,8,2,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,372,6,5,6,2.1,CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
16049024,63689,0,None,79,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,498,13,4,7,4.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807820,63689,0,None,79,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,498,13,4,7,4.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1,10.1016/j.bmcl.2011.05.097
118737358,118456,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,13,6,8,5.8,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1021/jm501915g
CHEMBL3426706,118456,0,None,-,1,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,13,6,8,5.8,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1021/jm501915g
10239722,111870,0,None,11,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298326,111870,0,None,11,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1,10.1016/j.bmcl.2014.04.095
66796015,111872,0,None,35,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,474,11,6,7,3.2,NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298328,111872,0,None,35,3,Human,10,pEC50,=,10,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,474,11,6,7,3.2,NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
10180590,69814,0,None,707,2,Human,10,pEC50,=,10,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940830,69814,0,None,707,2,Human,10,pEC50,=,10,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
10392857,88145,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,552,11,7,7,2.2,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccc(S(N)(=O)=O)cc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL235818,88145,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,552,11,7,7,2.2,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccc(S(N)(=O)=O)cc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
16049026,63690,0,None,25,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,432,13,4,7,2.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807821,63690,0,None,25,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,432,13,4,7,2.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
16049029,63691,0,None,25,2,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,482,13,4,7,3.7,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807822,63691,0,None,25,2,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,482,13,4,7,3.7,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1,10.1016/j.bmcl.2011.05.097
10461973,118447,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,655,15,6,8,4.9,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)NCCCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426697,118447,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,655,15,6,8,4.9,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)NCCCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
9871386,111683,3,None,8,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3290999,111683,3,None,8,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
90645344,111868,0,None,7,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN,10.1016/j.bmcl.2014.04.095
CHEMBL3298324,111868,0,None,7,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN,10.1016/j.bmcl.2014.04.095
56943545,111874,0,None,28,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,502,13,6,7,4,NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298330,111874,0,None,28,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,502,13,6,7,4,NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
11180293,111920,0,None,22,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,543,12,6,8,3.1,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
CHEMBL3298897,111920,0,None,22,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,543,12,6,8,3.1,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
46832232,14069,0,None,39,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,467,16,4,6,4.5,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O,10.1021/jm100326d
CHEMBL1085837,14069,0,None,39,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,467,16,4,6,4.5,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O,10.1021/jm100326d
CHEMBL1198923,14069,0,None,39,3,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,467,16,4,6,4.5,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O,10.1021/jm100326d
10217757,111682,0,None,10,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,497,12,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290998,111682,0,None,10,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,497,12,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
9871386,111683,3,None,8,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290999,111683,3,None,8,4,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
57398384,69817,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,6,6,3.2,O=c1ccc2c([C@@H](O)CNCCc3ccc(NC[C@H](O)c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.11.072
CHEMBL1940833,69817,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,6,6,3.2,O=c1ccc2c([C@@H](O)CNCCc3ccc(NC[C@H](O)c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.11.072
156015656,177617,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,378,7,4,5,2.3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cc(F)cc(F)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4639822,177617,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,378,7,4,5,2.3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cc(F)cc(F)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4651230,177617,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,378,7,4,5,2.3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cc(F)cc(F)c2)N1,10.1016/j.bmc.2019.115178
46938907,16496,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,609,12,6,7,4.3,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)cc(Cl)c2O)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243035,16496,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,609,12,6,7,4.3,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)cc(Cl)c2O)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
155524038,170174,0,None,120,2,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,414,8,4,4,4.2,O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4454489,170174,0,None,120,2,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,414,8,4,4,4.2,O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
2419,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.ejmech.2021.113697
5152,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.ejmech.2021.113697
559,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.ejmech.2021.113697
CHEMBL1263,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.ejmech.2021.113697
DB00938,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.ejmech.2021.113697
156020412,177623,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4648525,177623,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651243,177623,0,None,-,1,Human,9.9,pEC50,=,9.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
155550964,173228,0,None,575,2,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,8,4,4,2.9,O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4541263,173228,0,None,575,2,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,8,4,4,2.9,O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
1499,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0101500
3779,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0101500
536,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0101500
CHEMBL434,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0101500
DB01064,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0101500
1499,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0509445
3779,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0509445
536,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0509445
CHEMBL434,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0509445
DB01064,2038,40,None,-72,36,Human,9.8,pEC50,=,9.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm0509445
CHEMBL3426698,118448,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,681,12,6,8,5.3,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)N[C@H]1CC[C@H](CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1021/jm501915g
118737354,118451,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,703,12,6,8,5.8,Cc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426701,118451,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,703,12,6,8,5.8,Cc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
56943518,111873,0,None,25,3,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,488,12,6,7,3.6,NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298329,111873,0,None,25,3,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,488,12,6,7,3.6,NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
56943546,111890,0,None,25,3,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,518,14,6,8,3.2,NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298691,111890,0,None,25,3,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,518,14,6,8,3.2,NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
24901144,69912,0,None,-1,5,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1944691,69912,0,None,-1,5,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
10288976,66176,0,None,10,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,17,6,6,3.9,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835862,66176,0,None,10,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,17,6,6,3.9,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852543,66176,0,None,10,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,17,6,6,3.9,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1,10.1016/j.bmc.2011.08.043
9849126,12303,0,None,-3,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,507,18,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1,10.1021/jm801016j
CHEMBL1185969,12303,0,None,-3,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,507,18,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1,10.1021/jm801016j
CHEMBL443435,12303,0,None,-3,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,507,18,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1,10.1021/jm801016j
9891927,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL446840,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL483200,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL483201,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
9891927,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL446840,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL483200,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL483201,183455,4,None,5,4,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
155551133,173274,0,None,446,2,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,7,4,5,1.9,O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4542430,173274,0,None,446,2,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,7,4,5,1.9,O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
44434128,148470,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,489,10,7,6,3.3,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccc(O)cc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL394339,148470,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,489,10,7,6,3.3,C[C@H](Cc1ccc2[nH]c(C(=O)NCc3ccc(O)cc3)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
11534330,16493,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,575,12,6,7,3.6,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)ccc2O)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1243000,16493,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,575,12,6,7,3.6,CC(C)(Cc1cccc(CC(=O)NCc2cc(Cl)ccc2O)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
156020206,177616,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(O)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4648663,177616,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(O)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4651226,177616,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(O)c2)N1,10.1016/j.bmc.2019.115178
156015463,177625,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4640925,177625,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651254,177625,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
1239,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.01.043
3410,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.01.043
3465,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.01.043
CHEMBL1256786,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.01.043
DB00983,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.01.043
15981386,63154,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,459,12,4,7,2,CN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800472,63154,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,459,12,4,7,2,CN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
56663238,63705,0,None,251,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,465,13,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807872,63705,0,None,251,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,465,13,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
11857427,118443,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,6,8,6.1,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
CHEMBL3426693,118443,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,6,8,6.1,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
118737350,118444,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,6,8,6.1,Cc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426694,118444,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,6,8,6.1,Cc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
1239,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
3410,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
3465,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
CHEMBL1256786,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
DB00983,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
16738927,69941,0,None,31,3,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,11,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945034,69941,0,None,31,3,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,11,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
42625823,12540,0,None,251,3,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,576,19,5,7,4.7,O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1187371,12540,0,None,251,3,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,576,19,5,7,4.7,O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL500782,12540,0,None,251,3,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,576,19,5,7,4.7,O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
1239,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
3410,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
3465,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
CHEMBL1256786,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
DB00983,1626,45,None,-1,5,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
45483810,192822,0,None,3,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,356,6,4,5,2.4,CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL567863,192822,0,None,3,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,356,6,4,5,2.4,CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
1499,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2013.11.030
3779,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2013.11.030
536,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2013.11.030
CHEMBL434,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2013.11.030
DB01064,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2013.11.030
11577915,16397,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,591,12,6,7,4.1,CC(C)(Cc1cccc(CC(=O)NCc2ccc3cc(O)ccc3c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1240965,16397,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,591,12,6,7,4.1,CC(C)(Cc1cccc(CC(=O)NCc2ccc3cc(O)ccc3c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
1499,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2021.113697
3779,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2021.113697
536,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2021.113697
CHEMBL434,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2021.113697
DB01064,2038,40,None,-72,36,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenoreceptoroverexpressedinHEK293cellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2021.113697
156014685,177620,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2O)N1,10.1016/j.bmc.2019.115178
CHEMBL4636111,177620,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2O)N1,10.1016/j.bmc.2019.115178
CHEMBL4651237,177620,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2O)N1,10.1016/j.bmc.2019.115178
155536173,171446,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,442,8,4,4,4.9,CC(C)(CC(c1ccccc1)c1ccccc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
CHEMBL4473349,171446,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,442,8,4,4,4.9,CC(C)(CC(c1ccccc1)c1ccccc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.bmc.2018.10.043
155527926,170537,0,None,8709,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,451,11,5,5,3.9,CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
CHEMBL4460095,170537,0,None,8709,2,Human,9.7,pEC50,=,9.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,451,11,5,5,3.9,CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
11714238,16398,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,617,13,6,7,4.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(-c3ccc(O)cc3)cc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1240966,16398,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,617,13,6,7,4.6,CC(C)(Cc1cccc(CC(=O)NCc2ccc(-c3ccc(O)cc3)cc2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
11647002,15430,0,None,8,2,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,400,7,4,6,3.1,O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1,10.1016/j.bmcl.2014.06.014
CHEMBL1221681,15430,0,None,8,2,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,400,7,4,6,3.1,O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1,10.1016/j.bmcl.2014.06.014
CHEMBL4860455,184626,0,None,776,2,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationmeasuredafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenoceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationmeasuredafter60minsbyHTRFassay,ChEMBL,237,4,3,4,1.3,CC(C)NC(CO)c1cc(F)c(N)c(C#N)c1,10.1021/acs.jmedchem.0c01195
2419,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.05.064
5152,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.05.064
559,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.05.064
CHEMBL1263,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.05.064
DB00938,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.05.064
56672116,65962,0,None,316,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,570,19,5,8,2.4,NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1814276,65962,0,None,316,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,570,19,5,8,2.4,NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1851624,65962,0,None,316,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,570,19,5,8,2.4,NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
10372836,101833,31,None,6,2,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,739,13,6,9,6.4,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3039518,101833,31,None,6,2,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,739,13,6,9,6.4,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
10372344,118437,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,675,12,6,8,5.8,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm501915g
CHEMBL3426687,118437,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,675,12,6,8,5.8,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm501915g
10327462,118438,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,709,12,6,8,6.4,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1Cl,10.1021/jm501915g
CHEMBL3426688,118438,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,709,12,6,8,6.4,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1Cl,10.1021/jm501915g
118737348,118441,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.8,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426691,118441,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.8,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
118737351,118445,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,6,9,6.1,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1C,10.1021/jm501915g
CHEMBL3426695,118445,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,6,9,6.1,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1C,10.1021/jm501915g
118737355,118452,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,5,8,5.5,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm501915g
CHEMBL3426702,118452,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,689,12,5,8,5.5,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm501915g
56943515,111856,0,None,7,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,478,13,6,7,3.7,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298213,111856,0,None,7,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,478,13,6,7,3.7,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1,10.1016/j.bmcl.2014.04.095
10173878,111871,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,459,10,5,6,4.2,CCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298327,111871,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,459,10,5,6,4.2,CCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
24901210,69911,0,None,125,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,497,11,5,6,4.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1944690,69911,0,None,125,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,497,11,5,6,4.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
24901347,69916,0,None,17,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,463,11,5,6,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1944695,69916,0,None,17,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,463,11,5,6,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
24901413,69939,0,None,-3,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,516,11,6,6,4.3,Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12,10.1016/j.bmcl.2011.10.049
CHEMBL1945032,69939,0,None,-3,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,516,11,6,6,4.3,Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12,10.1016/j.bmcl.2011.10.049
2419,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm401532g
5152,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm401532g
559,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm401532g
CHEMBL1263,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm401532g
DB00938,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm401532g
156016062,177599,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,8,4,5,2.4,O=C1COc2c(cc(O)cc2C(O)CNCCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4643148,177599,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,8,4,5,2.4,O=C1COc2c(cc(O)cc2C(O)CNCCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4651124,177599,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,8,4,5,2.4,O=C1COc2c(cc(O)cc2C(O)CNCCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
2419,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.08.043
5152,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.08.043
559,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.08.043
CHEMBL1263,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.08.043
DB00938,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmc.2011.08.043
56672271,66137,0,None,1,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,530,19,7,7,2.7,NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835859,66137,0,None,1,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,530,19,7,7,2.7,NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852407,66137,0,None,1,4,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,530,19,7,7,2.7,NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
2419,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm801016j
5152,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm801016j
559,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm801016j
CHEMBL1263,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm801016j
DB00938,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm801016j
2419,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100326d
5152,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100326d
559,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100326d
CHEMBL1263,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100326d
DB00938,3377,76,None,17,6,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100326d
46832509,14066,0,None,50,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,510,18,5,8,2.7,CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1085399,14066,0,None,50,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,510,18,5,8,2.7,CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1198908,14066,0,None,50,3,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,510,18,5,8,2.7,CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
10006800,88197,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,517,12,6,6,3.6,COc1cccc(CCNC(=O)c2cc3cc(C[C@@H](C)NC[C@H](O)c4ccc(O)c(CO)c4)ccc3[nH]2)c1,10.1016/j.bmcl.2007.09.031
CHEMBL236042,88197,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,517,12,6,6,3.6,COc1cccc(CCNC(=O)c2cc3cc(C[C@@H](C)NC[C@H](O)c4ccc(O)c(CO)c4)ccc3[nH]2)c1,10.1016/j.bmcl.2007.09.031
10256921,144628,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,547,13,6,7,4,CC[C@H](Cc1ccc2[nH]c(C(=O)NCc3c(OC)cccc3OC)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
CHEMBL391308,144628,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,547,13,6,7,4,CC[C@H](Cc1ccc2[nH]c(C(=O)NCc3c(OC)cccc3OC)cc2c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2007.09.031
11505444,16399,9,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,617,13,6,7,4.6,CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
CHEMBL1240967,16399,9,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,617,13,6,7,4.6,CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,10.1021/jm1005989
11625619,77181,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,406,6,4,4,3.5,CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1016/j.bmcl.2012.07.096
CHEMBL2088201,77181,0,None,-,1,Human,9.6,pEC50,=,9.6,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,406,6,4,4,3.5,CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1016/j.bmcl.2012.07.096
16735257,85220,0,None,812,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
CHEMBL228992,85220,0,None,812,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
688468,141669,6,None,346,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL388570,141669,6,None,346,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
16735257,85220,0,None,812,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL228992,85220,0,None,812,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
155543518,174277,0,None,794,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,457,9,5,5,3.7,O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1,10.1016/j.bmc.2018.10.043
CHEMBL4566727,174277,0,None,794,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,457,9,5,5,3.7,O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1,10.1016/j.bmc.2018.10.043
3083544,462,43,None,1,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatbeta2-adrenergicreceptor(unknownorigin)Agonistactivityatbeta2-adrenergicreceptor(unknownorigin),ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2013.11.028
4943,462,43,None,1,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatbeta2-adrenergicreceptor(unknownorigin)Agonistactivityatbeta2-adrenergicreceptor(unknownorigin),ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2013.11.028
7479,462,43,None,1,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatbeta2-adrenergicreceptor(unknownorigin)Agonistactivityatbeta2-adrenergicreceptor(unknownorigin),ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2013.11.028
CHEMBL1363,462,43,None,1,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatbeta2-adrenergicreceptor(unknownorigin)Agonistactivityatbeta2-adrenergicreceptor(unknownorigin),ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2013.11.028
DB01274,462,43,None,1,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatbeta2-adrenergicreceptor(unknownorigin)Agonistactivityatbeta2-adrenergicreceptor(unknownorigin),ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2013.11.028
118737352,118446,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,6,9,6.1,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426696,118446,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,6,9,6.1,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
1499,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2018.10.043
1499,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2018.04.041
3779,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2018.10.043
3779,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2018.04.041
536,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2018.10.043
536,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2018.04.041
CHEMBL434,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2018.10.043
CHEMBL434,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2018.04.041
DB01064,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2018.10.043
DB01064,2038,40,None,-72,36,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2018.04.041
2419,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
5152,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
559,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
CHEMBL1263,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
DB00938,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
56943485,111915,0,None,12,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,544,12,5,8,3.6,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
CHEMBL3298831,111915,0,None,12,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,544,12,5,8,3.6,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
11592062,111869,0,None,25,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1,10.1016/j.bmcl.2014.04.095
CHEMBL3298325,111869,0,None,25,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1,10.1016/j.bmcl.2014.04.095
24901348,69910,0,None,70,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,531,11,5,6,4.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1944689,69910,0,None,70,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,531,11,5,6,4.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,10.1016/j.bmcl.2011.10.049
24901211,69914,0,None,158,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1944693,69914,0,None,158,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
24901351,69915,0,None,10,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
CHEMBL1944694,69915,0,None,10,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
24901209,69938,0,None,177,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,516,11,6,6,4.3,Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12,10.1016/j.bmcl.2011.10.049
CHEMBL1945031,69938,0,None,177,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,516,11,6,6,4.3,Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12,10.1016/j.bmcl.2011.10.049
24901143,69948,0,None,12,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,483,10,5,6,4.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945041,69948,0,None,12,4,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,483,10,5,6,4.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
156015043,177538,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,342,7,4,5,2,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4648975,177538,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,342,7,4,5,2,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4650763,177538,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,342,7,4,5,2,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
56668796,66198,0,None,31,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,598,20,7,7,4.3,O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1,10.1016/j.bmc.2011.08.043
CHEMBL1835860,66198,0,None,31,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,598,20,7,7,4.3,O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1,10.1016/j.bmc.2011.08.043
CHEMBL1852632,66198,0,None,31,3,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,598,20,7,7,4.3,O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1,10.1016/j.bmc.2011.08.043
2419,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
5152,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
559,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
CHEMBL1263,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
DB00938,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
2419,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
5152,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
559,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
CHEMBL1263,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
DB00938,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
9932018,69799,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940815,69799,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
57403562,69801,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,450,11,6,6,3.7,CC(C)(Cc1ccc(NCC(O)c2ccccc2)cc1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2011.11.072
CHEMBL1940817,69801,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,450,11,6,6,3.7,CC(C)(Cc1ccc(NCC(O)c2ccccc2)cc1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2011.11.072
10202462,69815,0,None,223,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940831,69815,0,None,223,2,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
2419,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100068m
5152,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100068m
559,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100068m
CHEMBL1263,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100068m
DB00938,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/jm100068m
9986442,58169,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,626,15,5,7,6.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683933,58169,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,626,15,5,7,6.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
2419,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.01.043
5152,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.01.043
559,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.01.043
CHEMBL1263,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.01.043
DB00938,3377,76,None,17,6,Human,9.5,pEC50,=,9.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.01.043
9874175,58170,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683934,58170,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
46938906,16491,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,603,13,5,7,4.4,CCN(Cc1ccc(O)cc1Cl)C(=O)Cc1cccc(CC(C)(C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
CHEMBL1242969,16491,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethodAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedaselevationincAMPlevelafter1hrbyflashplatemethod,ChEMBL,603,13,5,7,4.4,CCN(Cc1ccc(O)cc1Cl)C(=O)Cc1cccc(CC(C)(C)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)c1,10.1021/jm1005989
156019922,177618,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccccc1CCCNCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4645720,177618,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccccc1CCCNCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4651233,177618,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccccc1CCCNCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
16049309,63703,0,None,100,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807870,63703,0,None,100,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1,10.1016/j.bmcl.2011.05.097
9874175,58170,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1021/jm501915g
CHEMBL1683934,58170,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1021/jm501915g
118737349,118442,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,739,13,6,9,6.4,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1Cl,10.1021/jm501915g
CHEMBL3426692,118442,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,739,13,6,9,6.4,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1Cl,10.1021/jm501915g
9871386,111683,3,None,8,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3290999,111683,3,None,8,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
24901349,69913,0,None,56,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1944692,69913,0,None,56,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,10.1016/j.bmcl.2011.10.049
57398562,69943,0,None,112,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,477,11,5,6,4.1,CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,10.1016/j.bmcl.2011.10.049
CHEMBL1945036,69943,0,None,112,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,477,11,5,6,4.1,CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,10.1016/j.bmcl.2011.10.049
24900942,69972,0,None,31,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945299,69972,0,None,31,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.5,COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
10184665,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm401532g
4799,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm401532g
7353,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm401532g
CHEMBL1198857,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm401532g
DB09082,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm401532g
10184665,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1016/j.bmc.2011.08.043
4799,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1016/j.bmc.2011.08.043
7353,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1016/j.bmc.2011.08.043
CHEMBL1198857,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1016/j.bmc.2011.08.043
DB09082,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1016/j.bmc.2011.08.043
9871386,111683,3,None,8,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290999,111683,3,None,8,4,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,521,10,5,6,5.5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
10184665,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm100326d
4799,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm100326d
7353,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm100326d
CHEMBL1198857,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm100326d
DB09082,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,10.1021/jm100326d
46832798,14057,0,None,19,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O,10.1021/jm100326d
CHEMBL1084648,14057,0,None,19,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O,10.1021/jm100326d
CHEMBL1198879,14057,0,None,19,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,485,16,4,6,4.6,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O,10.1021/jm100326d
10225563,14063,0,None,12,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,445,16,4,6,3.9,Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1084891,14063,0,None,12,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,445,16,4,6,3.9,Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1198889,14063,0,None,12,3,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,445,16,4,6,3.9,Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
22712045,69800,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,423,11,5,6,2.9,OCc1cc(C(O)CNCCc2ccc(OCC(O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940816,69800,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,423,11,5,6,2.9,OCc1cc(C(O)CNCCc2ccc(OCC(O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
12093446,69818,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,5,5,4.6,Nc1c(Cl)cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)cc1Cl,10.1016/j.bmcl.2011.11.072
CHEMBL1940834,69818,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,5,5,4.6,Nc1c(Cl)cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)cc1Cl,10.1016/j.bmcl.2011.11.072
1239,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.10.013
3410,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.10.013
3465,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.10.013
CHEMBL1256786,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.10.013
DB00983,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.10.013
45483816,192814,0,None,12,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.10.013
CHEMBL567833,192814,0,None,12,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.10.013
45483864,194585,0,None,9,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL584498,194585,0,None,9,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
53379897,63250,0,None,151,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL1800961,63250,0,None,151,2,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
1239,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.06.104
3410,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.06.104
3465,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.06.104
CHEMBL1256786,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.06.104
DB00983,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.06.104
1239,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.12.087
3410,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.12.087
3465,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.12.087
CHEMBL1256786,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.12.087
DB00983,1626,45,None,-1,5,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2009.12.087
156009486,177536,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4632876,177536,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4650738,177536,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
45483852,192436,0,None,14,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,392,6,4,5,2.6,CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL565267,192436,0,None,14,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,392,6,4,5,2.6,CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
45484568,194027,0,None,10,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,541,13,6,8,1.8,CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.06.104
CHEMBL576428,194027,0,None,10,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,541,13,6,8,1.8,CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.06.104
2419,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
5152,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
559,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
CHEMBL1263,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
DB00938,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.11.072
9892481,69816,8,None,-3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940832,69816,8,None,-3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
1239,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.05.064
3410,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.05.064
3465,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.05.064
CHEMBL1256786,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.05.064
DB00983,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.05.064
1239,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.04.135
3410,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.04.135
3465,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.04.135
CHEMBL1256786,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.04.135
DB00983,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.04.135
19082200,109640,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,443,12,3,7,2.9,CN(CCNCCc1ccc(O)c2nc(O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL323776,109640,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,443,12,3,7,2.9,CN(CCNCCc1ccc(O)c2nc(O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
16049377,63701,0,None,112,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,465,13,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807832,63701,0,None,112,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,465,13,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
10484922,118439,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.8,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
CHEMBL3426689,118439,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.8,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
10327461,118440,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,709,12,6,8,6.4,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c(Cl)c1,10.1021/jm501915g
CHEMBL3426690,118440,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,709,12,6,8,6.4,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c(Cl)c1,10.1021/jm501915g
10439505,118449,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,675,12,6,8,5.2,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCNC(=O)c2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)CC1,10.1021/jm501915g
CHEMBL3426699,118449,0,None,-,1,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,675,12,6,8,5.2,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCNC(=O)c2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)CC1,10.1021/jm501915g
155515718,169246,0,None,2884,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.bmc.2018.10.043
CHEMBL4441752,169246,0,None,2884,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.bmc.2018.10.043
155551006,173223,0,None,44,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
CHEMBL4541169,173223,0,None,44,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
90645345,111891,0,None,11,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,574,12,6,8,4.7,CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298692,111891,0,None,11,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,574,12,6,8,4.7,CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
90645346,111907,0,None,2,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,578,13,6,7,4.7,O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298762,111907,0,None,2,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,578,13,6,7,4.7,O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1,10.1016/j.bmcl.2014.04.095
2419,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
5152,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
559,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
CHEMBL1263,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
DB00938,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.095
9892481,69816,8,None,-3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.095
CHEMBL1940832,69816,8,None,-3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,435,12,6,6,3,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.095
10239722,111870,0,None,11,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298326,111870,0,None,11,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1,10.1016/j.bmcl.2014.04.095
66796015,111872,0,None,35,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,474,11,6,7,3.2,NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298328,111872,0,None,35,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,474,11,6,7,3.2,NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
24900685,69940,0,None,-3,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,11,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945033,69940,0,None,-3,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,11,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
24900426,69944,0,None,31,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,477,12,5,6,3.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945037,69944,0,None,31,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,477,12,5,6,3.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1,10.1016/j.bmcl.2011.10.049
24901141,70121,0,None,39,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,531,11,5,6,4.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1947157,70121,0,None,39,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,531,11,5,6,4.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
3083544,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm401532g
4943,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm401532g
7479,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm401532g
CHEMBL1363,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm401532g
DB01274,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm401532g
10482960,105813,0,None,316,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.1,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1,10.1021/jm401532g
CHEMBL3126383,105813,0,None,316,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.1,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1,10.1021/jm401532g
CHEMBL3139365,105813,0,None,316,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.1,Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1,10.1021/jm401532g
3083544,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.08.043
4943,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.08.043
7479,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.08.043
CHEMBL1363,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.08.043
DB01274,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1016/j.bmc.2011.08.043
56658405,66184,0,None,25,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.08.043
CHEMBL1835856,66184,0,None,25,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.08.043
CHEMBL1852565,66184,0,None,25,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.08.043
56658407,66234,0,None,15,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,18,6,6,3.3,NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835857,66234,0,None,15,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,18,6,6,3.3,NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852796,66234,0,None,15,3,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,487,18,6,6,3.3,NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
2419,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
5152,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
559,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
CHEMBL1263,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
DB00938,3377,76,None,17,6,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2014.04.069
1239,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm801016j
3410,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm801016j
3465,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm801016j
CHEMBL1256786,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm801016j
DB00983,1626,45,None,-1,5,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm801016j
42625513,12422,0,None,3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm801016j
CHEMBL1186722,12422,0,None,3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm801016j
CHEMBL475389,12422,0,None,3,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm801016j
42625517,12582,0,None,19,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,536,19,5,7,3.8,CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1187654,12582,0,None,19,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,536,19,5,7,3.8,CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL514032,12582,0,None,19,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,536,19,5,7,3.8,CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
3083544,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm100326d
4943,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm100326d
7479,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm100326d
CHEMBL1363,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm100326d
DB01274,462,43,None,1,4,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/jm100326d
10128077,111681,0,None,1,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290997,111681,0,None,1,2,Human,9.3,pEC50,=,9.3,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
45483843,192714,0,None,9,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,384,7,4,5,2.9,CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.10.013
CHEMBL567192,192714,0,None,9,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,384,7,4,5,2.9,CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.10.013
45483868,192900,0,None,6,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL568273,192900,0,None,6,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
156010782,177544,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4632435,177544,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4650800,177544,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,446,8,4,5,4.3,CC(C)(CC(c1ccccc1)c1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
56678847,65974,0,None,99,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
CHEMBL1814274,65974,0,None,99,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
CHEMBL1851691,65974,0,None,99,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
9871096,66246,0,None,1,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814268,66246,0,None,1,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1852860,66246,0,None,1,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
16049234,63697,0,None,177,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807828,63697,0,None,177,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1,10.1016/j.bmcl.2011.05.097
56673674,63700,0,None,1258,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,513,13,5,8,2.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807831,63700,0,None,1258,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,513,13,5,8,2.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
183812,201378,17,None,15,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.05.097
CHEMBL82663,201378,17,None,15,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.05.097
56943517,111916,0,None,3,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,621,13,5,9,2.8,CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1,10.1016/j.bmcl.2014.04.095
CHEMBL3298832,111916,0,None,3,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorexpressedincellsbycAMPaccumulationassay,ChEMBL,621,13,5,9,2.8,CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1,10.1016/j.bmcl.2014.04.095
56943518,111873,0,None,25,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,488,12,6,7,3.6,NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298329,111873,0,None,25,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,488,12,6,7,3.6,NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
56943545,111874,0,None,28,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,502,13,6,7,4,NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298330,111874,0,None,28,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,502,13,6,7,4,NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
56943546,111890,0,None,25,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,518,14,6,8,3.2,NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298691,111890,0,None,25,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,518,14,6,8,3.2,NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
90645347,111925,0,None,7,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,578,12,6,7,5.6,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298987,111925,0,None,7,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,578,12,6,7,5.6,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.095
24900689,69946,0,None,-3,5,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945039,69946,0,None,-3,5,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
24900813,69949,0,None,7,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,467,10,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945042,69949,0,None,7,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,467,10,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
24900812,69950,0,None,25,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,450,10,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945043,69950,0,None,25,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,450,10,5,7,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
24900937,69967,0,None,199,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,413,8,4,6,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945294,69967,0,None,199,4,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,413,8,4,6,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1,10.1016/j.bmcl.2011.10.049
24900424,70120,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,525,11,5,6,5.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(-c4cccc(CNCc5ccccc5)c4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1947156,70120,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,525,11,5,6,5.1,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(-c4cccc(CNCc5ccccc5)c4)c3)c2s1,10.1016/j.bmcl.2011.10.049
183812,201378,17,None,15,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.10.049
CHEMBL82663,201378,17,None,15,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.10.049
56672269,66183,0,None,50,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,515,19,6,6,3.9,CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835858,66183,0,None,50,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,515,19,6,6,3.9,CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852564,66183,0,None,50,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,515,19,6,6,3.9,CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
42625515,12591,0,None,794,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,508,18,5,7,3,CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1187711,12591,0,None,794,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,508,18,5,7,3,CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL516056,12591,0,None,794,3,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,508,18,5,7,3,CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
10077662,89721,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,623,14,5,8,5.1,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2n1Cc1ccccc1,10.1016/j.bmcl.2007.09.031
CHEMBL238347,89721,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,623,14,5,8,5.1,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2n1Cc1ccccc1,10.1016/j.bmcl.2007.09.031
156015718,177529,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4648695,177529,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
CHEMBL4650694,177529,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1cccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmc.2019.115178
45483814,192950,0,None,5,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,440,7,4,6,3.3,CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL568531,192950,0,None,5,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,440,7,4,6,3.3,CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
1499,2038,40,None,-72,36,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.7b00762
3779,2038,40,None,-72,36,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.7b00762
536,2038,40,None,-72,36,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.7b00762
CHEMBL434,2038,40,None,-72,36,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.7b00762
DB01064,2038,40,None,-72,36,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.7b00762
46232769,196510,0,None,6,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL601036,196510,0,None,6,2,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
44434116,165896,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,547,12,5,8,3.6,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2n1C,10.1016/j.bmcl.2007.09.031
CHEMBL428027,165896,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,547,12,5,8,3.6,COc1cccc(OC)c1CNC(=O)c1cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc2n1C,10.1016/j.bmcl.2007.09.031
2419,3377,76,None,17,6,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/acs.jmedchem.0c01195
5152,3377,76,None,17,6,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/acs.jmedchem.0c01195
559,3377,76,None,17,6,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/acs.jmedchem.0c01195
CHEMBL1263,3377,76,None,17,6,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/acs.jmedchem.0c01195
DB00938,3377,76,None,17,6,Human,9.2,pEC50,=,9.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1021/acs.jmedchem.0c01195
156014816,177577,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,360,7,4,5,2.1,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4645932,177577,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,360,7,4,5,2.1,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4650992,177577,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,360,7,4,5,2.1,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
63952,8474,36,None,-2,2,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,368,7,4,5,2.5,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm100068m
86306667,8474,36,None,-2,2,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,368,7,4,5,2.5,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm100068m
CHEMBL1094785,8474,36,None,-2,2,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,368,7,4,5,2.5,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1021/jm100068m
4183,1972,58,None,1,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/acs.jmedchem.0c01195
6918554,1972,58,None,1,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/acs.jmedchem.0c01195
7455,1972,58,None,1,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/acs.jmedchem.0c01195
CHEMBL1095777,1972,58,None,1,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/acs.jmedchem.0c01195
DB05039,1972,58,None,1,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/acs.jmedchem.0c01195
56658246,64100,0,None,-3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814277,64100,0,None,-3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814278,64100,0,None,-3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
53357712,66003,0,None,79,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,5,7,3.9,CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1814271,66003,0,None,79,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,5,7,3.9,CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1851848,66003,0,None,79,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,5,7,3.9,CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
56678849,66222,0,None,31,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,18,5,8,2.7,O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1814275,66222,0,None,31,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,18,5,8,2.7,O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
CHEMBL1852744,66222,0,None,31,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,18,5,8,2.7,O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O,10.1016/j.bmc.2011.05.064
2419,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.04.135
5152,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.04.135
559,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.04.135
CHEMBL1263,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.04.135
DB00938,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.04.135
16049289,63169,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,501,15,4,7,3.2,CCCCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800660,63169,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,501,15,4,7,3.2,CCCCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
2419,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.05.097
5152,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.05.097
559,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.05.097
CHEMBL1263,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.05.097
DB00938,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.05.097
16049090,63692,0,None,316,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,447,13,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807823,63692,0,None,316,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,447,13,5,7,2.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1,10.1016/j.bmcl.2011.05.097
56673609,63706,0,None,112,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,499,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807873,63706,0,None,112,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,499,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
319,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
321,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
444031,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
784,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
CHEMBL1346,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
DB00496,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1021/jm501915g
118737356,118453,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,753,13,5,9,6.5,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426703,118453,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,753,13,5,9,6.5,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
118737360,118458,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,14,6,9,5.8,COc1ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426708,118458,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,14,6,9,5.8,COc1ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
90645344,111868,0,None,7,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN,10.1016/j.bmcl.2014.04.095
CHEMBL3298324,111868,0,None,7,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,550,11,6,7,5,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN,10.1016/j.bmcl.2014.04.095
2419,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.10.049
5152,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.10.049
559,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.10.049
CHEMBL1263,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.10.049
DB00938,3377,76,None,17,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,10.1016/j.bmcl.2011.10.049
24900750,69962,0,None,5,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1,10.1016/j.bmcl.2011.10.049
CHEMBL1945289,69962,0,None,5,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1,10.1016/j.bmcl.2011.10.049
24901285,69970,0,None,25,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,545,11,5,6,5.2,CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12,10.1016/j.bmcl.2011.10.049
CHEMBL1945297,69970,0,None,25,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,545,11,5,6,5.2,CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12,10.1016/j.bmcl.2011.10.049
156015629,177526,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4648440,177526,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
CHEMBL4650679,177526,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,482,8,4,5,4.6,CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmc.2019.115178
10238776,66072,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,473,17,6,6,3.6,NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835853,66072,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,473,17,6,6,3.6,NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852214,66072,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,473,17,6,6,3.6,NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
10217757,111682,0,None,10,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,497,12,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290998,111682,0,None,10,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,497,12,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
42625511,12598,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm801016j
CHEMBL1187778,12598,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm801016j
CHEMBL520313,12598,0,None,3,4,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm801016j
10203169,14093,0,None,25,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,433,16,5,7,3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O,10.1021/jm100326d
CHEMBL1086536,14093,0,None,25,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,433,16,5,7,3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O,10.1021/jm100326d
CHEMBL1199300,14093,0,None,25,3,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,433,16,5,7,3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O,10.1021/jm100326d
319,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
321,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
444031,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
784,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
CHEMBL1346,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
DB00496,1288,35,None,-2,6,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.01.043
1499,2038,40,None,-72,36,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassayAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2009.06.083
3779,2038,40,None,-72,36,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassayAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2009.06.083
536,2038,40,None,-72,36,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassayAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2009.06.083
CHEMBL434,2038,40,None,-72,36,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassayAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2009.06.083
DB01064,2038,40,None,-72,36,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassayAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasstimulationofcAMPlevelafter1hrbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2009.06.083
156014807,177503,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(O)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4643561,177503,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(O)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4650530,177503,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,5,6,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCCc2ccc(O)cc2)N1,10.1016/j.bmc.2019.115178
45484536,192892,0,None,5,2,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,527,13,7,8,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL568239,192892,0,None,5,2,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,527,13,7,8,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL1683942,58177,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,722,17,5,10,5.3,C[N+]1(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)[C@@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@H]12,10.1016/j.bmcl.2011.01.043
155541614,172315,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,437,10,5,5,3.5,CC(C)CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
CHEMBL4518961,172315,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,437,10,5,5,3.5,CC(C)CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.bmc.2018.10.043
156010796,177575,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4632700,177575,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4650979,177575,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,372,8,4,6,2,COc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
11091850,46924,0,None,25,3,Human,9,pEC50,=,9,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,465,11,4,4,4.6,Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
CHEMBL154370,46924,0,None,25,3,Human,9,pEC50,=,9,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,465,11,4,4,4.6,Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
53357711,64101,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,531,19,7,7,3.3,O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814279,64101,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,531,19,7,7,3.3,O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814280,64101,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,531,19,7,7,3.3,O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
56673241,63164,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,457,13,3,6,2.9,CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800656,63164,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,457,13,3,6,2.9,CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
1239,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.05.097
3410,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.05.097
3465,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.05.097
CHEMBL1256786,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.05.097
DB00983,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.05.097
16049450,63696,0,None,125,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807827,63696,0,None,125,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
11169365,111924,0,None,22,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,502,11,6,7,4,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298986,111924,0,None,22,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,502,11,6,7,4,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
45484585,13954,0,None,3,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL1197807,13954,0,None,3,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL587197,13954,0,None,3,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
45101519,194200,0,None,1,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,498,11,8,7,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL577917,194200,0,None,1,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,498,11,8,7,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
1239,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.10.049
3410,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.10.049
3465,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.10.049
CHEMBL1256786,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.10.049
DB00983,1626,45,None,-1,5,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2011.10.049
24900872,69945,0,None,89,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,478,12,5,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945038,69945,0,None,89,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,478,12,5,7,3.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1,10.1016/j.bmcl.2011.10.049
57391554,69951,0,None,25,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945044,69951,0,None,25,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1,10.1016/j.bmcl.2011.10.049
24901140,70117,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,503,9,4,6,4.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCC(c5ccccc5)CC4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1947153,70117,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,503,9,4,6,4.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCC(c5ccccc5)CC4)c3)c2s1,10.1016/j.bmcl.2011.10.049
10053159,105704,0,None,398,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,545,18,4,7,4.6,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1,10.1021/jm401532g
CHEMBL3124955,105704,0,None,398,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,545,18,4,7,4.6,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1,10.1021/jm401532g
CHEMBL3139033,105704,0,None,398,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,545,18,4,7,4.6,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1,10.1021/jm401532g
56665368,66055,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835854,66055,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852119,66055,0,None,1,4,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,501,18,6,6,4.2,CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.08.043
56678973,66175,0,None,2,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,555,18,6,6,5.6,O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1,10.1016/j.bmc.2011.08.043
CHEMBL1835855,66175,0,None,2,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,555,18,6,6,5.6,O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1,10.1016/j.bmc.2011.08.043
CHEMBL1852541,66175,0,None,2,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,555,18,6,6,5.6,O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1,10.1016/j.bmc.2011.08.043
56675663,66185,0,None,25,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,6,6,4.6,NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1,10.1016/j.bmc.2011.08.043
CHEMBL1835861,66185,0,None,25,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,6,6,4.6,NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1,10.1016/j.bmc.2011.08.043
CHEMBL1852575,66185,0,None,25,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,541,17,6,6,4.6,NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1,10.1016/j.bmc.2011.08.043
42625821,12407,0,None,630,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,522,18,4,7,3.4,CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1186678,12407,0,None,630,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,522,18,4,7,3.4,CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL474393,12407,0,None,630,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,522,18,4,7,3.4,CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
42625587,12561,0,None,125,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,562,18,4,7,4.3,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1,10.1021/jm801016j
CHEMBL1187520,12561,0,None,125,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,562,18,4,7,4.3,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1,10.1021/jm801016j
CHEMBL506518,12561,0,None,125,3,Human,9,pEC50,=,9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,562,18,4,7,4.3,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1,10.1021/jm801016j
9958539,102537,0,None,5,3,Human,9,pEC50,=,9,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,527,3,2,5,3.4,COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I,10.1016/s0960-894x(00)00459-5
CHEMBL307647,102537,0,None,5,3,Human,9,pEC50,=,9,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,527,3,2,5,3.4,COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I,10.1016/s0960-894x(00)00459-5
87142783,118454,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",719,13,5,9,5.8,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3426704,118454,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",719,13,5,9,5.8,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548101,123757,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3639442,123757,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548063,124558,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,16,6,9,6.3,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645274,124558,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,16,6,9,6.3,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548134,124559,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",804,17,6,10,6,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645275,124559,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",804,17,6,10,6,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
66791483,124561,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,16,6,9,6.6,Cc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645277,124561,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,16,6,9,6.6,Cc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548074,124562,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",838,17,6,10,6.7,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645278,124562,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",838,17,6,10,6.7,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548094,124564,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,17,6,9,6.4,CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645280,124564,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,17,6,9,6.4,CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548099,124565,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645281,124565,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
68057677,124566,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645282,124566,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548122,124567,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,17,6,9,6.7,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645283,124567,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,17,6,9,6.7,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548079,124568,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",818,18,6,10,6.4,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645284,124568,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",818,18,6,10,6.4,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548056,124569,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",818,18,6,10,6.4,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645285,124569,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",818,18,6,10,6.4,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548067,124570,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",852,18,6,10,7.1,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645286,124570,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",852,18,6,10,7.1,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548141,124571,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,18,6,9,6.4,CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645287,124571,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,18,6,9,6.4,CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548102,124572,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,18,6,9,6.4,CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645288,124572,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",802,18,6,9,6.4,CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
68057804,124573,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645289,124573,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548054,124574,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645290,124574,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548125,124575,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645291,124575,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",830,19,6,9,6.2,C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548051,124576,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,14,6,9,7.4,Cc1ccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645292,124576,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,14,6,9,7.4,Cc1ccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548107,124577,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,14,6,9,7.4,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
CHEMBL3645293,124577,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,14,6,9,7.4,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
59548124,124578,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,14,6,9,7.7,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1ccc(C)c(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
CHEMBL3645294,124578,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,14,6,9,7.7,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1ccc(C)c(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
59548081,124579,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",838,15,6,10,7.1,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
CHEMBL3645295,124579,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",838,15,6,10,7.1,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1,nan
59548120,124580,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,14,6,9,7.7,Cc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645296,124580,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,14,6,9,7.7,Cc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548093,124582,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,15,6,9,7.1,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1,nan
CHEMBL3645298,124582,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",822,15,6,9,7.1,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1,nan
59548119,124583,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.4,Cc1ccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645299,124583,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.4,Cc1ccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548129,124586,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,CC(Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645301,124586,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,CC(Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
70843902,124587,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,15,6,9,7.8,Cc1ccc(C(=O)Nc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645302,124587,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,15,6,9,7.8,Cc1ccc(C(=O)Nc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548098,124588,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645303,124588,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548123,124589,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645304,124589,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548138,124590,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,CC(Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645305,124590,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,CC(Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548095,124592,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645307,124592,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548130,124593,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645308,124593,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.5,C[C@@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548100,124594,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,CC(Cc1cccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645309,124594,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,CC(Cc1cccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548136,124595,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,16,6,9,7.5,Cc1ccc(C(=O)NCc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645310,124595,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,16,6,9,7.5,Cc1ccc(C(=O)NCc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
66791606,124596,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645311,124596,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
70843738,124598,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645313,124598,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
70843742,124599,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645314,124599,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
70843734,124601,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645316,124601,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.2,C[C@@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548091,124602,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.4,CC(Cc1cccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645317,124602,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.4,CC(Cc1cccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548132,124606,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645320,124606,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548118,124607,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645321,124607,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548139,124609,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645323,124609,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.2,C[C@@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548061,124612,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",886,16,6,10,7.6,COc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645326,124612,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",886,16,6,10,7.6,COc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548066,124613,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,16,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1,nan
CHEMBL3645327,124613,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,16,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1,nan
59548076,124614,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,16,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1,nan
CHEMBL3645328,124614,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,16,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1,nan
59548128,124615,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,nan
CHEMBL3645329,124615,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,nan
59548117,124616,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
CHEMBL3645330,124616,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
59548058,124617,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645331,124617,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548121,124618,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645332,124618,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548110,124619,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645333,124619,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548080,124620,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,17,6,9,7.4,Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645334,124620,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,17,6,9,7.4,Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548135,124621,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,17,6,9,7.4,Cc1c(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cccc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645335,124621,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,17,6,9,7.4,Cc1c(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cccc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548052,124623,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1cc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645337,124623,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1cc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548059,124627,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
CHEMBL3645340,124627,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,17,6,9,6.7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
59548142,124628,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645341,124628,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548084,124629,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645342,124629,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548083,124630,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645343,124630,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,C[C@@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548114,124631,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645344,124631,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",864,17,6,9,7.1,CC(Cc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548140,124632,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645345,124632,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548050,124633,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645346,124633,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548069,124635,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1cc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645348,124635,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1cc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548085,124636,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645349,124636,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548115,124637,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645350,124637,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548103,124638,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,CC(Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645351,124638,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,CC(Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548057,124639,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645352,124639,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548078,124640,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.5,CC(Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645353,124640,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.5,CC(Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548082,124641,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.5,C[C@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645354,124641,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.5,C[C@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548090,124643,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1CC(=O)NCc1ccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1,nan
CHEMBL3645356,124643,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",894,18,6,10,7.1,COc1ccc(CC(C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1CC(=O)NCc1ccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1,nan
59548137,124644,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1ccc(F)c(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645357,124644,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",882,17,6,9,7.2,CC(Cc1ccc(F)c(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548068,124646,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,17,6,9,6,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645359,124646,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,17,6,9,6,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548105,124648,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.4,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645361,124648,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",836,15,6,9,7.4,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
56953428,124650,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,17,6,9,6.4,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645363,124650,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",788,17,6,9,6.4,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
49785227,124652,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645365,124652,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",878,18,6,9,7.1,C[C@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
49785225,127822,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,17,6,9,7,Cc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3666068,127822,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,17,6,9,7,Cc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
49785142,142607,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,C[C@@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3896828,142607,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",816,18,6,9,5.8,C[C@@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
118405092,149583,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",848,15,5,8,8.9,Cc1ccc(C(=O)Nc2ccc(CC(C)NC[C@H](C)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3952427,149583,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",848,15,5,8,8.9,Cc1ccc(C(=O)Nc2ccc(CC(C)NC[C@H](C)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
118405970,151135,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",848,17,5,8,7.6,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NCCc1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3965175,151135,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",848,17,5,8,7.6,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NCCc1ccc(O)c2[nH]c(=O)ccc12,nan
118405900,152998,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",852,15,6,10,7.4,COc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3981221,152998,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",852,15,6,10,7.4,COc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
118405964,160085,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.3,C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)c1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1,nan
CHEMBL4114219,160085,0,None,-,1,Human,9,pEC50,=,9,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)","orCHO-K1celllinesstablyexpressingclonedhumanβ3adrenergicreceptorsweregrowntonearconfluencyinHamsF-12mediasupplementedwith10%FBSandGeneticin(250μg/mL).CellswererinsedwithPBSanddetachedindPBS(Dulbecco'sPhosphateBufferedSaline,withoutCaCl2andMgCl2)containing2mMEDTAorTrypsin-EDTAsolution(0.05%trypsin/0.53mMEDTA).AftercountingcellsinCoultercellcounter,cellswerepelletedbycentrifugationat1,000rpmandre-suspendedinstimulationbuffercontainingTBMX(PerkinElmerKit)pre-warmedtoroomtemperaturetoaconcentrationof1.6×106to2.8×106cells/mL.About40,000to80,000cellsperwellwereusedinthisassay.Testcompounds(10mMinDMSO)weredilutedintoPBScontaining0.1%BSAinBeckmanBiomek-2000andtestedat11differentconcentrationsrangingfrom100μMto1pM.Reactionswereincubatedfor10minat37°C.andstoppedbyadding100μLofcolddetectionbuffercontaining[125I]-cAMP(NENSMP004,PerkinElmerLifeSciences,Boston,Mass.).cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",850,16,6,9,7.3,C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)c1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1,nan
11214499,85500,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,516,11,5,5,4.3,C[C@H](Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2010.10.132
CHEMBL230490,85500,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,516,11,5,5,4.3,C[C@H](Cc1cccc(CC(=O)NCc2ccc(Cl)c(Cl)c2)c1)NC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2010.10.132
45484583,194169,0,None,3,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,456,10,6,7,2,CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL577702,194169,0,None,3,2,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,456,10,6,7,2,CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
10438748,58168,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,612,14,5,7,6.2,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683932,58168,0,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,612,14,5,7,6.2,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
10326800,58173,2,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683938,58173,2,None,-,1,Human,9,pEC50,=,9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
1499,2038,40,None,-72,36,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.9b00418
3779,2038,40,None,-72,36,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.9b00418
536,2038,40,None,-72,36,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.9b00418
CHEMBL434,2038,40,None,-72,36,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.9b00418
DB01064,2038,40,None,-72,36,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOK1cellsco-expressingGalpha15assessedasincreaseincalciuminfluxbymeasuringfluorescenceintensitybyFLIPRassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/acs.jnatprod.9b00418
45484569,193311,0,None,4,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,596,13,6,9,1.5,CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1,10.1016/j.bmcl.2009.06.104
CHEMBL570834,193311,0,None,4,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,596,13,6,9,1.5,CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1,10.1016/j.bmcl.2009.06.104
45101520,194460,0,None,3,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,513,12,7,8,1.2,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL583235,194460,0,None,3,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,513,12,7,8,1.2,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
44396736,66463,0,None,-11,3,Human,8.9,pEC50,=,8.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,617,12,4,9,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL186271,66463,0,None,-11,3,Human,8.9,pEC50,=,8.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,617,12,4,9,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
10180590,69814,0,None,707,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940830,69814,0,None,707,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
57398384,69817,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,6,6,3.2,O=c1ccc2c([C@@H](O)CNCCc3ccc(NC[C@H](O)c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.11.072
CHEMBL1940833,69817,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,459,10,6,6,3.2,O=c1ccc2c([C@@H](O)CNCCc3ccc(NC[C@H](O)c4ccccc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.11.072
9893058,65979,0,None,39,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1,10.1016/j.bmc.2011.05.064
CHEMBL1814267,65979,0,None,39,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1,10.1016/j.bmc.2011.05.064
CHEMBL1851721,65979,0,None,39,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,525,17,5,8,2.9,O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1,10.1016/j.bmc.2011.05.064
56675511,66005,0,None,31,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814273,66005,0,None,31,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
CHEMBL1851850,66005,0,None,31,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,527,18,5,7,3.2,O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1016/j.bmc.2011.05.064
16049374,63702,0,None,89,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807869,63702,0,None,89,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,481,13,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
118737359,118457,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,14,6,9,5.8,COc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
CHEMBL3426707,118457,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,14,6,9,5.8,COc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
24901284,69969,0,None,2,4,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,545,12,5,6,5.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945296,69969,0,None,2,4,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,545,12,5,6,5.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,10.1016/j.bmcl.2011.10.049
42625897,12340,0,None,501,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,564,18,4,8,3.1,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1,10.1021/jm801016j
CHEMBL1186265,12340,0,None,501,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,564,18,4,8,3.1,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1,10.1021/jm801016j
CHEMBL456485,12340,0,None,501,3,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,564,18,4,8,3.1,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1,10.1021/jm801016j
10311070,111672,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290989,111672,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
10310047,111675,0,None,158,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,422,11,5,6,3.9,CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290991,111675,0,None,158,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,422,11,5,6,3.9,CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
145989945,166090,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c([C@@H](CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4284146,166090,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c([C@@H](CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
1239,1626,45,None,-1,5,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm100068m
3410,1626,45,None,-1,5,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm100068m
3465,1626,45,None,-1,5,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm100068m
CHEMBL1256786,1626,45,None,-1,5,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm100068m
DB00983,1626,45,None,-1,5,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/jm100068m
53318455,58167,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,556,10,5,7,4.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683931,58167,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,556,10,5,7,4.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
11703823,196824,0,None,131,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,390,6,4,5,3,CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL603274,196824,0,None,131,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,390,6,4,5,3,CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
44396715,67040,0,None,-20,3,Human,8.9,pEC50,=,8.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,612,12,4,9,4.4,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL189081,67040,0,None,-20,3,Human,8.9,pEC50,=,8.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,612,12,4,9,4.4,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
156015726,177550,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,410,7,4,5,3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(C(F)(F)F)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4647449,177550,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,410,7,4,5,3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(C(F)(F)F)c2)N1,10.1016/j.bmc.2019.115178
CHEMBL4650846,177550,0,None,-,1,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,410,7,4,5,3,O=C1COc2c(cc(O)cc2C(O)CNCCCc2cccc(C(F)(F)F)c2)N1,10.1016/j.bmc.2019.115178
46232973,196458,0,None,19,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL600617,196458,0,None,19,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
9800339,196822,6,None,251,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
CHEMBL603271,196822,6,None,251,2,Human,8.9,pEC50,=,8.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
4183,1972,58,None,1,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2014.06.014
6918554,1972,58,None,1,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2014.06.014
7455,1972,58,None,1,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2014.06.014
CHEMBL1095777,1972,58,None,1,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2014.06.014
DB05039,1972,58,None,1,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevelAgonistactivityatadrenergicbeta2receptorinhumanA431cellsassessedaselevationofcAMPlevel,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2014.06.014
45483844,194073,0,None,4,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,398,7,4,5,3.5,CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.10.013
CHEMBL576848,194073,0,None,4,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,398,7,4,5,3.5,CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.10.013
44392566,64431,0,None,11,2,Human,8.8,pEC50,=,8.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,457,11,4,6,3.7,C=C(C)CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL181964,64431,0,None,11,2,Human,8.8,pEC50,=,8.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,457,11,4,6,3.7,C=C(C)CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
2233849,33096,8,None,-,1,Human,8.8,pEC50,=,8.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,446,10,1,7,4.1,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Cl)cc1,nan
CHEMBL1419122,33096,8,None,-,1,Human,8.8,pEC50,=,8.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,446,10,1,7,4.1,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Cl)cc1,nan
44339091,9328,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,429,12,4,7,2.6,O=C(CCOCCc1ccccc1)NCCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.04.135
CHEMBL111775,9328,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,429,12,4,7,2.6,O=C(CCOCCc1ccccc1)NCCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2011.04.135
53307432,63167,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,485,15,3,6,3.7,CCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800659,63167,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,485,15,3,6,3.7,CCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
16049448,63698,0,None,56,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,4.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807829,63698,0,None,56,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,4.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
16049376,63704,0,None,44,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,4.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807871,63704,0,None,44,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,4.2,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1,10.1016/j.bmcl.2011.05.097
53307432,63167,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,485,15,3,6,3.7,CCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL1800659,63167,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,485,15,3,6,3.7,CCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
118737353,118450,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.2,COc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426700,118450,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,705,13,6,9,5.2,COc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
145989075,166393,0,None,524,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,324,6,4,4,2.1,O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4289813,166393,0,None,524,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,324,6,4,4,2.1,O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
90645346,111907,0,None,2,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,578,13,6,7,4.7,O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298762,111907,0,None,2,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,578,13,6,7,4.7,O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1,10.1016/j.bmcl.2014.04.095
11180293,111920,0,None,22,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,543,12,6,8,3.1,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
CHEMBL3298897,111920,0,None,22,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,543,12,6,8,3.1,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
24901416,69942,0,None,-2,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945035,69942,0,None,-2,4,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,481,11,5,6,3.6,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1,10.1016/j.bmcl.2011.10.049
10370605,105857,0,None,158,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.2,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1,10.1021/jm401532g
CHEMBL3126385,105857,0,None,158,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.2,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1,10.1021/jm401532g
CHEMBL3139615,105857,0,None,158,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,561,18,4,7,5.2,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1,10.1021/jm401532g
42625588,179684,0,None,630,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,508,18,5,7,2.9,NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL475237,179684,0,None,630,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,508,18,5,7,2.9,NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
46833102,14060,0,None,31,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,496,17,5,8,1.9,NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1084656,14060,0,None,31,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,496,17,5,8,1.9,NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1198882,14060,0,None,31,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,496,17,5,8,1.9,NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
46832507,14068,0,None,12,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,475,17,6,7,2.8,NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1085638,14068,0,None,12,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,475,17,6,7,2.8,NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
CHEMBL1198915,14068,0,None,12,3,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,475,17,6,7,2.8,NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm100326d
57400045,69804,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,456,11,6,6,3.5,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(Cl)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940820,69804,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,456,11,6,6,3.5,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(Cl)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
149373618,177522,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,4,6,1.6,COc1ccc(CCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4642893,177522,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,4,6,1.6,COc1ccc(CCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4650643,177522,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,358,7,4,6,1.6,COc1ccc(CCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
73056754,103705,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,331,8,4,5,2.8,CC[C@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
CHEMBL3099659,103705,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,331,8,4,5,2.8,CC[C@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
45483847,192491,0,None,2,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,432,7,4,5,4,CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL565686,192491,0,None,2,2,Human,8.8,pEC50,=,8.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,432,7,4,5,4,CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
45101522,194693,0,None,5,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,578,15,7,9,2,CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL585751,194693,0,None,5,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,578,15,7,9,2,CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
11962616,219,5,None,40,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxationAgonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxation,ChEMBL,460,13,4,5,4.2,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O,10.1021/acs.jmedchem.0c01195
9326,219,5,None,40,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxationAgonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxation,ChEMBL,460,13,4,5,4.2,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O,10.1021/acs.jmedchem.0c01195
CHEMBL3039530,219,5,None,40,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxationAgonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxation,ChEMBL,460,13,4,5,4.2,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O,10.1021/acs.jmedchem.0c01195
DB12100,219,5,None,40,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxationAgonistactivityatbeta2adrenoceptorhumanbronchiassessedasinductionofmaximumrelaxation,ChEMBL,460,13,4,5,4.2,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O,10.1021/acs.jmedchem.0c01195
56678845,66002,0,None,15,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.05.064
CHEMBL1814269,66002,0,None,15,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.05.064
CHEMBL1851839,66002,0,None,15,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmc.2011.05.064
145981405,165799,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3ccccc3Cl)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4278577,165799,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3ccccc3Cl)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
145987168,166516,0,None,316,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2018.04.041
CHEMBL4291941,166516,0,None,316,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1,10.1016/j.ejmech.2018.04.041
10173878,111871,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,459,10,5,6,4.2,CCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298327,111871,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,459,10,5,6,4.2,CCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
24901283,69965,0,None,-2,5,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,417,11,5,7,1.9,COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945292,69965,0,None,-2,5,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,417,11,5,7,1.9,COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
10076176,105859,0,None,50,5,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1,10.1021/jm401532g
CHEMBL3126382,105859,0,None,50,5,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1,10.1021/jm401532g
CHEMBL3139683,105859,0,None,50,5,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1,10.1021/jm401532g
46832804,6881,0,None,50,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,496,17,5,8,1.9,NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm100326d
CHEMBL1084655,6881,0,None,50,3,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,496,17,5,8,1.9,NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm100326d
10310564,111671,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,454,10,5,5,5.2,OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290988,111671,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,454,10,5,5,5.2,OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
57396615,69802,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,436,11,5,6,2.9,CN(CC(O)c1ccccc1)c1ccc(CCNCC(O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmcl.2011.11.072
CHEMBL1940818,69802,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,436,11,5,6,2.9,CN(CC(O)c1ccccc1)c1ccc(CCNCC(O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmcl.2011.11.072
57391344,69805,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,440,11,6,6,3,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(F)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940821,69805,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,440,11,6,6,3,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(F)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
10902809,47770,0,None,-1,3,Human,8,pEC50,=,8,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,304,7,3,3,3.5,C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL155072,47770,0,None,-1,3,Human,8,pEC50,=,8,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,304,7,3,3,3.5,C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
11005613,119181,0,None,1,3,Human,8,pEC50,=,8,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,501,12,4,5,4.3,Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
CHEMBL348269,119181,0,None,1,3,Human,8,pEC50,=,8,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,501,12,4,5,4.3,Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
90655867,110681,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,562,17,3,7,3.9,CCN(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
CHEMBL3265164,110681,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,562,17,3,7,3.9,CCN(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
16036676,110684,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,3,7,4.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccc2ccccc2c1,10.1021/ml4005232
CHEMBL3265168,110684,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,3,7,4.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccc2ccccc2c1,10.1021/ml4005232
54586985,61421,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,583,15,5,7,5,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773262,61421,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,583,15,5,7,5,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
145981007,165894,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3ccccc3O)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4280227,165894,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3ccccc3O)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
145994130,166681,0,None,83,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,338,7,4,4,2.5,O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4294937,166681,0,None,83,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,338,7,4,4,2.5,O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
24900423,70118,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,537,9,4,6,5.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(-c4cccc(CN5Cc6ccccc6C5)c4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1947154,70118,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,537,9,4,6,5.3,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(-c4cccc(CN5Cc6ccccc6C5)c4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
45271518,190768,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,479,11,4,6,3.9,COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1203999,190768,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,479,11,4,6,3.9,COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL549689,190768,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,479,11,4,6,3.9,COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
45272431,190793,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,547,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1204002,190793,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,547,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL549960,190793,0,None,6,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,547,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45271523,190812,0,None,10,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,10,4,4,4.4,Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1204000,190812,0,None,10,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,10,4,4,4.4,Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL550096,190812,0,None,10,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,10,4,4,4.4,Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
45270697,190854,0,None,20,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1203995,190854,0,None,20,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL550444,190854,0,None,20,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
45272430,191127,0,None,8,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,439,10,4,4,4.2,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1204001,191127,0,None,8,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,439,10,4,4,4.2,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL552374,191127,0,None,8,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,439,10,4,4,4.2,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45269025,191827,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,500,11,5,6,2.7,NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1203991,191827,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,500,11,5,6,2.7,NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL561173,191827,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,500,11,5,6,2.7,NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
45267257,192361,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,449,12,4,4,3.8,O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1203987,192361,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,449,12,4,4,3.8,O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL564648,192361,0,None,3,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,449,12,4,4,3.8,O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
11605652,12418,0,None,501,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1186715,12418,0,None,501,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL475236,12418,0,None,501,3,Human,8,pEC50,=,8,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
59119455,111674,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,408,10,5,6,3.5,COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1,10.1016/j.bmcl.2014.04.069
CHEMBL3290990,111674,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,408,10,5,6,3.5,COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1,10.1016/j.bmcl.2014.04.069
44392457,165258,0,None,-34,3,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,457,11,4,6,3.7,C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL425161,165258,0,None,-34,3,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,457,11,4,6,3.7,C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
10121328,4348,0,None,4,3,Human,8,pEC50,=,8,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,593,11,5,10,1.4,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL101606,4348,0,None,4,3,Human,8,pEC50,=,8,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,593,11,5,10,1.4,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
73056757,103703,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,303,7,4,5,2,COc1ccc(CCNC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL3099657,103703,0,None,-,1,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,303,7,4,5,2,COc1ccc(CCNC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
11539348,196457,0,None,9,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,434,6,4,5,3.1,CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL600616,196457,0,None,9,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,434,6,4,5,3.1,CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
6852397,59854,1,None,-,1,Human,8,pEC50,=,8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,330,8,4,5,2.4,COc1ccc([C@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1,nan
CHEMBL1735137,59854,1,None,-,1,Human,8,pEC50,=,8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,330,8,4,5,2.4,COc1ccc([C@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1,nan
CHEMBL1740818,59854,1,None,-,1,Human,8,pEC50,=,8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,330,8,4,5,2.4,COc1ccc([C@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1,nan
44441226,93148,0,None,-7,3,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL246908,93148,0,None,-7,3,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
44441231,147385,0,None,-50,3,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL393470,147385,0,None,-50,3,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
57397010,70078,0,None,-,1,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,515,11,4,5,5.3,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1946761,70078,0,None,-,1,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,515,11,4,5,5.3,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,10.1016/j.bmcl.2011.10.049
11124502,119092,0,None,-630,2,Human,6,pEC50,=,6,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,551,13,4,7,3.3,C[C@H](CNc1cccc(CCS(=O)(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL347400,119092,0,None,-630,2,Human,6,pEC50,=,6,Functional,"Activityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcellsActivityagainsthumanbeta2adrenergicreceptor(AR),expressedinCHOcells",ChEMBL,551,13,4,7,3.3,C[C@H](CNc1cccc(CCS(=O)(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
11647543,137582,0,None,-3981,3,Human,6,pEC50,=,6,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
CHEMBL377028,137582,0,None,-3981,3,Human,6,pEC50,=,6,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
127045854,138907,0,None,-3,2,Human,6,pEC50,=,6,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3797205,138907,0,None,-3,2,Human,6,pEC50,=,6,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
1499,2038,40,None,-72,36,Human,6,pEC50,=,6,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
3779,2038,40,None,-72,36,Human,6,pEC50,=,6,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
536,2038,40,None,-72,36,Human,6,pEC50,=,6,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
CHEMBL434,2038,40,None,-72,36,Human,6,pEC50,=,6,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
DB01064,2038,40,None,-72,36,Human,6,pEC50,=,6,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
90644152,111664,0,None,-,1,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,503,11,5,6,3.1,O=C(Cc1ccccc1)NC1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
CHEMBL3290981,111664,0,None,-,1,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,503,11,5,6,3.1,O=C(Cc1ccccc1)NC1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
44331425,4355,0,None,-100,3,Human,6,pEC50,=,6,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,576,13,6,8,2.5,CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O,10.1016/s0960-894x(02)00608-x
CHEMBL101630,4355,0,None,-100,3,Human,6,pEC50,=,6,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,576,13,6,8,2.5,CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O,10.1016/s0960-894x(02)00608-x
11718543,165133,0,None,-251,3,Human,5,pEC50,=,5,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,411,9,4,5,3.8,O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1,10.1021/jm0509445
CHEMBL424866,165133,0,None,-251,3,Human,5,pEC50,=,5,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,411,9,4,5,3.8,O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1,10.1021/jm0509445
2685,871,12,None,-,1,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
541,871,12,None,-,1,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
CHEMBL280822,871,12,None,-,1,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
12578,917,48,None,-1348,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,219,4,3,4,1.2,CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O,10.1021/jm400348g
2755,917,48,None,-1348,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,219,4,3,4,1.2,CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O,10.1021/jm400348g
CHEMBL1374751,917,48,None,-1348,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,219,4,3,4,1.2,CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O,10.1021/jm400348g
5311116,2281,5,None,-4365,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
544,2281,5,None,-4365,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
CHEMBL207802,2281,5,None,-4365,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
66653268,87738,0,None,-3311,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,491,14,4,6,3.8,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1,10.1021/jm400348g
CHEMBL2348201,87738,0,None,-3311,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,491,14,4,6,3.8,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1,10.1021/jm400348g
56598967,87748,0,None,-2238,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,457,14,4,6,3.2,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1,10.1021/jm400348g
CHEMBL2348211,87748,0,None,-2238,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,457,14,4,6,3.2,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1,10.1021/jm400348g
56598833,87754,0,None,-436,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,433,14,5,7,2,CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1,10.1021/jm400348g
CHEMBL2348217,87754,0,None,-436,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,433,14,5,7,2,CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1,10.1021/jm400348g
56598832,87755,0,None,-4365,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,527,16,5,7,3.3,O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348218,87755,0,None,-4365,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,527,16,5,7,3.3,O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
56597179,87756,0,None,-2754,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,473,14,5,7,2.9,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348219,87756,0,None,-2754,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,473,14,5,7,2.9,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
56598831,88627,0,None,-1023,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348220,88627,0,None,-1023,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2365796,88627,0,None,-1023,3,Human,5,pEC50,=,5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
90644151,111663,0,None,-,1,Human,5,pEC50,=,5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,413,8,4,6,1.4,CC(=O)N1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
CHEMBL3290980,111663,0,None,-,1,Human,5,pEC50,=,5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,413,8,4,6,1.4,CC(=O)N1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
73056758,103706,0,None,-,1,Human,6,pEC50,=,6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,331,8,4,5,2.8,CC[C@@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
CHEMBL3099660,103706,0,None,-,1,Human,6,pEC50,=,6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,331,8,4,5,2.8,CC[C@@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
90666108,108755,0,None,-,1,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,718,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)cc(F)c3O)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219038,108755,0,None,-,1,Human,7,pEC50,=,7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,718,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)cc(F)c3O)CC2)ccc1O,10.1039/C1MD00140J
2952103,29067,13,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,376,3,0,5,3.9,CCOC(=O)N1CCN(c2nnc(-c3ccc(C)cc3)c3ccccc23)CC1,nan
CHEMBL1383120,29067,13,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,376,3,0,5,3.9,CCOC(=O)N1CCN(c2nnc(-c3ccc(C)cc3)c3ccccc23)CC1,nan
2945777,31496,11,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,454,8,1,9,4,COc1cc(OC)nc(NC(=O)CSc2nnc(-c3ccccc3)n2C2CCCCC2)n1,nan
CHEMBL1405897,31496,11,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,454,8,1,9,4,COc1cc(OC)nc(NC(=O)CSc2nnc(-c3ccccc3)n2C2CCCCC2)n1,nan
10745501,109965,0,None,-288,2,Human,5,pEC50,=,5,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,13,5,8,2.4,CCCCN(CC(=O)O)C(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
CHEMBL32521,109965,0,None,-288,2,Human,5,pEC50,=,5,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,13,5,8,2.4,CCCCN(CC(=O)O)C(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
659759,46964,11,None,14,2,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
CHEMBL1543973,46964,11,None,14,2,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
18559738,35044,8,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,0,6,4.3,COc1cc2ncc(S(=O)(=O)c3ccccc3)c(N3CCCC(C)C3)c2cc1OC,nan
CHEMBL1436649,35044,8,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,0,6,4.3,COc1cc2ncc(S(=O)(=O)c3ccccc3)c(N3CCCC(C)C3)c2cc1OC,nan
664890,40117,9,None,9,3,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,431,8,1,7,5,Cc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
CHEMBL1482007,40117,9,None,9,3,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,431,8,1,7,5,Cc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
3759952,22248,7,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,368,5,3,6,2.8,CCOC(=O)C1(C)C=C(Nc2ccc(O)cc2)C(=O)N1c1ccc(O)cc1,nan
4017821,22248,7,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,368,5,3,6,2.8,CCOC(=O)C1(C)C=C(Nc2ccc(O)cc2)C(=O)N1c1ccc(O)cc1,nan
CHEMBL1325241,22248,7,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,368,5,3,6,2.8,CCOC(=O)C1(C)C=C(Nc2ccc(O)cc2)C(=O)N1c1ccc(O)cc1,nan
4183,1972,58,None,1,4,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/jm100068m
6918554,1972,58,None,1,4,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/jm100068m
7455,1972,58,None,1,4,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/jm100068m
CHEMBL1095777,1972,58,None,1,4,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/jm100068m
DB05039,1972,58,None,1,4,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1021/jm100068m
44392480,64182,0,None,-1,2,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,471,12,4,6,4.1,CC/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL181603,64182,0,None,-1,2,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,471,12,4,6,4.1,CC/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
59548053,124642,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,878,18,6,9,7.5,C[C@@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645355,124642,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,878,18,6,9,7.5,C[C@@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
45484538,13953,0,None,2,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL1197779,13953,0,None,2,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL585382,13953,0,None,2,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,556,13,6,7,1.9,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
1287365,37544,9,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,2,3,5.3,Cc1ccc(SCC(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc1,nan
CHEMBL1458579,37544,9,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,2,3,5.3,Cc1ccc(SCC(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc1,nan
46232857,196428,0,None,19,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,440,7,4,6,3.3,CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL600400,196428,0,None,19,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,440,7,4,6,3.3,CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
1155,1579,43,None,2,3,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,nan
3343,1579,43,None,2,3,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,nan
557,1579,43,None,2,3,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,nan
CHEMBL32800,1579,43,None,2,3,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,nan
DB01288,1579,43,None,2,3,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,nan
24895263,190307,0,None,-31622,3,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,475,10,4,6,4.6,Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1,10.1021/jm8000345
CHEMBL529659,190307,0,None,-31622,3,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,475,10,4,6,4.6,Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1,10.1021/jm8000345
44591508,178256,0,None,-31622,3,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,475,10,4,6,4.6,Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1,10.1021/jm9000709
CHEMBL470857,178256,0,None,-31622,3,Human,6,pEC50,=,6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,475,10,4,6,4.6,Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1,10.1021/jm9000709
1542103,22249,22,None,-3,3,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,418,4,0,6,4.2,Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1,nan
CHEMBL1325250,22249,22,None,-3,3,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,418,4,0,6,4.2,Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1,nan
46221604,8444,0,None,-1,2,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1ccc(CC)c2c1CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
CHEMBL1094487,8444,0,None,-1,2,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,392,6,4,4,3.1,CCc1ccc(CC)c2c1CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
44589133,175121,0,None,-1,3,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityatadrenergicbeta-2receptorAgonistactivityatadrenergicbeta-2receptor,ChEMBL,354,8,2,4,3.4,CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1,10.1016/j.bmc.2008.11.030
CHEMBL458541,175121,0,None,-1,3,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityatadrenergicbeta-2receptorAgonistactivityatadrenergicbeta-2receptor,ChEMBL,354,8,2,4,3.4,CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1,10.1016/j.bmc.2008.11.030
54586986,61422,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,780,27,6,8,8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)CCCCCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773263,61422,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,780,27,6,8,8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)CCCCCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
44610361,123347,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,14,5,9,4.9,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc(C(O)(c6ccccc6)c6ccccc6)n5)CC4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
CHEMBL3629357,123347,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,14,5,9,4.9,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc(C(O)(c6ccccc6)c6ccccc6)n5)CC4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
2488220,28581,2,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,409,5,0,6,1.1,CN(CC(=O)N1CCN(c2ncccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
CHEMBL1379002,28581,2,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,409,5,0,6,1.1,CN(CC(=O)N1CCN(c2ncccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
145986105,164672,0,None,-83,3,Human,6.9,pEC50,=,6.9,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,429,10,4,4,4,O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.03.032
CHEMBL4237453,164672,0,None,-83,3,Human,6.9,pEC50,=,6.9,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,429,10,4,4,4,O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.03.032
2560512,23820,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,335,4,2,9,1.7,Nc1cc(N)nc(SCc2cc([N+](=O)[O-])cc3c2OCOC3)n1,nan
CHEMBL1338286,23820,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,335,4,2,9,1.7,Nc1cc(N)nc(SCc2cc([N+](=O)[O-])cc3c2OCOC3)n1,nan
1267856,45644,11,None,31,2,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,351,6,1,7,2.2,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccccc3)n2)cc1,nan
CHEMBL1532219,45644,11,None,31,2,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,351,6,1,7,2.2,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccccc3)n2)cc1,nan
5182299,24694,9,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,457,5,1,4,4.5,O=C(Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1)c1c(F)cccc1F,nan
CHEMBL1345891,24694,9,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,457,5,1,4,4.5,O=C(Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1)c1c(F)cccc1F,nan
9871800,56135,0,None,-120,3,Human,5.9,pEC50,=,5.9,Functional,AgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptorAgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptor,ChEMBL,534,9,5,9,2,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O,10.1016/s0960-894x(01)00063-4
CHEMBL163262,56135,0,None,-120,3,Human,5.9,pEC50,=,5.9,Functional,AgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptorAgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptor,ChEMBL,534,9,5,9,2,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O,10.1016/s0960-894x(01)00063-4
44396509,66890,0,None,-6,2,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,513,11,4,6,5.1,CC(C)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL188315,66890,0,None,-6,2,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,513,11,4,6,5.1,CC(C)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
44331444,4181,0,None,2,3,Human,7.9,pEC50,=,7.9,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,709,13,5,8,4.2,CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(02)00608-x
CHEMBL100589,4181,0,None,2,3,Human,7.9,pEC50,=,7.9,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,709,13,5,8,4.2,CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(02)00608-x
16222317,196551,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,392,6,4,5,2.6,CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL601429,196551,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,392,6,4,5,2.6,CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
11189433,196553,0,None,57,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL601430,196553,0,None,57,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
16735495,85275,0,None,3,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL229401,85275,0,None,3,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
16049160,63694,0,None,10,3,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,491,15,5,8,3.3,CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.05.097
CHEMBL1807825,63694,0,None,10,3,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,491,15,5,8,3.3,CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.05.097
90655869,110683,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,574,15,3,7,4,O=C(CCOCCc1cccc(Cl)c1)N(CCNCCc1ccc(O)c2[nH]c(=O)sc12)CCN1CCCCC1,10.1021/ml4005232
CHEMBL3265166,110683,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,574,15,3,7,4,O=C(CCOCCc1cccc(Cl)c1)N(CCNCCc1ccc(O)c2[nH]c(=O)sc12)CCN1CCCCC1,10.1021/ml4005232
145992462,166242,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,8,4,4,2.9,O=c1ccc2c(C(CO)NCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4287029,166242,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,8,4,4,2.9,O=c1ccc2c(C(CO)NCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
76315639,84809,0,None,-1,3,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,507,10,4,6,4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1,10.1007/s00044-009-9257-x
CHEMBL2260987,84809,0,None,-1,3,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,507,10,4,6,4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1,10.1007/s00044-009-9257-x
127045855,139007,0,None,-2,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
CHEMBL3797876,139007,0,None,-2,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
44565932,186267,0,None,-15135,3,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,528,11,4,8,3.4,CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O,10.1021/jm9000709
CHEMBL490733,186267,0,None,-15135,3,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,528,11,4,8,3.4,CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O,10.1021/jm9000709
CHEMBL4850904,184007,0,None,-,1,Human,4.9,pEC50,=,4.9,Functional,AntagonistactivityatADRB2(unknownorigin)AntagonistactivityatADRB2(unknownorigin),ChEMBL,390,3,0,6,2.3,O=C(Cc1ccc(Cl)c(Cl)c1)N1CCN(c2ccc3nncn3n2)CC1,10.1021/acs.jmedchem.1c01136
580005,44035,10,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,319,4,0,6,3.5,c1ccc(CSc2nnnn2-c2cccc3ccccc23)nc1,nan
CHEMBL1517798,44035,10,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,319,4,0,6,3.5,c1ccc(CSc2nnnn2-c2cccc3ccccc23)nc1,nan
651592,45601,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,5,0,6,4,CN(C)c1ccc(-c2noc(C3CCN(S(=O)(=O)c4cccc(Cl)c4)CC3)n2)cc1,nan
CHEMBL1531826,45601,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,5,0,6,4,CN(C)c1ccc(-c2noc(C3CCN(S(=O)(=O)c4cccc(Cl)c4)CC3)n2)cc1,nan
53307431,63156,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,499,15,2,6,4,CCCCN(CCN(C)CCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800475,63156,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,499,15,2,6,4,CCCCN(CCN(C)CCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
9888047,92862,0,None,-501,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,414,9,4,5,4.4,C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL245673,92862,0,None,-501,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,414,9,4,5,4.4,C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
44441227,147380,0,None,-7,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL393469,147380,0,None,-7,3,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
929341,26790,8,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,307,3,0,4,4.5,N#Cc1cc(-c2ccccc2)nc(Oc2ccc(Cl)cc2)n1,nan
CHEMBL1364979,26790,8,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,307,3,0,4,4.5,N#Cc1cc(-c2ccccc2)nc(Oc2ccc(Cl)cc2)n1,nan
1025603,28196,11,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,430,8,1,4,3.4,CN(Cc1ccccc1)S(=O)(=O)c1ccc(NS(=O)(=O)Cc2ccccc2)cc1,nan
CHEMBL1375364,28196,11,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,430,8,1,4,3.4,CN(Cc1ccccc1)S(=O)(=O)c1ccc(NS(=O)(=O)Cc2ccccc2)cc1,nan
9512,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,10.1021/jm0509445
9887812,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,10.1021/jm0509445
CHEMBL208427,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,10.1021/jm0509445
DB06190,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,10.1021/jm0509445
90644148,111659,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,474,10,4,6,3.9,O=C(c1ccccc1)C1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
CHEMBL3290977,111659,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,474,10,4,6,3.9,O=C(c1ccccc1)C1CCN(c2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)CC1,10.1016/j.bmcl.2014.04.069
16013947,21450,6,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,442,6,1,8,1.9,CC(=O)Nc1ccc(S(=O)(=O)N2CCC(Oc3ccc(-n4cnnn4)cc3)CC2)cc1,nan
CHEMBL1318405,21450,6,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,442,6,1,8,1.9,CC(=O)Nc1ccc(S(=O)(=O)N2CCC(Oc3ccc(-n4cnnn4)cc3)CC2)cc1,nan
2475524,23287,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,332,4,0,5,4.4,CN(Cc1cccs1)c1nc(-c2cccnc2)nc2ccccc12,nan
CHEMBL1333885,23287,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,332,4,0,5,4.4,CN(Cc1cccs1)c1nc(-c2cccnc2)nc2ccccc12,nan
1499,2038,40,None,-72,36,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulationAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
3779,2038,40,None,-72,36,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulationAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
536,2038,40,None,-72,36,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulationAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
CHEMBL434,2038,40,None,-72,36,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulationAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
DB01064,2038,40,None,-72,36,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulationAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinDU145cellsassessedasincreaseincAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
90666103,108751,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cccc(O)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219033,108751,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cccc(O)c3)CC2)ccc1O,10.1039/C1MD00140J
24876564,61389,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,668,20,5,7,7.5,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773074,61389,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,668,20,5,7,7.5,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
24791478,30342,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,420,8,1,7,2.7,COCCc1ncc(CN2CCC(C(=O)Nc3ccc(-n4cccn4)cc3)CC2)cn1,nan
CHEMBL1393806,30342,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,420,8,1,7,2.7,COCCc1ncc(CN2CCC(C(=O)Nc3ccc(-n4cccn4)cc3)CC2)cn1,nan
76315638,84808,0,None,-23,3,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,543,11,4,7,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,10.1007/s00044-009-9257-x
CHEMBL2260986,84808,0,None,-23,3,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,543,11,4,7,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,10.1007/s00044-009-9257-x
6916441,98777,1,None,-158,3,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,402,9,4,4,3.5,CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
CHEMBL282190,98777,1,None,-158,3,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,402,9,4,4,3.5,CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
9874175,58170,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1039/C1MD00140J
CHEMBL1683934,58170,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,640,16,5,7,7,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1039/C1MD00140J
90666123,108774,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,752,16,6,10,6.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(OCCCN3CCC(OC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)CC3)cc2)ccc1O,10.1039/C1MD00140J
CHEMBL3219056,108774,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,752,16,6,10,6.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(OCCCN3CCC(OC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)CC3)cc2)ccc1O,10.1039/C1MD00140J
54583100,61423,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,731,21,5,8,7.4,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773264,61423,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,731,21,5,8,7.4,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
44554514,123346,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,692,18,5,9,5.9,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)c5ccccc5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
CHEMBL3629356,123346,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,692,18,5,9,5.9,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)c5ccccc5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
5493324,98354,15,None,-416,3,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,402,9,4,4,3.5,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
CHEMBL279260,98354,15,None,-416,3,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,402,9,4,4,3.5,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
11785699,64443,0,None,-12,2,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,519,12,4,6,4.9,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC/C=C/c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL182018,64443,0,None,-12,2,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,519,12,4,6,4.9,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC/C=C/c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
44396798,168677,0,None,-27,3,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,542,10,5,7,3.2,C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1,10.1016/j.bmcl.2004.09.054
CHEMBL442225,168677,0,None,-27,3,Human,7.9,pEC50,=,7.9,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,542,10,5,7,3.2,C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1,10.1016/j.bmcl.2004.09.054
1608445,23913,10,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,396,4,2,8,3.8,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCCO)ncnc4c23)CO1,nan
CHEMBL1339094,23913,10,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,396,4,2,8,3.8,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCCO)ncnc4c23)CO1,nan
45483846,192490,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,412,6,4,5,3.7,CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL565685,192490,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,412,6,4,5,3.7,CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
9896817,102318,0,None,-44,3,Human,5.9,pEC50,=,5.9,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL305891,102318,0,None,-44,3,Human,5.9,pEC50,=,5.9,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1,10.1016/s0960-894x(00)00459-5
45483838,192611,0,None,14,2,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,383,7,4,4,3.5,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
CHEMBL566352,192611,0,None,14,2,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,383,7,4,4,3.5,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
CHEMBL1365995,26912,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,8,2,7,2.4,CCCCCCN1C(=O)NC(=O)/C(=C\Nc2c(C)n(C)n(-c3ccccc3)c2=O)C1=O,nan
1267856,45644,11,None,31,2,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,351,6,1,7,2.2,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccccc3)n2)cc1,nan
CHEMBL1532219,45644,11,None,31,2,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,351,6,1,7,2.2,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccccc3)n2)cc1,nan
645398,50602,9,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,336,4,3,4,3.8,Cc1ccc(O)c(NC(=O)c2cccc(NC(=O)c3ccco3)c2)c1,nan
CHEMBL1577767,50602,9,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,336,4,3,4,3.8,Cc1ccc(O)c(NC(=O)c2cccc(NC(=O)c3ccco3)c2)c1,nan
24891819,55105,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,481,9,1,6,6.9,COc1ccc(CSc2ccc(-c3nc4ccccn4c3NCc3ccccc3)cc2OC)cc1,nan
CHEMBL1406272,55105,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,481,9,1,6,6.9,COc1ccc(CSc2ccc(-c3nc4ccccn4c3NCc3ccccc3)cc2OC)cc1,nan
CHEMBL1619809,55105,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,481,9,1,6,6.9,COc1ccc(CSc2ccc(-c3nc4ccccn4c3NCc3ccccc3)cc2OC)cc1,nan
2231941,33947,8,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,457,11,1,9,3.4,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1cccc([N+](=O)[O-])c1,nan
CHEMBL1426242,33947,8,None,-,1,Human,6.9,pEC50,=,6.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,457,11,1,9,3.4,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1cccc([N+](=O)[O-])c1,nan
1084214,45236,9,None,-,1,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
CHEMBL1528594,45236,9,None,-,1,Human,5.9,pEC50,=,5.9,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
70684522,76344,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,343,4,3,4,1.4,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(c1ccccc1)O2,10.1016/j.bmc.2011.11.054
CHEMBL2068577,76344,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,343,4,3,4,1.4,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(c1ccccc1)O2,10.1016/j.bmc.2011.11.054
70684522,76344,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,343,4,3,4,1.4,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(c1ccccc1)O2,10.1016/j.bmc.2011.11.054
CHEMBL2068577,76344,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,343,4,3,4,1.4,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(c1ccccc1)O2,10.1016/j.bmc.2011.11.054
1028,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
139148732,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
479,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
5816,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
CHEMBL679,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
DB00668,287,65,None,-15,16,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNC[C@@H](c1ccc(c(c1)O)O)O,nan
24794116,66684,1,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,6,0,4,4.7,CSc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
CHEMBL1873201,66684,1,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,6,0,4,4.7,CSc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
54757772,65588,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPproduction,ChEMBL,675,16,5,9,6,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Oc4nn(-c5c(O)cccc5F)c5c4CCCC5)CC3)ccc(O)c2[nH]1,10.1021/jm2007535
CHEMBL1836647,65588,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPproduction,ChEMBL,675,16,5,9,6,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Oc4nn(-c5c(O)cccc5F)c5c4CCCC5)CC3)ccc(O)c2[nH]1,10.1021/jm2007535
90666112,108761,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,730,18,6,9,7.2,Cc1ccc(-c2ccc(O)c(Cl)c2)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c1,10.1039/C1MD00140J
CHEMBL3219044,108761,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,730,18,6,9,7.2,Cc1ccc(-c2ccc(O)c(Cl)c2)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c1,10.1039/C1MD00140J
46221397,8587,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,420,8,4,4,3.9,CCCc1cc2c(cc1CCC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
CHEMBL1095778,8587,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,420,8,4,4,3.9,CCCc1cc2c(cc1CCC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
44609903,123349,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,18,5,9,6.4,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc([C@](O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
CHEMBL3629359,123349,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,18,5,9,6.4,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc([C@](O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
10054373,58172,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,603,17,5,7,6.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683936,58172,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,603,17,5,7,6.6,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)CC1,10.1016/j.bmcl.2011.01.043
46233013,196973,0,None,19,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.12.087
CHEMBL604125,196973,0,None,19,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.12.087
3145649,39195,9,None,177,2,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,395,4,0,4,4.7,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCCC1,nan
CHEMBL1472233,39195,9,None,177,2,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,395,4,0,4,4.7,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCCC1,nan
3145570,46694,5,None,1,2,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,397,4,0,5,3.5,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCOCC1,nan
CHEMBL1541608,46694,5,None,1,2,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,397,4,0,5,3.5,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCOCC1,nan
127047221,139273,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
CHEMBL3799593,139273,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
10722793,112752,0,None,-114,3,Human,5.9,pEC50,=,5.9,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,640,12,3,8,6.4,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1,10.1021/jm000286i
CHEMBL331744,112752,0,None,-114,3,Human,5.9,pEC50,=,5.9,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,640,12,3,8,6.4,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1,10.1021/jm000286i
2382050,36602,7,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,487,9,1,7,3.3,O=C(CCc1ccc(S(=O)(=O)N2CCOCC2)cc1)Nc1nc(COc2ccccc2)cs1,nan
CHEMBL1450612,36602,7,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,487,9,1,7,3.3,O=C(CCc1ccc(S(=O)(=O)N2CCOCC2)cc1)Nc1nc(COc2ccccc2)cs1,nan
24789191,39407,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,453,11,3,6,2.4,NC(=O)CC(NC(=O)c1ccccc1)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
CHEMBL1475105,39407,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,453,11,3,6,2.4,NC(=O)CC(NC(=O)c1ccccc1)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
2340194,34385,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,461,7,2,7,4.8,Cc1ccc(C(=O)OCC(=O)Nc2nc(-c3ccccc3)cs2)cc1NC(=O)c1ccco1,nan
CHEMBL1429919,34385,6,None,-,1,Human,5.9,pEC50,=,5.9,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,461,7,2,7,4.8,Cc1ccc(C(=O)OCC(=O)Nc2nc(-c3ccccc3)cs2)cc1NC(=O)c1ccco1,nan
145984324,165140,0,None,-25,3,Human,5.9,pEC50,=,5.9,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,449,11,4,4,4.6,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4248727,165140,0,None,-25,3,Human,5.9,pEC50,=,5.9,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,449,11,4,4,4.6,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
655617,30154,3,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,5,0,7,3.4,CC(=O)c1cccc(S(=O)(=O)N2CCCC(c3nc(-c4ccc(C)o4)no3)C2)c1,nan
CHEMBL1392252,30154,3,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,5,0,7,3.4,CC(=O)c1cccc(S(=O)(=O)N2CCCC(c3nc(-c4ccc(C)o4)no3)C2)c1,nan
123600,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
123600,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
4184788,24973,6,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,3,0,4,4.5,Cc1c(C(=O)N2CCc3ccccc3C2)oc2ccc(S(=O)(=O)N3CCCCCC3)cc12,nan
CHEMBL1348147,24973,6,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,3,0,4,4.5,Cc1c(C(=O)N2CCc3ccccc3C2)oc2ccc(S(=O)(=O)N3CCCCCC3)cc12,nan
54583092,61404,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,695,19,6,7,7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(C[C@@H](C)NC[C@H](O)c3cc(O)cc(O)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773198,61404,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,695,19,6,7,7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(C[C@@H](C)NC[C@H](O)c3cc(O)cc(O)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
11625493,196382,0,None,12,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,8,4,6,2.8,CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
CHEMBL600007,196382,0,None,12,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,8,4,6,2.8,CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
1094286,50515,15,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
CHEMBL1577023,50515,15,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
319,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
321,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
444031,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
784,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
CHEMBL1346,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
DB00496,1288,35,None,-2,6,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2011.05.097
90655865,110679,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,514,16,3,7,2.9,CN(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL3265162,110679,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,514,16,3,7,2.9,CN(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
4183,1972,58,None,1,4,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2011.10.049
6918554,1972,58,None,1,4,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2011.10.049
7455,1972,58,None,1,4,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2011.10.049
CHEMBL1095777,1972,58,None,1,4,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2011.10.049
DB05039,1972,58,None,1,4,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,392,6,4,4,3.1,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O,10.1016/j.bmcl.2011.10.049
24900874,69966,0,None,8,3,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,417,11,5,7,1.9,COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
CHEMBL1945293,69966,0,None,8,3,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,417,11,5,7,1.9,COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
44312924,164128,0,None,-39,3,Human,5.8,pEC50,=,5.8,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,421,6,3,6,4.2,COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
CHEMBL421871,164128,0,None,-39,3,Human,5.8,pEC50,=,5.8,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,421,6,3,6,4.2,COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
10651147,110099,0,None,-380,3,Human,5.8,pEC50,=,5.8,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,596,12,6,8,2.5,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL32599,110099,0,None,-380,3,Human,5.8,pEC50,=,5.8,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,596,12,6,8,2.5,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
3986625,42898,5,None,-,1,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,344,4,1,3,3.7,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCOCC2)cc1,nan
CHEMBL1505690,42898,5,None,-,1,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,344,4,1,3,3.7,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCOCC2)cc1,nan
5307895,49811,7,None,9,2,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,441,8,1,8,2.9,COc1ccc(OC)c(CCNC(=O)C2CCN(c3nnc(-n4cccc4)s3)CC2)c1,nan
CHEMBL1570251,49811,7,None,9,2,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,441,8,1,8,2.9,COc1ccc(OC)c(CCNC(=O)C2CCN(c3nnc(-n4cccc4)s3)CC2)c1,nan
1104203,44576,13,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,350,4,1,7,3.6,O=C(Nc1ccc(-c2nc3ncccc3o2)cc1)c1ccc([N+](=O)[O-])o1,nan
CHEMBL1522618,44576,13,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,350,4,1,7,3.6,O=C(Nc1ccc(-c2nc3ncccc3o2)cc1)c1ccc([N+](=O)[O-])o1,nan
1266768,33763,11,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,365,6,1,7,2.5,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccc(C)cc3)n2)cc1,nan
CHEMBL1424678,33763,11,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,365,6,1,7,2.5,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccc(C)cc3)n2)cc1,nan
3301343,59367,10,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,414,4,2,9,2.3,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCCN)ncnc4c23)CO1,nan
CHEMBL1724644,59367,10,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,414,4,2,9,2.3,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCCN)ncnc4c23)CO1,nan
44441229,93229,0,None,-199,3,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL247315,93229,0,None,-199,3,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
57395241,70080,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,448,11,4,6,3.4,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1946763,70080,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,448,11,4,6,3.4,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
57391792,70081,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,523,10,3,6,5,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CN4CC[C@@H](Oc5ccc(Cl)cc5)C4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1946764,70081,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,523,10,3,6,5,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CN4CC[C@@H](Oc5ccc(Cl)cc5)C4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
90644144,111655,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,442,10,5,5,4.5,OCc1cc(C(O)CNCCc2ccc(NCc3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290973,111655,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,442,10,5,5,4.5,OCc1cc(C(O)CNCCc2ccc(NCc3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
11495581,76884,0,None,-50,3,Human,5.8,pEC50,=,5.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,425,9,4,5,4.2,C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
CHEMBL208328,76884,0,None,-50,3,Human,5.8,pEC50,=,5.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,425,9,4,5,4.2,C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
11546349,140669,0,None,-50,3,Human,5.8,pEC50,=,5.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
CHEMBL383511,140669,0,None,-50,3,Human,5.8,pEC50,=,5.8,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
90644143,111654,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,460,10,5,5,4.7,OCc1cc(C(O)CNCCc2ccc(NCc3ccc(Cl)c(Cl)c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290972,111654,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,460,10,5,5,4.7,OCc1cc(C(O)CNCCc2ccc(NCc3ccc(Cl)c(Cl)c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
90644147,111658,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,488,12,4,5,5,OCc1cc(C(O)CNCCc2ccc(N3CCC(CCCc4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290976,111658,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,488,12,4,5,5,OCc1cc(C(O)CNCCc2ccc(N3CCC(CCCc4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
145984042,164977,0,None,-3467,3,Human,4.8,pEC50,=,4.8,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,475,13,4,5,3.1,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
CHEMBL4244929,164977,0,None,-3467,3,Human,4.8,pEC50,=,4.8,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,475,13,4,5,3.1,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
44392519,123155,0,None,-1,2,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,493,11,4,6,4.4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccccc2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL362293,123155,0,None,-1,2,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,493,11,4,6,4.4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccccc2)c1,10.1016/j.bmcl.2004.12.033
56663519,63249,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,5,5,2.4,CC[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL1800960,63249,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,5,5,2.4,CC[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
44392558,64858,0,None,-2,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,471,11,4,6,4.1,CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
CHEMBL182770,64858,0,None,-2,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,471,11,4,6,4.1,CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
24817062,28530,7,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,5,0,3,4.1,O=C(c1ccc(OC2CCN(Cc3ccc(F)cc3)CC2)cc1)N1CCCC1,nan
CHEMBL1378531,28530,7,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,5,0,3,4.1,O=C(c1ccc(OC2CCN(Cc3ccc(F)cc3)CC2)cc1)N1CCCC1,nan
2307884,66968,7,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,347,3,0,2,4.7,O=C(COc1ccccc1F)N1c2ccccc2CCc2ccccc21,nan
CHEMBL1886907,66968,7,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,347,3,0,2,4.7,O=C(COc1ccccc1F)N1c2ccccc2CCc2ccccc21,nan
1292336,32023,11,None,9,2,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,403,8,1,6,5.1,CCCc1ccc(OCc2nc(-c3ccc(NC(=O)c4ccco4)cc3)no2)cc1,nan
CHEMBL1410048,32023,11,None,9,2,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,403,8,1,6,5.1,CCCc1ccc(OCc2nc(-c3ccc(NC(=O)c4ccco4)cc3)no2)cc1,nan
1084214,45236,9,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
CHEMBL1528594,45236,9,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
16832456,50986,9,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,402,7,2,6,2.7,CC(=O)Nc1ccc(S(=O)(=O)NCCc2csc(-c3cccnc3)n2)cc1,nan
CHEMBL1581044,50986,9,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,402,7,2,6,2.7,CC(=O)Nc1ccc(S(=O)(=O)NCCc2csc(-c3cccnc3)n2)cc1,nan
70686652,76343,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,283,3,4,5,-0.1,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(O)O2,10.1016/j.bmc.2011.11.054
CHEMBL2068576,76343,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,283,3,4,5,-0.1,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(O)O2,10.1016/j.bmc.2011.11.054
70686652,76343,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,283,3,4,5,-0.1,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(O)O2,10.1016/j.bmc.2011.11.054
CHEMBL2068576,76343,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,283,3,4,5,-0.1,CC(C)(C)NC[C@H](O)c1ccc2c(c1)C[OH+][B-](O)(O)O2,10.1016/j.bmc.2011.11.054
6407382,44880,4,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,527,4,1,6,5.8,Cc1cccc(Nc2nnc(-c3ccc(C(=O)N4C[C@H]5C[C@H](C4)c4cccc(=O)n4C5)cc3)c3ccccc23)c1,nan
CHEMBL1525540,44880,4,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,527,4,1,6,5.8,Cc1cccc(Nc2nnc(-c3ccc(C(=O)N4C[C@H]5C[C@H](C4)c4cccc(=O)n4C5)cc3)c3ccccc23)c1,nan
2953239,30991,5,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
CHEMBL1401186,30991,5,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
2233849,33096,8,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,10,1,7,4.1,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Cl)cc1,nan
CHEMBL1419122,33096,8,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,10,1,7,4.1,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Cl)cc1,nan
90666119,108770,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,728,19,6,9,6.7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@H]3C[C@@]3(COC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O,10.1039/C1MD00140J
CHEMBL3219052,108770,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,728,19,6,9,6.7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@H]3C[C@@]3(COC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O,10.1039/C1MD00140J
54580128,61402,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,723,20,6,7,7.2,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(CO)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773196,61402,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,723,20,6,7,7.2,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(CO)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
44392457,165258,0,None,-34,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,457,11,4,6,3.7,C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
CHEMBL425161,165258,0,None,-34,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,457,11,4,6,3.7,C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
45483831,192693,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,343,8,4,4,3.1,CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmcl.2009.10.013
CHEMBL566992,192693,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,343,8,4,4,3.1,CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c(CO)c2)cc1,10.1016/j.bmcl.2009.10.013
1271047,44063,11,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,301,5,1,1,4.7,O=C(Nc1ccccc1)c1ccccc1CCc1ccccc1,nan
CHEMBL1518070,44063,11,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,301,5,1,1,4.7,O=C(Nc1ccccc1)c1ccccc1CCc1ccccc1,nan
664105,29531,8,None,-,1,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,468,4,1,9,2.8,CC1(C)Cc2c(c(N3CCCC3)nc3sc4c(N5CCN(CCO)CC5)ncnc4c23)CO1,nan
CHEMBL1387056,29531,8,None,-,1,Human,5.8,pEC50,=,5.8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,468,4,1,9,2.8,CC1(C)Cc2c(c(N3CCCC3)nc3sc4c(N5CCN(CCO)CC5)ncnc4c23)CO1,nan
54580133,61424,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,654,19,5,7,7.7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(O)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773265,61424,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,654,19,5,7,7.7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(O)c3)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
6404528,44499,24,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,307,3,0,4,4.5,N#Cc1cc(-c2ccccc2)nnc1Oc1ccccc1Cl,nan
CHEMBL1521880,44499,24,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,307,3,0,4,4.5,N#Cc1cc(-c2ccccc2)nnc1Oc1ccccc1Cl,nan
1231538,27276,20,None,1,3,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,523,6,1,6,6,O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1,nan
CHEMBL1368962,27276,20,None,1,3,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,523,6,1,6,6,O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1,nan
135799875,185677,0,None,-,1,Human,4.8,pEC50,=,4.8,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,276,3,4,4,1.7,CC(C)(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4876155,185677,0,None,-,1,Human,4.8,pEC50,=,4.8,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,276,3,4,4,1.7,CC(C)(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
24791840,59433,5,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,406,6,0,3,4.9,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCCC4)cc3)CC2)cc1,nan
CHEMBL1727257,59433,5,None,-,1,Human,5.8,pEC50,=,5.8,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,406,6,0,3,4.9,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCCC4)cc3)CC2)cc1,nan
46221603,8443,0,None,-7,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,396,6,4,6,2,COc1cc2c(cc1OC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
CHEMBL1094486,8443,0,None,-7,2,Human,7.8,pEC50,=,7.8,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,396,6,4,6,2,COc1cc2c(cc1OC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
44392577,121906,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,455,10,4,6,3.2,CC#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL360133,121906,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,455,10,4,6,3.2,CC#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
11432806,65795,0,None,-134,3,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.09.054
11432806,65795,0,None,-134,3,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL184407,65795,0,None,-134,3,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.09.054
CHEMBL184407,65795,0,None,-134,3,Human,7.8,pEC50,=,7.8,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
44396568,66878,0,None,-34,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,529,12,5,7,3.7,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL188196,66878,0,None,-34,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,529,12,5,7,3.7,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
9873257,84436,10,None,-47,3,Human,5.8,pEC50,=,5.8,Functional,AgonisticactivityagainsttheclonedhumanBeta-2adrenergicreceptorwasmeasuredbyitsbyitsabilitytostimulateadenylylcyclaseAgonisticactivityagainsttheclonedhumanBeta-2adrenergicreceptorwasmeasuredbyitsbyitsabilitytostimulateadenylylcyclase,ChEMBL,591,14,3,10,3.5,O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1,10.1016/s0960-894x(99)00182-1
CHEMBL22375,84436,10,None,-47,3,Human,5.8,pEC50,=,5.8,Functional,AgonisticactivityagainsttheclonedhumanBeta-2adrenergicreceptorwasmeasuredbyitsbyitsabilitytostimulateadenylylcyclaseAgonisticactivityagainsttheclonedhumanBeta-2adrenergicreceptorwasmeasuredbyitsbyitsabilitytostimulateadenylylcyclase,ChEMBL,591,14,3,10,3.5,O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1,10.1016/s0960-894x(99)00182-1
11758172,100376,0,None,-147,3,Human,5.8,pEC50,=,5.8,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,592,11,3,7,5.8,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1,10.1021/jm000286i
CHEMBL293994,100376,0,None,-147,3,Human,5.8,pEC50,=,5.8,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,592,11,3,7,5.8,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1,10.1021/jm000286i
2005835,22334,8,None,6,2,Human,5.7,pEC50,=,5.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,459,5,1,9,5.2,CSc1nc(SCCO)c2sc3nc(-c4ccco4)c4c(c3c2n1)CC(C)(C)OC4,nan
CHEMBL1326167,22334,8,None,6,2,Human,5.7,pEC50,=,5.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,459,5,1,9,5.2,CSc1nc(SCCO)c2sc3nc(-c4ccco4)c4c(c3c2n1)CC(C)(C)OC4,nan
24791840,59433,5,None,-,1,Human,5.7,pEC50,=,5.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,406,6,0,3,4.9,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCCC4)cc3)CC2)cc1,nan
CHEMBL1727257,59433,5,None,-,1,Human,5.7,pEC50,=,5.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,406,6,0,3,4.9,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCCC4)cc3)CC2)cc1,nan
76319327,84818,0,None,-14,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,584,14,4,7,4.5,CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL2261203,84818,0,None,-14,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,584,14,4,7,4.5,CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
44396568,66878,0,None,-34,3,Human,7.7,pEC50,=,7.7,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,529,12,5,7,3.7,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL188196,66878,0,None,-34,3,Human,7.7,pEC50,=,7.7,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,529,12,5,7,3.7,C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
44392552,64129,0,None,-35,3,Human,7.7,pEC50,=,7.7,Functional,Effectiveconcentrationagainsthumanbeta-2adrenergicreceptorEffectiveconcentrationagainsthumanbeta-2adrenergicreceptor,ChEMBL,543,11,4,7,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL181440,64129,0,None,-35,3,Human,7.7,pEC50,=,7.7,Functional,Effectiveconcentrationagainsthumanbeta-2adrenergicreceptorEffectiveconcentrationagainsthumanbeta-2adrenergicreceptor,ChEMBL,543,11,4,7,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
2977891,21568,8,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
CHEMBL1319376,21568,8,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
10863093,50008,0,None,-3,3,Human,7.7,pEC50,=,7.7,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,439,10,4,6,2.1,C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL157210,50008,0,None,-3,3,Human,7.7,pEC50,=,7.7,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,439,10,4,6,2.1,C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
145987938,166361,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4289233,166361,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
76329060,105860,0,None,199,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,493,17,4,7,3.5,CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm401532g
CHEMBL3126381,105860,0,None,199,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,493,17,4,7,3.5,CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm401532g
CHEMBL3139685,105860,0,None,199,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,493,17,4,7,3.5,CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm401532g
90644153,111665,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,470,11,5,6,5.3,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290982,111665,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,470,11,5,6,5.3,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
1369799,44172,8,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,401,5,1,5,5.2,CC(C)(C)c1ccc(OCC(=O)Nc2ccc(-c3nc4cccnc4o3)cc2)cc1,nan
CHEMBL1519042,44172,8,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,401,5,1,5,5.2,CC(C)(C)c1ccc(OCC(=O)Nc2ccc(-c3nc4cccnc4o3)cc2)cc1,nan
135799865,185847,0,None,-,1,Human,4.7,pEC50,=,4.7,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,262,4,4,4,1.3,CC(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4878555,185847,0,None,-,1,Human,4.7,pEC50,=,4.7,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,262,4,4,4,1.3,CC(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
24819471,30029,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,408,9,0,6,3.9,CC(=O)c1ccc(OCc2cc(C(=O)N(C)CCOc3ccc(C)cc3)no2)cc1,nan
CHEMBL1391134,30029,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,408,9,0,6,3.9,CC(=O)c1ccc(OCc2cc(C(=O)N(C)CCOc3ccc(C)cc3)no2)cc1,nan
90666117,108768,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,744,20,6,9,7.6,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219050,108768,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,744,20,6,9,7.6,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
24817788,33229,1,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,407,7,1,7,3.2,Cc1ccc(OCc2cc(C(=O)NCc3cnn(-c4cccc(F)c4)c3)no2)cn1,nan
CHEMBL1420188,33229,1,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,407,7,1,7,3.2,Cc1ccc(OCc2cc(C(=O)NCc3cnn(-c4cccc(F)c4)c3)no2)cn1,nan
1073012,33463,15,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,403,5,0,5,1.3,CCOC(=O)N1CCN(C(=O)CN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1,nan
CHEMBL1422244,33463,15,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,403,5,0,5,1.3,CCOC(=O)N1CCN(C(=O)CN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1,nan
105,3375,81,None,-23,3,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.04.135
2083,3375,81,None,-23,3,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.04.135
558,3375,81,None,-23,3,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.04.135
CHEMBL714,3375,81,None,-23,3,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.04.135
DB01001,3375,81,None,-23,3,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.04.135
90644149,111660,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,447,9,4,6,3.1,OCc1cc(C(O)CNCCc2ccc(N3CCN(c4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290978,111660,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,447,9,4,6,3.1,OCc1cc(C(O)CNCCc2ccc(N3CCN(c4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
90644154,111668,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,428,9,5,5,4.6,OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290985,111668,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,428,9,5,5,4.6,OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
90644140,111678,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,394,9,6,6,3.2,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290994,111678,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,394,9,6,6,3.2,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
1499,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm800222k
3779,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm800222k
536,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm800222k
CHEMBL434,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm800222k
DB01064,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm800222k
16736091,85221,0,None,251,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
CHEMBL228996,85221,0,None,251,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
16736091,85221,0,None,251,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL228996,85221,0,None,251,2,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
1499,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm8000345
3779,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm8000345
536,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm8000345
CHEMBL434,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm8000345
DB01064,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm8000345
1499,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm9000709
3779,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm9000709
536,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm9000709
CHEMBL434,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm9000709
DB01064,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm9000709
1499,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2004.11.001
3779,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2004.11.001
536,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2004.11.001
CHEMBL434,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2004.11.001
DB01064,2038,40,None,-72,36,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcelllinesexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2004.11.001
2953239,30991,5,None,-,1,Human,8.7,pEC50,=,8.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
CHEMBL1401186,30991,5,None,-,1,Human,8.7,pEC50,=,8.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
68057795,124560,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,804,17,6,10,6,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645276,124560,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,804,17,6,10,6,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548077,124604,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,880,17,6,10,7.4,COc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645319,124604,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,880,17,6,10,7.4,COc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548088,124624,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,836,16,6,9,6.6,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
CHEMBL3645338,124624,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,836,16,6,9,6.6,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
59548072,124625,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,836,16,6,9,6.6,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,nan
CHEMBL3645339,124625,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,836,16,6,9,6.6,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,nan
59548116,124634,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645347,124634,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,894,18,6,10,7.1,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548085,124636,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,878,18,6,9,7.1,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645349,124636,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,878,18,6,9,7.1,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
319,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
321,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
444031,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
784,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
CHEMBL1346,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
DB00496,1288,35,None,-2,6,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassayAgonistactivityatbeta2-adrenoceptorinhumanbronchialsmooth-musclecellbycAMPassay,ChEMBL,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,10.1016/j.bmcl.2012.07.096
44392534,64841,0,None,1,2,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,443,11,4,6,3.4,C=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL182689,64841,0,None,1,2,Human,8.7,pEC50,=,8.7,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,443,11,4,6,3.4,C=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
156014385,177624,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4636080,177624,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
CHEMBL4651252,177624,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,356,7,4,5,2.3,Cc1ccc(CCCNCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmc.2019.115178
156015552,177568,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,328,6,4,5,1.6,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4641339,177568,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,328,6,4,5,1.6,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4650961,177568,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,328,6,4,5,1.6,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccccc2)N1,10.1016/j.bmc.2019.115178
44419254,82647,0,None,4,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevelsAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevels,ChEMBL,587,14,4,8,4.5,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCCC3)c12,10.1016/j.bmcl.2006.08.010
CHEMBL218210,82647,0,None,4,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevelsAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevels,ChEMBL,587,14,4,8,4.5,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCCC3)c12,10.1016/j.bmcl.2006.08.010
53239456,61426,0,None,1,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,705,19,5,7,7.8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773267,61426,0,None,1,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,705,19,5,7,7.8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
53239456,61426,0,None,1,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,705,19,5,7,7.8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2015.10.008
CHEMBL1773267,61426,0,None,1,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,705,19,5,7,7.8,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C,10.1016/j.bmcl.2015.10.008
46232768,195307,0,None,14,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,356,6,4,5,2.4,CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL592879,195307,0,None,14,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,356,6,4,5,2.4,CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
56675509,64099,0,None,79,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmc.2011.05.064
CHEMBL1814270,64099,0,None,79,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1016/j.bmc.2011.05.064
56658244,66004,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
CHEMBL1814272,66004,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
CHEMBL1851849,66004,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,513,17,5,7,3.2,O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1,10.1016/j.bmc.2011.05.064
56670092,63707,0,None,112,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,445,13,4,7,2.5,CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1,10.1016/j.bmcl.2011.05.097
CHEMBL1807874,63707,0,None,112,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,445,13,4,7,2.5,CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1,10.1016/j.bmcl.2011.05.097
1239,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/ml4005232
3410,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/ml4005232
3465,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/ml4005232
CHEMBL1256786,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/ml4005232
DB00983,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1021/ml4005232
145987415,166549,0,None,1258,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4292648,166549,0,None,1258,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
155540608,172218,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,493,11,5,5,4.9,CC(CC(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)CC(C)(C)C,10.1016/j.bmc.2018.10.043
CHEMBL4516838,172218,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,493,11,5,5,4.9,CC(CC(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)CC(C)(C)C,10.1016/j.bmc.2018.10.043
1239,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
3410,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
3465,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
CHEMBL1256786,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
DB00983,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.095
90645345,111891,0,None,11,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,574,12,6,8,4.7,CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298692,111891,0,None,11,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,574,12,6,8,4.7,CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1,10.1016/j.bmcl.2014.04.095
57400229,69971,0,None,5,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,497,12,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945298,69971,0,None,5,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,497,12,5,7,3.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1,10.1016/j.bmcl.2011.10.049
57401435,69983,0,None,31,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,458,11,5,6,2.8,O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.10.049
CHEMBL1945503,69983,0,None,31,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,458,11,5,6,2.8,O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1,10.1016/j.bmcl.2011.10.049
1239,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
3410,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
3465,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
CHEMBL1256786,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
DB00983,1626,45,None,-1,5,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2014.04.069
42625898,184512,0,None,125,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,591,17,7,9,1.5,NS(=O)(=O)O.NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL485847,184512,0,None,125,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,591,17,7,9,1.5,NS(=O)(=O)O.NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
46832801,14058,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,431,16,4,6,3.6,Cc1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm100326d
CHEMBL1084649,14058,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,431,16,4,6,3.6,Cc1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm100326d
CHEMBL1198880,14058,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,431,16,4,6,3.6,Cc1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1,10.1021/jm100326d
46832803,14059,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,451,16,4,6,4,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(Cl)cc2)ccc1O,10.1021/jm100326d
CHEMBL1084654,14059,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,451,16,4,6,4,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(Cl)cc2)ccc1O,10.1021/jm100326d
CHEMBL1198881,14059,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,451,16,4,6,4,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(Cl)cc2)ccc1O,10.1021/jm100326d
46832505,14089,0,None,12,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,417,16,4,6,3.3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O,10.1021/jm100326d
CHEMBL1085395,14089,0,None,12,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,417,16,4,6,3.3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O,10.1021/jm100326d
CHEMBL1199261,14089,0,None,12,3,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,417,16,4,6,3.3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O,10.1021/jm100326d
59119467,111666,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,428,9,5,5,4.6,OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290983,111666,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,428,9,5,5,4.6,OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
90644139,111676,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,424,10,5,6,4.2,CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290992,111676,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,424,10,5,6,4.2,CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
59119410,111677,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,436,11,5,6,4.3,CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290993,111677,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,436,11,5,6,4.3,CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
57391347,69809,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,436,11,6,6,3.2,Cc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
CHEMBL1940825,69809,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,436,11,6,6,3.2,Cc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
44434117,89233,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,561,13,5,8,4.1,CCn1c(C(=O)NCc2c(OC)cccc2OC)cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc21,10.1016/j.bmcl.2007.09.031
CHEMBL237709,89233,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevelsAgonistactivityathumanrecombinantadrenergicbeta-2receptorexpressedinCHOcellsassessedaselevationincAMPlevels,ChEMBL,561,13,5,8,4.1,CCn1c(C(=O)NCc2c(OC)cccc2OC)cc2cc(C[C@@H](C)NC[C@H](O)c3ccc(O)c(CO)c3)ccc21,10.1016/j.bmcl.2007.09.031
10348864,58171,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,616,18,5,7,6.7,O=CNc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O,10.1016/j.bmcl.2011.01.043
CHEMBL1683935,58171,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,616,18,5,7,6.7,O=CNc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O,10.1016/j.bmcl.2011.01.043
3083544,462,43,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/acs.jmedchem.0c01195
4943,462,43,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/acs.jmedchem.0c01195
7479,462,43,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/acs.jmedchem.0c01195
CHEMBL1363,462,43,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/acs.jmedchem.0c01195
DB01274,462,43,None,1,4,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O,10.1021/acs.jmedchem.0c01195
16735272,85301,0,None,57,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL229614,85301,0,None,57,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
45483815,194119,0,None,11,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL577289,194119,0,None,11,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
53380559,63245,0,None,4265,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,5,5,2.4,CC[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL1800936,63245,0,None,4265,2,Human,8.6,pEC50,=,8.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,5,5,2.4,CC[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
45375919,192690,0,None,87,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL566973,192690,0,None,87,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.10.013
CHEMBL4859326,184559,0,None,831,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseincAMPlevelincubatedfor30minsbyimmunoassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseincAMPlevelincubatedfor30minsbyimmunoassay,ChEMBL,427,9,5,6,1.6,CN(C)C(=O)CNc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2,10.1021/acs.jmedchem.0c01195
45375919,192690,0,None,87,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL566973,192690,0,None,87,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,7,5,6,2.1,CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
44396531,66430,0,None,-38,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,647,18,4,8,6.4,CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL186135,66430,0,None,-38,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,647,18,4,8,6.4,CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
45483830,192674,0,None,14,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,329,7,4,4,2.8,Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
CHEMBL566777,192674,0,None,14,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,329,7,4,4,2.8,Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
90666115,108765,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,702,17,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219048,108765,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,702,17,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
9933039,162348,0,None,1,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,442,11,4,6,2.8,O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL417613,162348,0,None,1,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,442,11,4,6,2.8,O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1,10.1016/j.bmc.2009.06.031
45271517,190735,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,499,10,4,4,4.8,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1203998,190735,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,499,10,4,4,4.8,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL549487,190735,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,499,10,4,4,4.8,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45270690,190805,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1203994,190805,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL550037,190805,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
44517694,190855,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
CHEMBL1203996,190855,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
CHEMBL550445,190855,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
44517696,191452,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1204007,191452,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL557705,191452,0,None,3,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,451,11,4,5,4.1,COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
44517692,192348,0,None,4,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1203990,192348,0,None,4,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL564516,192348,0,None,4,3,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1,10.1016/j.bmc.2009.06.031
44331443,4359,0,None,1,3,Human,7.7,pEC50,=,7.7,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,689,14,7,9,2.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL101674,4359,0,None,1,3,Human,7.7,pEC50,=,7.7,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,689,14,7,9,2.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
3931,2194,39,None,-691,4,Human,7.7,pEC50,=,7.7,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,584,17,6,7,4.5,CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O,10.1021/jm000544b
9829836,2194,39,None,-691,4,Human,7.7,pEC50,=,7.7,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,584,17,6,7,4.5,CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O,10.1021/jm000544b
CHEMBL12998,2194,39,None,-691,4,Human,7.7,pEC50,=,7.7,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,584,17,6,7,4.5,CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O,10.1021/jm000544b
10697841,162172,0,None,4,2,Human,7.7,pEC50,=,7.7,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,546,9,5,8,1.7,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N4CCC[C@H]4C(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL417325,162172,0,None,4,2,Human,7.7,pEC50,=,7.7,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,546,9,5,8,1.7,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N4CCC[C@H]4C(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
2297789,40432,7,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,469,11,2,6,4.8,CCCCN(CCCC)c1nc2ccccc2nc1NS(=O)(=O)c1ccc(NC(C)=O)cc1,nan
CHEMBL1484690,40432,7,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,469,11,2,6,4.8,CCCCN(CCCC)c1nc2ccccc2nc1NS(=O)(=O)c1ccc(NC(C)=O)cc1,nan
1913590,19547,7,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,5,2,8,4.1,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCCCO)ncnc4c23)CO1,nan
CHEMBL1301481,19547,7,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,5,2,8,4.1,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCCCO)ncnc4c23)CO1,nan
44610056,123350,0,None,-1,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,704,14,5,9,5.5,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc([C@](O)(c6ccccc6)C6CCCCC6)n5)CC4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
CHEMBL3629360,123350,0,None,-1,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,704,14,5,9,5.5,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc([C@](O)(c6ccccc6)C6CCCCC6)n5)CC4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
44331351,203751,0,None,-645,3,Human,4.7,pEC50,=,4.7,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,610,13,6,8,2.7,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL98088,203751,0,None,-645,3,Human,4.7,pEC50,=,4.7,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,610,13,6,8,2.7,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
2952777,190352,7,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,443,6,1,6,6,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccco3)cc2)no1,nan
CHEMBL531401,190352,7,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,443,6,1,6,6,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccco3)cc2)no1,nan
666902,24745,9,None,213,2,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,451,8,1,7,5.3,Clc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
CHEMBL1346316,24745,9,None,213,2,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,451,8,1,7,5.3,Clc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
893042,51607,11,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,331,5,1,6,2.3,CCn1c(SCC(=O)N2CCCC2)nnc1-c1ccc(N)cc1,nan
CHEMBL1586182,51607,11,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,331,5,1,6,2.3,CCn1c(SCC(=O)N2CCCC2)nnc1-c1ccc(N)cc1,nan
90666116,108766,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,730,19,6,9,7.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219049,108766,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,730,19,6,9,7.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
59145957,123348,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,18,5,9,6.4,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
CHEMBL3629358,123348,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,698,18,5,9,6.4,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1,10.1016/j.bmcl.2015.10.008
44396532,66352,0,None,-42,3,Human,7.7,pEC50,=,7.7,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,455,9,4,5,4.3,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL185836,66352,0,None,-42,3,Human,7.7,pEC50,=,7.7,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,455,9,4,5,4.3,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
9997789,185558,0,None,177,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,310,3,3,3,3.4,CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1,10.1021/acs.jmedchem.0c01195
CHEMBL4874511,185558,0,None,177,2,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,310,3,3,3,3.4,CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1,10.1021/acs.jmedchem.0c01195
73057083,103704,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,303,7,4,5,2,COc1ccc(CCNC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL3099658,103704,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,303,7,4,5,2,COc1ccc(CCNC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
665098,19581,9,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,384,7,0,6,4.7,CCn1c(COc2ccc(Cl)cc2)nnc1SCc1ccc(C#N)cc1,nan
CHEMBL1301877,19581,9,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,384,7,0,6,4.7,CCn1c(COc2ccc(Cl)cc2)nnc1SCc1ccc(C#N)cc1,nan
6407382,44880,4,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,527,4,1,6,5.8,Cc1cccc(Nc2nnc(-c3ccc(C(=O)N4C[C@H]5C[C@H](C4)c4cccc(=O)n4C5)cc3)c3ccccc23)c1,nan
CHEMBL1525540,44880,4,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,527,4,1,6,5.8,Cc1cccc(Nc2nnc(-c3ccc(C(=O)N4C[C@H]5C[C@H](C4)c4cccc(=O)n4C5)cc3)c3ccccc23)c1,nan
16746244,48602,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,552,8,2,7,3.4,NC(=O)CC(NC(=O)c1ccc(Br)cc1)c1ccc(N2CCN(c3ccccn3)CC2)c([N+](=O)[O-])c1,nan
CHEMBL1559831,48602,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,552,8,2,7,3.4,NC(=O)CC(NC(=O)c1ccc(Br)cc1)c1ccc(N2CCN(c3ccccn3)CC2)c([N+](=O)[O-])c1,nan
2212788,27911,9,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,490,10,1,7,4.2,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Br)cc1,nan
CHEMBL1373386,27911,9,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,490,10,1,7,4.2,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Br)cc1,nan
3145649,39195,9,None,177,2,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,395,4,0,4,4.7,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCCC1,nan
CHEMBL1472233,39195,9,None,177,2,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,395,4,0,4,4.7,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCCC1,nan
3986625,42898,5,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,1,3,3.7,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCOCC2)cc1,nan
CHEMBL1505690,42898,5,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,1,3,3.7,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCOCC2)cc1,nan
44396715,67040,0,None,-20,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,612,12,4,9,4.4,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL189081,67040,0,None,-20,3,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,612,12,4,9,4.4,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
90666110,108758,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,718,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)c(O)cc3F)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219041,108758,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,718,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)c(O)cc3F)CC2)ccc1O,10.1039/C1MD00140J
1165076,39670,5,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,466,5,1,7,4.8,Cc1ccc(Cn2ccc(NC(=O)c3cc4nc(-c5ccco5)cc(C(F)(F)F)n4n3)n2)cc1,nan
CHEMBL1478198,39670,5,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,466,5,1,7,4.8,Cc1ccc(Cn2ccc(NC(=O)c3cc4nc(-c5ccco5)cc(C(F)(F)F)n4n3)n2)cc1,nan
24789160,35092,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,501,12,3,6,2.9,NC(=O)CC(NC(=O)Cc1ccc(Cl)cc1)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
CHEMBL1437255,35092,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,501,12,3,6,2.9,NC(=O)CC(NC(=O)Cc1ccc(Cl)cc1)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
3119289,47186,4,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,378,8,2,4,5,CCCCOc1cccc(C(=O)Nc2ccc(NC(=O)c3ccco3)cc2)c1,nan
CHEMBL1545591,47186,4,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,378,8,2,4,5,CCCCOc1cccc(C(=O)Nc2ccc(NC(=O)c3ccco3)cc2)c1,nan
24789183,32615,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,552,8,2,7,3.4,NC(=O)CC(NC(=O)c1cccc(Br)c1)c1ccc(N2CCN(c3ccccn3)CC2)c([N+](=O)[O-])c1,nan
CHEMBL1414874,32615,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,552,8,2,7,3.4,NC(=O)CC(NC(=O)c1cccc(Br)c1)c1ccc(N2CCN(c3ccccn3)CC2)c([N+](=O)[O-])c1,nan
2234461,43485,9,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
CHEMBL1510834,43485,9,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
16279412,58997,5,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,467,10,2,7,3.5,CCOc1ccccc1C(=O)NCC(=O)OCc1csc(CC(=O)Nc2ccc(C)cc2)n1,nan
CHEMBL1708092,58997,5,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,467,10,2,7,3.5,CCOc1ccccc1C(=O)NCC(=O)OCc1csc(CC(=O)Nc2ccc(C)cc2)n1,nan
59707188,108763,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,734,18,6,9,7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219046,108763,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,734,18,6,9,7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
90666121,108772,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,742,18,6,9,7.4,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C3CCC2CC(OC(=O)Nc2ccccc2-c2ccc(O)c(Cl)c2)C3)ccc1O,10.1039/C1MD00140J
CHEMBL3219054,108772,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,742,18,6,9,7.4,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C3CCC2CC(OC(=O)Nc2ccccc2-c2ccc(O)c(Cl)c2)C3)ccc1O,10.1039/C1MD00140J
11324939,93940,0,None,-6,2,Human,7.6,pEC50,=,7.6,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,CC(Cc1c[nH]c2ccccc12)NCC(O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
CHEMBL25133,93940,0,None,-6,2,Human,7.6,pEC50,=,7.6,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,CC(Cc1c[nH]c2ccccc12)NCC(O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
659759,46964,11,None,14,2,Human,7.6,pEC50,=,7.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
CHEMBL1543973,46964,11,None,14,2,Human,7.6,pEC50,=,7.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
1854978,37441,8,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,422,5,1,7,5.5,CC(C)Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2,nan
CHEMBL1457704,37441,8,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,422,5,1,7,5.5,CC(C)Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2,nan
10028830,2192,27,None,-1949,3,Human,4.6,pEC50,=,4.6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,497,13,4,6,2.7,O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1,10.1016/j.ejmech.2018.03.032
3932,2192,27,None,-1949,3,Human,4.6,pEC50,=,4.6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,497,13,4,6,2.7,O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1,10.1016/j.ejmech.2018.03.032
CHEMBL4238084,2192,27,None,-1949,3,Human,4.6,pEC50,=,4.6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,497,13,4,6,2.7,O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1,10.1016/j.ejmech.2018.03.032
102139105,185588,0,None,-,1,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrsAgonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrs,ChEMBL,392,10,5,7,2.5,COc1cc(CCC(O)CC(O)CCc2cc(O)c(O)c(OC)c2)ccc1O,10.1021/acs.jmedchem.0c01195
CHEMBL4874899,185588,0,None,-,1,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrsAgonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrs,ChEMBL,392,10,5,7,2.5,COc1cc(CCC(O)CC(O)CCc2cc(O)c(O)c(OC)c2)ccc1O,10.1021/acs.jmedchem.0c01195
1499,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
3779,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
536,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
CHEMBL434,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
DB01064,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
90666118,108769,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,702,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CC[C@@H](OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O,10.1039/C1MD00140J
CHEMBL3219051,108769,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,702,18,6,9,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CC[C@@H](OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O,10.1039/C1MD00140J
1499,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
3779,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
536,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
CHEMBL434,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
DB01064,2038,40,None,-72,36,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountingAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcounting,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.11.054
3038500,9222,5,None,-575,6,Human,5.6,pEC50,=,5.6,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,624,11,3,7,6.6,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1021/jm000286i
CHEMBL111201,9222,5,None,-575,6,Human,5.6,pEC50,=,5.6,Functional,InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.InvitrofunctionalefficacyinstimulatingincreaseincAMPinchinesehamsterovary(CHO)cellsexpressingtheclonedhumanbeta-2receptor.,ChEMBL,624,11,3,7,6.6,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1021/jm000286i
3145657,36414,13,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,381,4,0,4,4.3,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCC1,nan
CHEMBL1449091,36414,13,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,381,4,0,4,4.3,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCCC1,nan
652434,53763,5,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,399,6,1,8,3.7,CCOc1ccc2nc(NC(=O)CSc3nc4cccnc4n3C)sc2c1,nan
CHEMBL1606638,53763,5,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,399,6,1,8,3.7,CCOc1ccc2nc(NC(=O)CSc3nc4cccnc4n3C)sc2c1,nan
44142358,21433,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,311,0,1,3,3.9,Nc1cccc(C#Cc2ccc3c(=O)c4ccccc4oc3c2)c1,nan
CHEMBL1318214,21433,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,311,0,1,3,3.9,Nc1cccc(C#Cc2ccc3c(=O)c4ccccc4oc3c2)c1,nan
5182299,24694,9,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,457,5,1,4,4.5,O=C(Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1)c1c(F)cccc1F,nan
CHEMBL1345891,24694,9,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,457,5,1,4,4.5,O=C(Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1)c1c(F)cccc1F,nan
20959170,28535,5,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,5,0,4,4.7,Cc1ccc(N(C)S(=O)(=O)c2cc(-c3cnc(C4CC4)o3)ccc2C)cc1,nan
CHEMBL1378598,28535,5,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,5,0,4,4.7,Cc1ccc(N(C)S(=O)(=O)c2cc(-c3cnc(C4CC4)o3)ccc2C)cc1,nan
9927453,96151,0,None,-18,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
CHEMBL26393,96151,0,None,-18,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
46221398,8588,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,448,10,4,4,4.7,CCCCc1cc2c(cc1CCCC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
CHEMBL1095779,8588,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,448,10,4,4,4.7,CCCCc1cc2c(cc1CCCC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
9927453,96151,0,None,-18,3,Human,7.6,pEC50,=,7.6,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
CHEMBL26393,96151,0,None,-18,3,Human,7.6,pEC50,=,7.6,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
90644142,111653,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,365,7,4,4,2.5,OCc1cc(C(O)CNCCc2ccc(Br)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290971,111653,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,365,7,4,4,2.5,OCc1cc(C(O)CNCCc2ccc(Br)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
105,3375,81,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.11.072
2083,3375,81,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.11.072
558,3375,81,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.11.072
CHEMBL714,3375,81,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.11.072
DB01001,3375,81,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1016/j.bmcl.2011.11.072
3366873,24101,6,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,10,3,6,4.2,COc1ccc(CNC(=O)CCCCCNc2nc(S)nc3ccccc23)cc1,nan
CHEMBL1340869,24101,6,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,410,10,3,6,4.2,COc1ccc(CNC(=O)CCCCCNc2nc(S)nc3ccccc23)cc1,nan
105,3375,81,None,-23,3,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/acs.jmedchem.0c01195
2083,3375,81,None,-23,3,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/acs.jmedchem.0c01195
558,3375,81,None,-23,3,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/acs.jmedchem.0c01195
CHEMBL714,3375,81,None,-23,3,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/acs.jmedchem.0c01195
DB01001,3375,81,None,-23,3,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnologyAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasincreaseinintracellularcAMPlevelincubatedfor1hrbyalphascreentechnology,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/acs.jmedchem.0c01195
145989107,166430,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,424,13,4,5,3.7,O=c1ccc2c(C(CO)NCCCCOCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4290441,166430,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,424,13,4,5,3.7,O=c1ccc2c(C(CO)NCCCCOCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
11038599,47561,0,None,-15,3,Human,6.6,pEC50,=,6.6,Functional,"Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.",ChEMBL,516,11,5,6,3.7,C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL154906,47561,0,None,-15,3,Human,6.6,pEC50,=,6.6,Functional,"Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.",ChEMBL,516,11,5,6,3.7,C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
9801145,92902,0,None,-316,3,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,9,4,5,4,O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1016/j.bmcl.2007.05.069
CHEMBL245874,92902,0,None,-316,3,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,400,9,4,5,4,O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1016/j.bmcl.2007.05.069
46832227,14051,0,None,5,2,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,327,13,5,6,1.1,OCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm100326d
CHEMBL1083884,14051,0,None,5,2,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,327,13,5,6,1.1,OCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm100326d
CHEMBL1198851,14051,0,None,5,2,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,327,13,5,6,1.1,OCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,10.1021/jm100326d
42625743,12463,0,None,-12,3,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1186943,12463,0,None,-12,3,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL483407,12463,0,None,-12,3,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
2816345,29073,5,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,4,1,7,5.2,Cc1cc(C)c2c(N)c(-c3nnc(SCc4ccc(Cl)cc4)n3C)sc2n1,nan
CHEMBL1383213,29073,5,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,4,1,7,5.2,Cc1cc(C)c2c(N)c(-c3nnc(SCc4ccc(Cl)cc4)n3C)sc2n1,nan
4384568,162406,8,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,438,6,0,4,3.4,O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,nan
CHEMBL417709,162406,8,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,438,6,0,4,3.4,O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,nan
1481480,24029,12,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,484,8,0,7,4.9,CN(CCOc1ccc(-c2ccn(S(=O)(=O)c3cccc4ccccc34)n2)cc1)c1ccccn1,nan
CHEMBL1340208,24029,12,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,484,8,0,7,4.9,CN(CCOc1ccc(-c2ccn(S(=O)(=O)c3cccc4ccccc34)n2)cc1)c1ccccn1,nan
8441531,45150,6,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,394,8,2,4,5.4,CCCCOc1cccc(C(=O)Nc2ccc(NC(=O)c3cccs3)cc2)c1,nan
CHEMBL1527861,45150,6,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,394,8,2,4,5.4,CCCCOc1cccc(C(=O)Nc2ccc(NC(=O)c3cccs3)cc2)c1,nan
24794188,33461,1,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,5,0,3,5.4,O=C(c1ccc(OC2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1)N1CCCCC1,nan
CHEMBL1422222,33461,1,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,446,5,0,3,5.4,O=C(c1ccc(OC2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1)N1CCCCC1,nan
44396530,66682,0,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,591,14,4,8,4.8,CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL187317,66682,0,None,-23,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,591,14,4,8,4.8,CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
76333795,84807,0,None,-56,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,558,11,5,8,3.1,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1,10.1007/s00044-009-9257-x
CHEMBL2260985,84807,0,None,-56,3,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,558,11,5,8,3.1,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1,10.1007/s00044-009-9257-x
90666102,108750,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)cc3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219032,108750,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)cc3)CC2)ccc1O,10.1039/C1MD00140J
59707195,108757,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,700,18,6,9,6.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(F)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219040,108757,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,700,18,6,9,6.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(F)c3)CC2)ccc1O,10.1039/C1MD00140J
1362375,22750,14,None,-,1,Human,6.6,pEC50,=,6.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,388,6,2,5,4.8,CCc1ccc(OCC(=O)Nc2ccc(-c3nc4ccccc4o3)c(O)c2)cc1,nan
CHEMBL1329712,22750,14,None,-,1,Human,6.6,pEC50,=,6.6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,388,6,2,5,4.8,CCc1ccc(OCC(=O)Nc2ccc(-c3nc4ccccc4o3)c(O)c2)cc1,nan
127046951,139245,0,None,-,1,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3799427,139245,0,None,-,1,Human,5.6,pEC50,=,5.6,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
659759,46964,11,None,14,2,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
CHEMBL1543973,46964,11,None,14,2,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,4,1,4,3,CC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
4508,3061,85,None,1,2,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNCC(c1ccc(c(c1)O)O)O,nan
4866774,3061,85,None,1,2,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNCC(c1ccc(c(c1)O)O)O,nan
509,3061,85,None,1,2,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNCC(c1ccc(c(c1)O)O)O,nan
838,3061,85,None,1,2,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNCC(c1ccc(c(c1)O)O)O,nan
CHEMBL1740,3061,85,None,1,2,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,183,3,4,4,0.4,CNCC(c1ccc(c(c1)O)O)O,nan
73056755,103707,0,None,-,1,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,8,4,5,3,COc1ccc(C[C@H](NC[C@H](O)c2cc(O)cc(O)c2)C(C)C)cc1,10.1016/j.bmc.2013.11.030
CHEMBL3099661,103707,0,None,-,1,Human,4.6,pEC50,=,4.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,8,4,5,3,COc1ccc(C[C@H](NC[C@H](O)c2cc(O)cc(O)c2)C(C)C)cc1,10.1016/j.bmc.2013.11.030
2803618,58916,6,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,324,5,0,3,4.8,COc1ccc(C(C)=O)cc1COc1ccc(Cl)cc1Cl,nan
CHEMBL1704973,58916,6,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,324,5,0,3,4.8,COc1ccc(C(C)=O)cc1COc1ccc(Cl)cc1Cl,nan
49837874,54612,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2,10.1021/acs.jmedchem.0c01195
CHEMBL1615159,54612,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)Agonistactivityatbeta2adrenoceptor(unknownorigin),ChEMBL,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2,10.1021/acs.jmedchem.0c01195
44219641,177713,0,None,3,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,498,13,3,6,4.1,CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1,10.1016/j.bmc.2009.03.044
CHEMBL466088,177713,0,None,3,3,Human,7.6,pEC50,=,7.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,498,13,3,6,4.1,CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1,10.1016/j.bmc.2009.03.044
22422248,21935,1,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,4,3.6,CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N(C)c3ccc(OC)cc3)c21,nan
CHEMBL1322514,21935,1,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,4,3.6,CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)N(C)c3ccc(OC)cc3)c21,nan
10575455,99425,0,None,-13,3,Human,6.6,pEC50,=,6.6,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,448,8,5,7,1.2,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL286574,99425,0,None,-13,3,Human,6.6,pEC50,=,6.6,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,448,8,5,7,1.2,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O,10.1021/jm000544b
44313150,103208,0,None,-3,3,Human,5.6,pEC50,=,5.6,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL308868,103208,0,None,-3,3,Human,5.6,pEC50,=,5.6,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1,10.1016/s0960-894x(00)00459-5
2964893,49762,8,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,374,5,0,5,1.1,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccccc1,nan
CHEMBL1569866,49762,8,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,374,5,0,5,1.1,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccccc1,nan
123600,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
123600,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMboricacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
3104427,16887,8,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,7,2,3,4.4,O=C(C[n+]1cccc(NC(=O)c2ccccc2)c1)c1ccc(NC(=O)c2ccccc2)cc1,nan
CHEMBL125497,16887,8,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,7,2,3,4.4,O=C(C[n+]1cccc(NC(=O)c2ccccc2)c1)c1ccc(NC(=O)c2ccccc2)cc1,nan
CHEMBL1461759,16887,8,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,7,2,3,4.4,O=C(C[n+]1cccc(NC(=O)c2ccccc2)c1)c1ccc(NC(=O)c2ccccc2)cc1,nan
160510,100567,30,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
CHEMBL1506260,100567,30,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
CHEMBL295234,100567,30,None,-,1,Human,5.6,pEC50,=,5.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
2234461,43485,9,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
CHEMBL1510834,43485,9,None,-,1,Human,6.6,pEC50,=,6.6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
145982607,165021,0,None,-32,3,Human,6.6,pEC50,=,6.6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,432,12,3,4,4,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4245968,165021,0,None,-32,3,Human,6.6,pEC50,=,6.6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,432,12,3,4,4,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
5307895,49811,7,None,9,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,8,1,8,2.9,COc1ccc(OC)c(CCNC(=O)C2CCN(c3nnc(-n4cccc4)s3)CC2)c1,nan
CHEMBL1570251,49811,7,None,9,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,8,1,8,2.9,COc1ccc(OC)c(CCNC(=O)C2CCN(c3nnc(-n4cccc4)s3)CC2)c1,nan
44396596,122663,0,None,-25,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,485,10,4,6,4.3,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL361505,122663,0,None,-25,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,485,10,4,6,4.3,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
2816338,46263,5,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,6,1,7,5.4,C=CCn1c(SCc2ccc(F)cc2)nnc1-c1sc2nc(C)cc(C)c2c1N,nan
CHEMBL1538061,46263,5,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,6,1,7,5.4,C=CCn1c(SCc2ccc(F)cc2)nnc1-c1sc2nc(C)cc(C)c2c1N,nan
567,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1007/s00044-009-9257-x
9841972,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1007/s00044-009-9257-x
CHEMBL284782,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1007/s00044-009-9257-x
44565931,12309,0,None,-9549,4,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,552,11,4,8,3.6,CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1,10.1021/jm9000709
CHEMBL1186040,12309,0,None,-9549,4,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,552,11,4,8,3.6,CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1,10.1021/jm9000709
CHEMBL446806,12309,0,None,-9549,4,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,552,11,4,8,3.6,CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1,10.1021/jm9000709
567,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1016/s0960-894x(03)00073-8
9841972,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1016/s0960-894x(03)00073-8
CHEMBL284782,712,7,None,-83,7,Human,6.5,pEC50,=,6.5,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1016/s0960-894x(03)00073-8
145982668,165215,0,None,-38,3,Human,6.5,pEC50,=,6.5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,418,11,3,4,4.1,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4250215,165215,0,None,-38,3,Human,6.5,pEC50,=,6.5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,418,11,3,4,4.1,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
3904428,20216,8,None,4,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,342,4,1,2,4.8,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCCCC2)cc1,nan
CHEMBL1306990,20216,8,None,4,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,342,4,1,2,4.8,Cc1ccc(NC(=O)C(c2ccc(Cl)cc2)N2CCCCC2)cc1,nan
1499,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.03.044
3779,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.03.044
536,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.03.044
CHEMBL434,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.03.044
DB01064,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.03.044
1499,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
3779,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
536,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
CHEMBL434,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
DB01064,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2009.06.031
1499,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2009.01.022
3779,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2009.01.022
536,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2009.01.022
CHEMBL434,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2009.01.022
DB01064,2038,40,None,-72,36,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassayAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedasincreaseincAMPproductionafter2daysbyradioimmunoassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.ejmech.2009.01.022
70843740,124597,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,864,16,6,9,7.5,Cc1ccc(C(=O)NCc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645312,124597,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,864,16,6,9,7.5,Cc1ccc(C(=O)NCc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
59548073,124610,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,822,15,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1,nan
CHEMBL3645324,124610,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,822,15,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1,nan
59548112,124611,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,850,15,6,9,7.6,Cc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645325,124611,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,850,15,6,9,7.6,Cc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
59548133,124645,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,850,17,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)CCc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
CHEMBL3645358,124645,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,850,17,6,9,7,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)CCc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1,nan
59548071,124649,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,774,16,6,9,6,CN(CCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
CHEMBL3645362,124649,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,774,16,6,9,6,CN(CCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,nan
44396779,66655,0,None,-17,3,Human,8.5,pEC50,=,8.5,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,611,12,4,8,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL187209,66655,0,None,-17,3,Human,8.5,pEC50,=,8.5,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,611,12,4,8,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
11810896,118871,0,None,2,3,Human,8.5,pEC50,=,8.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,375,9,4,4,3.1,CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1,10.1021/jm0101500
CHEMBL345304,118871,0,None,2,3,Human,8.5,pEC50,=,8.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,375,9,4,4,3.1,CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1,10.1021/jm0101500
16049162,63695,0,None,31,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,3.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807826,63695,0,None,31,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,515,13,5,7,3.9,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1,10.1016/j.bmcl.2011.05.097
145991661,166062,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4283676,166062,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
56943515,111856,0,None,7,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,478,13,6,7,3.7,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1,10.1016/j.bmcl.2014.04.095
CHEMBL3298213,111856,0,None,7,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,478,13,6,7,3.7,CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1,10.1016/j.bmcl.2014.04.095
56943485,111915,0,None,12,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,544,12,5,8,3.6,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
CHEMBL3298831,111915,0,None,12,3,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,544,12,5,8,3.6,O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1,10.1016/j.bmcl.2014.04.095
24900811,69947,0,None,5,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
CHEMBL1945040,69947,0,None,5,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
24900751,69963,0,None,3,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.8,CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945290,69963,0,None,3,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,12,5,7,3.8,CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
24900749,69964,0,None,22,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,11,4,7,3.8,COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1945291,69964,0,None,22,4,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,493,11,4,7,3.8,COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,10.1016/j.bmcl.2011.10.049
53319788,58174,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,624,17,5,6,5.4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)C1,10.1016/j.bmcl.2011.01.043
CHEMBL1683939,58174,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,624,17,5,6,5.4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)C1,10.1016/j.bmcl.2011.01.043
11567751,196429,0,None,29,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,374,6,4,5,2.5,CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL600401,196429,0,None,29,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,374,6,4,5,2.5,CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
46232856,197012,0,None,128,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL604333,197012,0,None,128,2,Human,8.5,pEC50,=,8.5,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,424,6,4,5,3.4,CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
5581,101097,7,None,-2,6,Human,8.5,pEC50,=,8.5,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,345,5,3,6,2.6,COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
CHEMBL299175,101097,7,None,-2,6,Human,8.5,pEC50,=,8.5,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,345,5,3,6,2.6,COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
24764458,108759,0,None,1,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,716,18,6,9,6.9,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219042,108759,0,None,1,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,716,18,6,9,6.9,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
122194235,123343,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,690,16,6,8,7.3,O=C(Nc1ccccc1-c1ccc(O)c(Cl)c1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2015.10.008
CHEMBL3629353,123343,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproductionAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsassessedasstumulationofintracellularcAMPproduction,ChEMBL,690,16,6,8,7.3,O=C(Nc1ccccc1-c1ccc(O)c(Cl)c1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2015.10.008
53380558,63252,2,None,4,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,367,7,4,5,3.5,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,10.1016/j.bmc.2009.11.062
CHEMBL1800963,63252,2,None,4,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,367,7,4,5,3.5,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,10.1016/j.bmc.2009.11.062
10202462,69815,0,None,223,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940831,69815,0,None,223,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatbeta2-adrenoceptorendogenouslyexpressedinhumanBEAS-2BcellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,422,11,6,6,2.9,OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
16049158,63693,0,None,12,3,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,475,14,5,7,3.4,CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.05.097
CHEMBL1807824,63693,0,None,12,3,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,475,14,5,7,3.4,CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.05.097
16049361,110675,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,544,17,4,8,2.7,CCN(CC)CCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL3265158,110675,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,544,17,4,8,2.7,CCN(CC)CCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
16049363,110676,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,4,8,3.4,CCN(CC)CCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
CHEMBL3265159,110676,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,4,8,3.4,CCN(CC)CCN(CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
118737357,118455,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,703,12,5,8,6.1,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
CHEMBL3426705,118455,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,703,12,5,8,6.1,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1,10.1021/jm501915g
145990793,166100,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,457,9,5,5,3.3,O=C(Cc1ccccc1)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4284345,166100,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,457,9,5,5,3.3,O=C(Cc1ccccc1)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
57398768,70082,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,459,10,4,5,4.3,O=c1[nH]c2c(O)ccc(CCNCCc3cccc(CN[C@H]4C[C@@H]4c4ccccc4)c3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1946765,70082,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,459,10,4,5,4.3,O=c1[nH]c2c(O)ccc(CCNCCc3cccc(CN[C@H]4C[C@@H]4c4ccccc4)c3)c2s1,10.1016/j.bmcl.2011.10.049
57403815,70119,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,539,11,5,6,5.7,C[C@@H](NCc1ccccc1-c1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,10.1016/j.bmcl.2011.10.049
CHEMBL1947155,70119,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,539,11,5,6,5.7,C[C@@H](NCc1ccccc1-c1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,10.1016/j.bmcl.2011.10.049
10128077,111681,0,None,1,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290997,111681,0,None,1,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassayAgonistactivityathumanbeta2receptorinBEAS-2BcellsassessedascAMPaccumulationbyradioimmunoassay,ChEMBL,484,11,5,6,5.2,COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1,10.1016/j.bmcl.2014.04.069
10287658,111667,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,408,10,5,6,3.5,COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290984,111667,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,408,10,5,6,3.5,COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
45269866,190978,0,None,-1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL2448072,190978,0,None,-1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL551389,190978,0,None,-1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45273276,191365,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,429,10,4,5,3.6,N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1204005,191365,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,429,10,4,5,3.6,N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL556689,191365,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,429,10,4,5,3.6,N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
45273280,191400,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,11,4,4,3.7,O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1204006,191400,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,11,4,4,3.7,O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL557095,191400,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,435,11,4,4,3.7,O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45268128,192002,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,427,10,4,4,3.9,O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL1203988,192002,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,427,10,4,4,3.9,O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL562315,192002,0,None,1,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,427,10,4,4,3.9,O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
45268136,192065,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
CHEMBL1203989,192065,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
CHEMBL562669,192065,0,None,2,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,466,11,4,6,4,O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1,10.1016/j.bmc.2009.06.031
10283146,106695,0,None,-2,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,656,12,5,9,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL317003,106695,0,None,-2,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,656,12,5,9,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
44331346,203998,0,None,-5,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,638,17,5,8,4.2,CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(02)00608-x
CHEMBL99599,203998,0,None,-5,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,638,17,5,8,4.2,CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(02)00608-x
44331302,203937,0,None,-6,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivitywasdeterminedbyameasurementofincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2adrenergicreceptorBeta-2adrenergicreceptoragonistactivitywasdeterminedbyameasurementofincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,667,12,6,8,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL99219,203937,0,None,-6,3,Human,7.5,pEC50,=,7.5,Functional,Beta-2adrenergicreceptoragonistactivitywasdeterminedbyameasurementofincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2adrenergicreceptorBeta-2adrenergicreceptoragonistactivitywasdeterminedbyameasurementofincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,667,12,6,8,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
44268267,18220,0,None,199,2,Human,7.5,pEC50,=,7.5,Functional,Compoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptorCompoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptor,ChEMBL,345,10,3,5,2.8,COc1ccc(CC[C@@H](C)NC[C@@H](O)COc2ccc(O)cc2)cc1,10.1016/s0960-894x(98)00169-3
CHEMBL12719,18220,0,None,199,2,Human,7.5,pEC50,=,7.5,Functional,Compoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptorCompoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptor,ChEMBL,345,10,3,5,2.8,COc1ccc(CC[C@@H](C)NC[C@@H](O)COc2ccc(O)cc2)cc1,10.1016/s0960-894x(98)00169-3
22554040,20085,4,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,4,1,5,3.7,CC1=C(C(=O)Nc2ccc(C(=O)N3CCN(c4ccccc4F)CC3)cc2)SCCO1,nan
CHEMBL1305925,20085,4,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,4,1,5,3.7,CC1=C(C(=O)Nc2ccc(C(=O)N3CCN(c4ccccc4F)CC3)cc2)SCCO1,nan
24790337,22523,5,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,417,7,0,7,3.7,Cc1ccc(OCc2cc(C(=O)N(C)Cc3cnn(-c4ccccc4C)c3)no2)cn1,nan
CHEMBL1327806,22523,5,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,417,7,0,7,3.7,Cc1ccc(OCc2cc(C(=O)N(C)Cc3cnn(-c4ccccc4C)c3)no2)cn1,nan
1094286,50515,15,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
CHEMBL1577023,50515,15,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
11060184,119114,0,None,-39,3,Human,7.5,pEC50,=,7.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,501,11,4,6,3.5,C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL347616,119114,0,None,-39,3,Human,7.5,pEC50,=,7.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,501,11,4,6,3.5,C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
57395043,69974,0,None,3,2,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,420,12,5,5,3.1,OCc1cc([C@@H](O)CNCCc2ccc(CNCCc3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.10.049
CHEMBL1945300,69974,0,None,3,2,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,420,12,5,5,3.1,OCc1cc([C@@H](O)CNCCc2ccc(CNCCc3ccccc3)cc2)ccc1O,10.1016/j.bmcl.2011.10.049
10347461,105703,0,None,12,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1,10.1021/jm401532g
CHEMBL3126384,105703,0,None,12,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1,10.1021/jm401532g
CHEMBL3139025,105703,0,None,12,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,547,18,4,7,4.8,O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1,10.1021/jm401532g
90644141,111679,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,396,9,5,5,3.6,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290995,111679,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,396,9,5,5,3.6,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
653846,38290,10,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,301,3,1,6,2.8,CCC(=O)Nc1ccc(-c2nn3c(C)nnc3s2)cc1C,nan
CHEMBL1464795,38290,10,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,301,3,1,6,2.8,CCC(=O)Nc1ccc(-c2nn3c(C)nnc3s2)cc1C,nan
1371669,37317,10,None,64,2,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
CHEMBL1456621,37317,10,None,64,2,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
44441233,147387,0,None,-79,3,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL393471,147387,0,None,-79,3,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
90655864,110678,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,486,15,4,7,2.3,NCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL3265161,110678,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,486,15,4,7,2.3,NCCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
145985170,165700,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,10,5,5,3.2,CCCCC(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4276877,165700,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,10,5,5,3.2,CCCCC(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
122680878,165850,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,392,6,4,4,3.1,CCc1cc2c(cc1CC)CC(NC(CO)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1016/j.ejmech.2018.04.041
CHEMBL4279466,165850,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,392,6,4,4,3.1,CCc1cc2c(cc1CC)CC(NC(CO)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1016/j.ejmech.2018.04.041
141465530,165868,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,363,6,5,4,2.6,O=c1ccc2c(C(CO)NCCc3c[nH]c4ccccc34)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4279788,165868,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,363,6,5,4,2.6,O=c1ccc2c(C(CO)NCCc3c[nH]c4ccccc34)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
57393524,70083,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,538,12,3,6,5.8,CCN(Cc1ccncc1)Cc1cccc(-c2ccc(CCNCCc3ccc(O)c4[nH]c(=O)sc34)cc2)c1,10.1016/j.bmcl.2011.10.049
CHEMBL1946766,70083,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,538,12,3,6,5.8,CCN(Cc1ccncc1)Cc1cccc(-c2ccc(CCNCCc3ccc(O)c4[nH]c(=O)sc34)cc2)c1,10.1016/j.bmcl.2011.10.049
10940242,164500,0,None,-31,3,Human,6.5,pEC50,=,6.5,Functional,"Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.",ChEMBL,515,12,4,6,3.8,C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL422876,164500,0,None,-31,3,Human,6.5,pEC50,=,6.5,Functional,"Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.Concentrationthatcauses50%inhibitionofhumanbeta2adrenergicreceptor(AR),expressedinCHOcells.",ChEMBL,515,12,4,6,3.8,C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
11002571,47792,0,None,-5,3,Human,5.5,pEC50,=,5.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,348,8,4,4,3.2,C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL155092,47792,0,None,-5,3,Human,5.5,pEC50,=,5.5,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,348,8,4,4,3.2,C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
2598,3690,48,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,225,3,4,4,1.5,OC(c1cc(O)cc(c1)O)CNC(C)(C)C,10.1016/j.bmcl.2011.04.135
5403,3690,48,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,225,3,4,4,1.5,OC(c1cc(O)cc(c1)O)CNC(C)(C)C,10.1016/j.bmcl.2011.04.135
560,3690,48,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,225,3,4,4,1.5,OC(c1cc(O)cc(c1)O)CNC(C)(C)C,10.1016/j.bmcl.2011.04.135
CHEMBL1760,3690,48,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,225,3,4,4,1.5,OC(c1cc(O)cc(c1)O)CNC(C)(C)C,10.1016/j.bmcl.2011.04.135
DB00871,3690,48,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,225,3,4,4,1.5,OC(c1cc(O)cc(c1)O)CNC(C)(C)C,10.1016/j.bmcl.2011.04.135
76315640,84810,0,None,-7,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,575,12,3,7,5.8,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12,10.1007/s00044-009-9257-x
CHEMBL2260988,84810,0,None,-7,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,575,12,3,7,5.8,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12,10.1007/s00044-009-9257-x
4611324,21536,6,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,401,7,1,4,4.1,CCCCC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
CHEMBL1319108,21536,6,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,401,7,1,4,4.1,CCCCC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
139368780,184489,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsco-expressingV2receptorassessedasinductionofbeta-arrestin2recruitmentpreincubatedfor20minsfollowedbybeta2receptoragonistandmeasuredafter6hrsbyBright-GloreagentbasedchemiluminescenceassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsco-expressingV2receptorassessedasinductionofbeta-arrestin2recruitmentpreincubatedfor20minsfollowedbybeta2receptoragonistandmeasuredafter6hrsbyBright-Gloreagentbasedchemiluminescenceassay,ChEMBL,611,12,2,6,5.4,COc1ccc(Sc2ccc(S(=O)(=O)N(C)C(C)C)cc2C(=O)N[C@@H](CC(N)=O)Cc2ccc(C(C)(C)C)cc2)cc1,10.1021/acs.jmedchem.0c01195
CHEMBL4858076,184489,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsco-expressingV2receptorassessedasinductionofbeta-arrestin2recruitmentpreincubatedfor20minsfollowedbybeta2receptoragonistandmeasuredafter6hrsbyBright-GloreagentbasedchemiluminescenceassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsco-expressingV2receptorassessedasinductionofbeta-arrestin2recruitmentpreincubatedfor20minsfollowedbybeta2receptoragonistandmeasuredafter6hrsbyBright-Gloreagentbasedchemiluminescenceassay,ChEMBL,611,12,2,6,5.4,COc1ccc(Sc2ccc(S(=O)(=O)N(C)C(C)C)cc2C(=O)N[C@@H](CC(N)=O)Cc2ccc(C(C)(C)C)cc2)cc1,10.1021/acs.jmedchem.0c01195
16222940,185731,0,None,-47863,4,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,433,10,4,5,4.1,CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O,10.1021/jm8000345
CHEMBL487682,185731,0,None,-47863,4,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,433,10,4,5,4.1,CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O,10.1021/jm8000345
44591507,178618,0,None,-47863,4,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,433,10,4,5,4.1,CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O,10.1021/jm9000709
CHEMBL473702,178618,0,None,-47863,4,Human,5.5,pEC50,=,5.5,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,433,10,4,5,4.1,CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O,10.1021/jm9000709
10626150,99473,0,None,-208,3,Human,5.5,pEC50,=,5.5,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,534,11,5,9,1.3,CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
CHEMBL286868,99473,0,None,-208,3,Human,5.5,pEC50,=,5.5,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,534,11,5,9,1.3,CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
145990515,166330,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c([C@H](CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4288610,166330,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c([C@H](CO)NCCc3ccc(O)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
16735259,85137,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL228417,85137,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
11270071,98442,0,None,-7,3,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
CHEMBL279931,98442,0,None,-7,3,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1,10.1007/s00044-009-9257-x
11270071,98442,0,None,-7,3,Human,6.5,pEC50,=,6.5,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
CHEMBL279931,98442,0,None,-7,3,Human,6.5,pEC50,=,6.5,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,328,6,3,2,4.1,C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1,10.1016/s0960-894x(03)00073-8
2839830,49743,9,None,9,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,287,4,0,2,3.9,CC(C)=CCC(C)(C)C1OCCN1C(=O)c1ccccc1,nan
CHEMBL1569630,49743,9,None,9,2,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,287,4,0,2,3.9,CC(C)=CCC(C)(C)C1OCCN1C(=O)c1ccccc1,nan
663855,32649,8,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,440,5,1,9,2.3,c1nc(NCCN2CCOCC2)c2sc3nc(N4CCOCC4)c4c(c3c2n1)CCC4,nan
CHEMBL1415227,32649,8,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,440,5,1,9,2.3,c1nc(NCCN2CCOCC2)c2sc3nc(N4CCOCC4)c4c(c3c2n1)CCC4,nan
24820094,59339,1,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,409,5,1,4,5.1,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)s1,nan
CHEMBL1723653,59339,1,None,-,1,Human,5.5,pEC50,=,5.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,409,5,1,4,5.1,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)s1,nan
4312580,39883,7,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,5,1,7,2.8,Cc1cc(C)n2nc(C(=O)Nc3cccc(S(=O)(=O)N(C)c4ccccc4)c3)nc2n1,nan
CHEMBL1479957,39883,7,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,5,1,7,2.8,Cc1cc(C)n2nc(C(=O)Nc3cccc(S(=O)(=O)N(C)c4ccccc4)c3)nc2n1,nan
9853471,200499,0,None,-177,3,Human,6.5,pEC50,=,6.5,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL75604,200499,0,None,-177,3,Human,6.5,pEC50,=,6.5,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
3167769,23766,5,None,28,2,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,531,6,0,8,6.6,O=C(CSc1nnc(-c2ccncc2)n1Cc1ccco1)N1c2ccccc2Sc2ccc(Cl)cc21,nan
CHEMBL1337858,23766,5,None,28,2,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,531,6,0,8,6.6,O=C(CSc1nnc(-c2ccncc2)n1Cc1ccco1)N1c2ccccc2Sc2ccc(Cl)cc21,nan
24794116,66684,1,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,410,6,0,4,4.7,CSc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
CHEMBL1873201,66684,1,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,410,6,0,4,4.7,CSc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
44444173,93460,0,None,-5,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevelAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevel,ChEMBL,516,11,4,7,3.3,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2,10.1016/j.bmcl.2007.09.011
CHEMBL248547,93460,0,None,-5,3,Human,7.5,pEC50,=,7.5,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevelAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPlevel,ChEMBL,516,11,4,7,3.3,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2,10.1016/j.bmcl.2007.09.011
2977891,21568,8,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
CHEMBL1319376,21568,8,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
1716469,59478,1,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,393,8,1,6,3.2,CCOC(=O)c1cn(C2CC2)c2c(F)c(NCCCN(C)C)c(F)cc2c1=O,nan
CHEMBL1728955,59478,1,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,393,8,1,6,3.2,CCOC(=O)c1cn(C2CC2)c2c(F)c(NCCCN(C)C)c(F)cc2c1=O,nan
9804536,164998,0,None,-169,3,Human,6.5,pEC50,=,6.5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,465,11,4,5,3.5,O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.03.032
CHEMBL4245391,164998,0,None,-169,3,Human,6.5,pEC50,=,6.5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,465,11,4,5,3.5,O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.03.032
135799890,185044,0,None,-,1,Human,4.5,pEC50,=,4.5,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,304,8,4,4,2.4,CCCCCCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4866730,185044,0,None,-,1,Human,4.5,pEC50,=,4.5,Functional,Agonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassayAgonistactivityatbeta2adrenoceptorinHEK293cellsco-expressingV2receptorassessedasincreaseincAMPaccumulationmeasuredafter30minsbyHTRFassay,ChEMBL,304,8,4,4,2.4,CCCCCCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
3164412,52836,9,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,408,5,0,5,1.7,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
CHEMBL1598434,52836,9,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset2.(Classofassay:confirmatory),ChEMBL,408,5,0,5,1.7,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
90666113,108762,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,744,18,6,9,7.5,Cc1cc(C)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c(-c2ccc(O)c(Cl)c2)c1,10.1039/C1MD00140J
CHEMBL3219045,108762,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,744,18,6,9,7.5,Cc1cc(C)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c(-c2ccc(O)c(Cl)c2)c1,10.1039/C1MD00140J
44392558,64858,0,None,-2,3,Human,7.4,pEC50,=,7.4,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,471,11,4,6,4.1,CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL182770,64858,0,None,-2,3,Human,7.4,pEC50,=,7.4,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,471,11,4,6,4.1,CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
9831168,200349,0,None,-1,3,Human,7.4,pEC50,=,7.4,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,552,11,6,6,5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL74085,200349,0,None,-1,3,Human,7.4,pEC50,=,7.4,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,552,11,6,6,5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1,10.1016/s0960-894x(00)00459-5
16013947,21450,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,442,6,1,8,1.9,CC(=O)Nc1ccc(S(=O)(=O)N2CCC(Oc3ccc(-n4cnnn4)cc3)CC2)cc1,nan
CHEMBL1318405,21450,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,442,6,1,8,1.9,CC(=O)Nc1ccc(S(=O)(=O)N2CCC(Oc3ccc(-n4cnnn4)cc3)CC2)cc1,nan
1236197,24728,10,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,352,5,1,5,4,CC(=O)Nc1ccc(-c2nnc(SCc3ccc(C)cc3)n2C)cc1,nan
CHEMBL1346173,24728,10,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,352,5,1,5,4,CC(=O)Nc1ccc(-c2nnc(SCc3ccc(C)cc3)n2C)cc1,nan
9896742,200589,0,None,2,3,Human,7.4,pEC50,=,7.4,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,618,12,6,7,6,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL76403,200589,0,None,2,3,Human,7.4,pEC50,=,7.4,Functional,Percentadenylylcyclaseactivationat10000nMofcompoundconcentrationPercentadenylylcyclaseactivationat10000nMofcompoundconcentration,ChEMBL,618,12,6,7,6,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1,10.1016/s0960-894x(00)00459-5
244359,39776,18,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,4,0,3,3.6,O=C(C(c1ccccc1)c1ccccc1)N1CCN(c2ccccn2)CC1,nan
CHEMBL1479163,39776,18,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,4,0,3,3.6,O=C(C(c1ccccc1)c1ccccc1)N1CCN(c2ccccn2)CC1,nan
1202551,26412,9,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,366,3,0,3,5.1,Cc1cccc2nc(COc3ccc4ccccc4c3Br)cn12,nan
CHEMBL1361693,26412,9,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,366,3,0,3,5.1,Cc1cccc2nc(COc3ccc4ccccc4c3Br)cn12,nan
24979207,35359,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,374,6,1,5,2.2,CCN(CC)S(=O)(=O)c1cc(NC(=O)C2=COCCO2)ccc1Cl,nan
CHEMBL1439691,35359,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,374,6,1,5,2.2,CCN(CC)S(=O)(=O)c1cc(NC(=O)C2=COCCO2)ccc1Cl,nan
3762,14301,18,None,-1,2,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,239,5,4,4,1.9,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,nan
CHEMBL1201153,14301,18,None,-1,2,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,239,5,4,4,1.9,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,nan
CHEMBL1201213,14301,18,None,-1,2,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,239,5,4,4,1.9,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,nan
46221396,8442,0,None,1,2,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,364,4,4,4,2.6,Cc1cc2c(cc1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
CHEMBL1094483,8442,0,None,1,2,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,364,4,4,4,2.6,Cc1cc2c(cc1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,10.1021/jm100068m
11957285,41326,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,8,2,7,2.4,O=C(CCCCCn1c(=O)[nH]c2ccsc2c1=O)NCc1ccc2c(c1)OCO2,nan
CHEMBL1491674,41326,6,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,8,2,7,2.4,O=C(CCCCCn1c(=O)[nH]c2ccsc2c1=O)NCc1ccc2c(c1)OCO2,nan
3164412,52836,9,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,408,5,0,5,1.7,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
CHEMBL1598434,52836,9,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,408,5,0,5,1.7,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Cl)cc1,nan
1499,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.05.064
3779,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.05.064
536,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.05.064
CHEMBL434,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.05.064
DB01064,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.05.064
1499,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2011.04.135
3779,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2011.04.135
536,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2011.04.135
CHEMBL434,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2011.04.135
DB01064,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmcl.2011.04.135
145981079,165983,0,None,39,2,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4282047,165983,0,None,39,2,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,358,6,4,4,2.8,O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
57400228,69968,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,413,8,4,6,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CN4CCCC4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1945295,69968,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,413,8,4,6,2.8,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CN4CCCC4)cc3)c2s1,10.1016/j.bmcl.2011.10.049
443372,10110,18,None,-3,8,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,10.1021/jm401532g
CHEMBL1160723,10110,18,None,-3,8,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,10.1021/jm401532g
CHEMBL2062275,10110,18,None,-3,8,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,10.1021/jm401532g
11318358,105856,0,None,50,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,519,16,4,7,3.8,O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
CHEMBL3126387,105856,0,None,50,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,519,16,4,7,3.8,O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
CHEMBL3139613,105856,0,None,50,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,519,16,4,7,3.8,O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
1499,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.08.043
3779,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.08.043
536,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.08.043
CHEMBL434,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.08.043
DB01064,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2011.08.043
1499,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm801016j
3779,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm801016j
536,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm801016j
CHEMBL434,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm801016j
DB01064,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm801016j
1499,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm100326d
3779,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm100326d
536,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm100326d
CHEMBL434,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm100326d
DB01064,2038,40,None,-72,36,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1021/jm100326d
57403563,69806,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,482,13,6,8,2.9,COc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c(OC)c1,10.1016/j.bmcl.2011.11.072
CHEMBL1940822,69806,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,482,13,6,8,2.9,COc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c(OC)c1,10.1016/j.bmcl.2011.11.072
57391348,69812,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,498,12,6,6,4.6,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(-c4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940828,69812,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,498,12,6,6,4.6,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(-c4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
1084214,45236,9,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
CHEMBL1528594,45236,9,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,8,1,6,2.7,CCOC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCC3)cc2)cc1,nan
5808,176054,16,None,1,5,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(C)NC[C@@H](O)c1ccc(O)c(O)c1,nan
CHEMBL1257092,176054,16,None,1,5,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(C)NC[C@@H](O)c1ccc(O)c(O)c1,nan
CHEMBL460574,176054,16,None,1,5,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(C)NC[C@@H](O)c1ccc(O)c(O)c1,nan
11003341,45994,0,None,-15,3,Human,6.4,pEC50,=,6.4,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,376,10,4,4,3.5,C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL153558,45994,0,None,-15,3,Human,6.4,pEC50,=,6.4,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,376,10,4,4,3.5,C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
11003341,45994,0,None,-15,3,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,376,10,4,4,3.5,C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL153558,45994,0,None,-15,3,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,376,10,4,4,3.5,C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
44441232,93268,0,None,-316,3,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL247519,93268,0,None,-316,3,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,415,9,4,6,3.8,C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
90644145,111656,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,446,9,4,5,4.1,OCc1cc(C(O)CNCCc2ccc(N3CCC(c4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290974,111656,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,446,9,4,5,4.1,OCc1cc(C(O)CNCCc2ccc(N3CCC(c4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
11661536,75542,0,None,-63,3,Human,5.4,pEC50,=,5.4,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,411,9,4,5,3.8,O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1,10.1021/jm0509445
CHEMBL205389,75542,0,None,-63,3,Human,5.4,pEC50,=,5.4,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,411,9,4,5,3.8,O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1,10.1021/jm0509445
56677231,63243,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,367,7,4,5,3.5,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,10.1016/j.bmc.2009.11.062
CHEMBL1800934,63243,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,367,7,4,5,3.5,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,10.1016/j.bmc.2009.11.062
59548060,124622,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,894,18,6,10,7.1,COc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645336,124622,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,894,18,6,10,7.1,COc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
45484558,192513,0,None,4,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,498,11,8,7,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL565770,192513,0,None,4,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,498,11,8,7,1.6,CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
22063464,196679,0,None,10,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.12.087
CHEMBL602257,196679,0,None,10,2,Human,8.4,pEC50,=,8.4,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,370,6,4,5,2.7,Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1,10.1016/j.bmcl.2009.12.087
2419,3377,76,None,17,6,Human,8.4,pEC50,=,8.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,nan
5152,3377,76,None,17,6,Human,8.4,pEC50,=,8.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,nan
559,3377,76,None,17,6,Human,8.4,pEC50,=,8.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,nan
CHEMBL1263,3377,76,None,17,6,Human,8.4,pEC50,=,8.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,nan
DB00938,3377,76,None,17,6,Human,8.4,pEC50,=,8.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,nan
4907596,48925,9,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,451,7,2,6,3.9,CC(=O)Nc1ccc(S(=O)(=O)N(Cc2ccco2)Cc2cc3ccccc3nc2O)cc1,nan
CHEMBL1562838,48925,9,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,451,7,2,6,3.9,CC(=O)Nc1ccc(S(=O)(=O)N(Cc2ccco2)Cc2cc3ccccc3nc2O)cc1,nan
688467,85287,2,None,107,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL229476,85287,2,None,107,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
156015491,177584,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,346,6,4,5,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4649718,177584,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,346,6,4,5,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
CHEMBL4651054,177584,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassayAgonistactivityathumanbeta2adrenoreceptoroverexpressedinhumanHEK293cellsassessedascAMPaccumulationincubatedfor60minsbyHTRFassay,ChEMBL,346,6,4,5,1.7,O=C1COc2c(cc(O)cc2C(O)CNCCc2ccc(F)cc2)N1,10.1016/j.bmc.2019.115178
44396513,66319,0,None,-30,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,577,12,4,8,4.4,CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL185660,66319,0,None,-30,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,577,12,4,8,4.4,CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
45273281,191419,0,None,1,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL2448075,191419,0,None,1,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL557295,191419,0,None,1,3,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
10553602,126508,0,None,1,3,Human,7.4,pEC50,=,7.4,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,506,10,6,8,0.9,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL36568,126508,0,None,1,3,Human,7.4,pEC50,=,7.4,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,506,10,6,8,0.9,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
2934084,51009,13,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,387,6,1,4,4.7,CC(=O)Nc1cc(C(=O)OC(C(=O)c2ccccc2)c2ccccc2)ccc1C,nan
CHEMBL1581214,51009,13,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,387,6,1,4,4.7,CC(=O)Nc1cc(C(=O)OC(C(=O)c2ccccc2)c2ccccc2)ccc1C,nan
4586131,36723,8,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,1,8,3.7,CN(C)CCNc1ncnc2c1sc1nc(N3CCCC3)c3c(c12)CC(C)(C)OC3,nan
CHEMBL1451649,36723,8,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,1,8,3.7,CN(C)CCNc1ncnc2c1sc1nc(N3CCCC3)c3c(c12)CC(C)(C)OC3,nan
1542103,22249,22,None,-3,3,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,418,4,0,6,4.2,Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1,nan
CHEMBL1325250,22249,22,None,-3,3,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,418,4,0,6,4.2,Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1,nan
2044389,48913,8,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,424,6,1,8,4.8,COCCCNc1ncnc2c1sc1nc(-c3ccco3)c3c(c12)CC(C)(C)OC3,nan
CHEMBL1562748,48913,8,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,424,6,1,8,4.8,COCCCNc1ncnc2c1sc1nc(-c3ccco3)c3c(c12)CC(C)(C)OC3,nan
2999219,45554,2,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,486,8,1,6,2.2,O=S(=O)(c1cc(C(F)(F)F)ccc1Cl)N1CCN(CC(O)COCC2CCCO2)CC1,nan
CHEMBL1531486,45554,2,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,486,8,1,6,2.2,O=S(=O)(c1cc(C(F)(F)F)ccc1Cl)N1CCN(CC(O)COCC2CCCO2)CC1,nan
CHEMBL3219053,108771,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,728,19,6,9,6.6,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@@H]3[C@@H](COC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)[C@@H]3C2)ccc1O,10.1039/C1MD00140J
2964893,49762,8,None,-,1,Human,7.4,pEC50,=,7.4,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,374,5,0,5,1.1,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccccc1,nan
CHEMBL1569866,49762,8,None,-,1,Human,7.4,pEC50,=,7.4,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,374,5,0,5,1.1,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccccc1,nan
3145570,46694,5,None,1,2,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,397,4,0,5,3.5,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCOCC1,nan
CHEMBL1541608,46694,5,None,1,2,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,397,4,0,5,3.5,CC(Sc1nc(-c2ccccc2)cc(C(F)(F)F)n1)C(=O)N1CCOCC1,nan
9541908,40262,6,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,1,5,4.9,O=S(=O)(Nc1cccc(-c2cn3cccnc3n2)c1)c1ccc(-c2ccccc2)cc1,nan
CHEMBL1483308,40262,6,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,426,5,1,5,4.9,O=S(=O)(Nc1cccc(-c2cn3cccnc3n2)c1)c1ccc(-c2ccccc2)cc1,nan
16746367,45598,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,473,7,0,4,5,COc1ccc(C2/C=C\CN(Cc3ccc(N(C)C)cc3)CC(=O)N2Cc2ccc(F)cc2)cc1,nan
CHEMBL1531814,45598,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,473,7,0,4,5,COc1ccc(C2/C=C\CN(Cc3ccc(N(C)C)cc3)CC(=O)N2Cc2ccc(F)cc2)cc1,nan
24747616,19742,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,487,7,0,4,5.4,COc1ccc([C@H]2/C=C\CN(Cc3ccc(N(C)C)cc3)[C@@H](C)C(=O)N2Cc2ccc(F)cc2)cc1,nan
CHEMBL1303120,19742,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,487,7,0,4,5.4,COc1ccc([C@H]2/C=C\CN(Cc3ccc(N(C)C)cc3)[C@@H](C)C(=O)N2Cc2ccc(F)cc2)cc1,nan
44392542,65460,0,None,-6,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,543,11,4,6,5.5,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1,10.1007/s00044-009-9257-x
CHEMBL183552,65460,0,None,-6,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,543,11,4,6,5.5,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1,10.1007/s00044-009-9257-x
11432806,65795,0,None,-134,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL184407,65795,0,None,-134,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,549,11,4,8,3.6,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
4144800,47469,7,None,28,2,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,372,4,1,7,2.5,O=C(CN1C(=O)CCC1=O)Nc1nc(-c2nc3ccccc3s2)cs1,nan
CHEMBL1548237,47469,7,None,28,2,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,372,4,1,7,2.5,O=C(CN1C(=O)CCC1=O)Nc1nc(-c2nc3ccccc3s2)cs1,nan
44392575,63975,0,None,-2,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,441,10,4,6,2.8,C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
CHEMBL181300,63975,0,None,-2,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,441,10,4,6,2.8,C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1007/s00044-009-9257-x
983630,42982,10,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,5,1,4,4.2,COc1ccc(CC(=O)Nc2ccc(-c3cn4ccccc4n3)cc2)cc1,nan
CHEMBL1506379,42982,10,None,-,1,Human,7.4,pEC50,=,7.4,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,5,1,4,4.2,COc1ccc(CC(=O)Nc2ccc(-c3cn4ccccc4n3)cc2)cc1,nan
3764964,42959,8,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,414,6,1,7,4.1,CCN(CCO)c1ncnc2c1sc1nc(CC(C)C)c3c(c12)CC(C)(C)OC3,nan
CHEMBL1506229,42959,8,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,414,6,1,7,4.1,CCN(CCO)c1ncnc2c1sc1nc(CC(C)C)c3c(c12)CC(C)(C)OC3,nan
10283539,167155,0,None,-346,3,Human,6.3,pEC50,=,6.3,Functional,InvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptorInvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,697,14,6,9,2.8,CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00607-8
CHEMBL431048,167155,0,None,-346,3,Human,6.3,pEC50,=,6.3,Functional,InvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptorInvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,697,14,6,9,2.8,CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00607-8
123600,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
123600,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
1575,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
9816,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
CHEMBL1002,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
DB13139,2261,0,None,1,2,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacidAgonistactivityatrecombinanthumanbeta2adrenoceptorexpressedinHEK293TcellsassessedasincreaseinIBMX-inducedcAMPaccumulationusing[3H]-cAMPafter30minsbyliquidscintillationcountinginpresenceof100uMphenylboronicacid,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O,10.1016/j.bmc.2011.11.054
44392508,64824,0,None,-3,2,Human,7.3,pEC50,=,7.3,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,494,11,3,6,4.3,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(OCc2ccccc2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL182614,64824,0,None,-3,2,Human,7.3,pEC50,=,7.3,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,494,11,3,6,4.3,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(OCc2ccccc2)c1,10.1016/j.bmcl.2004.12.033
73056756,103709,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,9,4,5,3.1,CCC[C@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
CHEMBL3099663,103709,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,9,4,5,3.1,CCC[C@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
24817832,66755,3,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,412,6,0,4,4.1,COc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)c(F)c1,nan
CHEMBL1876406,66755,3,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,412,6,0,4,4.1,COc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)c(F)c1,nan
2812,4687,91,None,-48,39,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,0,2,5.4,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,nan
CHEMBL104,4687,91,None,-48,39,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,0,2,5.4,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,nan
5309628,38018,6,None,134,2,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,397,4,0,4,3.3,CC(=O)N1CCc2cc(C(=O)CN3CCN(c4cccc(Cl)c4)CC3)ccc21,nan
CHEMBL1462616,38018,6,None,134,2,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,397,4,0,4,3.3,CC(=O)N1CCc2cc(C(=O)CN3CCN(c4cccc(Cl)c4)CC3)ccc21,nan
10648298,99167,0,None,-120,3,Human,5.3,pEC50,=,5.3,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,477,10,5,7,2.1,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL284788,99167,0,None,-120,3,Human,5.3,pEC50,=,5.3,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,477,10,5,7,2.1,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
127046952,139444,0,None,-87,2,Human,4.3,pEC50,=,4.3,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,421,12,3,5,4.5,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800636,139444,0,None,-87,2,Human,4.3,pEC50,=,4.3,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,421,12,3,5,4.5,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
1362375,22750,14,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,6,2,5,4.8,CCc1ccc(OCC(=O)Nc2ccc(-c3nc4ccccc4o3)c(O)c2)cc1,nan
CHEMBL1329712,22750,14,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,6,2,5,4.8,CCc1ccc(OCC(=O)Nc2ccc(-c3nc4ccccc4o3)c(O)c2)cc1,nan
20954901,44519,5,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,400,6,2,5,3.9,CSc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
CHEMBL1522050,44519,5,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,400,6,2,5,3.9,CSc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
44144146,59129,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,500,7,1,4,5.5,COC(=O)C1=C(c2cccc(OCc3ccccc3)c2)C[C@@H]2CC[C@H]1N2C(=O)NCc1cccc(F)c1,nan
CHEMBL1714856,59129,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,500,7,1,4,5.5,COC(=O)C1=C(c2cccc(OCc3ccccc3)c2)C[C@@H]2CC[C@H]1N2C(=O)NCc1cccc(F)c1,nan
1484653,50542,12,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,363,4,0,5,4.4,Cc1ccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)cc1,nan
CHEMBL1577237,50542,12,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,363,4,0,5,4.4,Cc1ccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)cc1,nan
3317235,46482,2,None,2,2,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,392,5,0,5,4.8,COc1ccc(C2=NN(C(=O)c3cccs3)C(c3ccc(OC)cc3)C2)cc1,nan
CHEMBL1539906,46482,2,None,2,2,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,392,5,0,5,4.8,COc1ccc(C2=NN(C(=O)c3cccs3)C(c3ccc(OC)cc3)C2)cc1,nan
44396736,66463,0,None,-11,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,617,12,4,9,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL186271,66463,0,None,-11,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,617,12,4,9,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
2986164,51512,11,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,338,7,1,2,4.7,CCCCN(C(=O)c1ccc(NC(=O)C(C)C)cc1)c1ccccc1,nan
CHEMBL1585368,51512,11,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,338,7,1,2,4.7,CCCCN(C(=O)c1ccc(NC(=O)C(C)C)cc1)c1ccccc1,nan
1016754,22459,12,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,395,5,1,5,5.3,O=C(CSc1ccc(Cl)cc1)Nc1ccc(-c2nc3ncccc3o2)cc1,nan
CHEMBL1327325,22459,12,None,-,1,Human,7.3,pEC50,=,7.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,395,5,1,5,5.3,O=C(CSc1ccc(Cl)cc1)Nc1ccc(-c2nc3ncccc3o2)cc1,nan
11668125,196680,0,None,4,2,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,384,7,4,5,2.9,CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
CHEMBL602258,196680,0,None,4,2,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,384,7,4,5,2.9,CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
962697,194772,4,None,51,2,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,332,5,3,6,4.3,Oc1ccccc1Nc1nc(NCc2ccco2)c2ccccc2n1,nan
CHEMBL531322,194772,4,None,51,2,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,332,5,3,6,4.3,Oc1ccccc1Nc1nc(NCc2ccco2)c2ccccc2n1,nan
CHEMBL588751,194772,4,None,51,2,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,332,5,3,6,4.3,Oc1ccccc1Nc1nc(NCc2ccco2)c2ccccc2n1,nan
46221395,8416,0,None,-6,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,336,4,4,4,2,O=c1ccc2c([C@@H](O)CNC3Cc4ccccc4C3)ccc(O)c2[nH]1,10.1021/jm100068m
CHEMBL1094323,8416,0,None,-6,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,336,4,4,4,2,O=c1ccc2c([C@@H](O)CNC3Cc4ccccc4C3)ccc(O)c2[nH]1,10.1021/jm100068m
44331426,4333,0,None,1,3,Human,8.3,pEC50,=,8.3,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,578,13,7,9,1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL101521,4333,0,None,1,3,Human,8.3,pEC50,=,8.3,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,578,13,7,9,1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
44268264,97691,0,None,120,2,Human,8.3,pEC50,=,8.3,Functional,Compoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptorCompoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptor,ChEMBL,345,10,3,5,2.8,COc1ccc(CC[C@@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1,10.1016/s0960-894x(98)00169-3
CHEMBL274361,97691,0,None,120,2,Human,8.3,pEC50,=,8.3,Functional,Compoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptorCompoundwastestedforagonistactivityagainstclonedhumanbeta-2adrenergicreceptor,ChEMBL,345,10,3,5,2.8,COc1ccc(CC[C@@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1,10.1016/s0960-894x(98)00169-3
11026016,46395,0,None,-1,3,Human,8.3,pEC50,=,8.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,411,10,4,5,2.5,C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL153916,46395,0,None,-1,3,Human,8.3,pEC50,=,8.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,411,10,4,5,2.5,C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
56670158,63699,0,None,15,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,497,13,5,7,2.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
CHEMBL1807830,63699,0,None,15,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60minsAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasstimulationofcAMPaccumulationafter60mins,ChEMBL,497,13,5,7,2.5,O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1,10.1016/j.bmcl.2011.05.097
90655866,110680,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,576,17,3,7,4.3,CC(C)N(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
CHEMBL3265163,110680,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,576,17,3,7,4.3,CC(C)N(C)CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
145980824,165947,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1ccccc1CCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2018.04.041
CHEMBL4281324,165947,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,354,7,4,5,2.1,COc1ccccc1CCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2018.04.041
145992510,166308,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,452,15,4,5,4.5,O=c1ccc2c(C(CO)NCCCCCCOCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4288132,166308,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,452,15,4,5,4.5,O=c1ccc2c(C(CO)NCCCCCCOCCCCc3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
57394848,69803,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,434,9,6,6,2.8,OCc1cc(C(O)CNC2Cc3ccc(NCC(O)c4ccccc4)cc3C2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940819,69803,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,434,9,6,6,2.8,OCc1cc(C(O)CNC2Cc3ccc(NCC(O)c4ccccc4)cc3C2)ccc1O,10.1016/j.bmcl.2011.11.072
9906822,161341,0,None,-40,3,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,358,7,3,3,4.1,COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL416012,161341,0,None,-40,3,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,358,7,3,3,4.1,COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12,10.1007/s00044-009-9257-x
11268355,95862,0,None,-40,3,Human,8.3,pEC50,=,8.3,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,358,7,3,3,4.1,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12,10.1016/s0960-894x(03)00073-8
CHEMBL26183,95862,0,None,-40,3,Human,8.3,pEC50,=,8.3,Functional,AgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-ARAgonisticactivityagainsthumanBeta-2adrenergicreceptorbymeasuringcAMPaccumulationinCHOcellsexpressingbeta3-AR,ChEMBL,358,7,3,3,4.1,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12,10.1016/s0960-894x(03)00073-8
45101521,192506,0,None,4,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,570,15,8,9,1.3,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL565747,192506,0,None,4,2,Human,8.3,pEC50,=,8.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,570,15,8,9,1.3,CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
2212788,27911,9,None,-,1,Human,8.3,pEC50,=,8.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,490,10,1,7,4.2,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Br)cc1,nan
CHEMBL1373386,27911,9,None,-,1,Human,8.3,pEC50,=,8.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,490,10,1,7,4.2,C=CCn1c(CCNC(=O)c2cccs2)nnc1SCC(=O)c1ccc(Br)cc1,nan
44396531,66430,0,None,-38,3,Human,8.3,pEC50,=,8.3,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,647,18,4,8,6.4,CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL186135,66430,0,None,-38,3,Human,8.3,pEC50,=,8.3,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,647,18,4,8,6.4,CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
54582151,61425,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,711,24,5,8,7.3,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773266,61425,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,711,24,5,8,7.3,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
49861320,54623,0,None,6,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,426,11,3,5,3.1,O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1204003,54623,0,None,6,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,426,11,3,5,3.1,O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
CHEMBL1615579,54623,0,None,6,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,426,11,3,5,3.1,O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1,10.1016/j.bmc.2009.06.031
45272417,191124,0,None,1,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL2448074,191124,0,None,1,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
CHEMBL552368,191124,0,None,1,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenolAgonistactivityathumanclonedadrenergicbeta2receptorexpressedinCHOcellsassessedas[125I]cAMPaccumulationafter2daysbyradioimmunoassayrelativetoisoproterenol,ChEMBL,455,10,4,4,4.7,O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1,10.1016/j.bmc.2009.06.031
567,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0101500
9841972,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0101500
CHEMBL284782,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0101500
44369602,46537,0,None,6,2,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1cccc(CC(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL154036,46537,0,None,6,2,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1cccc(CC(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
9799092,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL154419,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
567,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0509445
9841972,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0509445
CHEMBL284782,712,7,None,-83,7,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,363,9,3,4,3.1,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O,10.1021/jm0509445
9799092,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
CHEMBL154419,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
9845282,75518,0,None,-501,3,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
CHEMBL205224,75518,0,None,-501,3,Human,7.3,pEC50,=,7.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.8,C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0509445
9799092,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL154419,46999,0,None,-12,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,362,9,4,4,3.1,C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
44441230,93267,0,None,-31,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL247518,93267,0,None,-31,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
44441228,167062,0,None,-7,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL430390,167062,0,None,-7,3,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,431,9,4,6,4.3,C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
87142783,118454,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,5,9,5.8,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
CHEMBL3426704,118454,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcountingAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedascAMPaccumulationusing[125I]cAMPbyscintillationcounting,ChEMBL,719,13,5,9,5.8,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/jm501915g
141465526,165741,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,6,4,4,2.9,CC(C)(Cc1ccccc1)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2018.04.041
CHEMBL4277527,165741,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,352,6,4,4,2.9,CC(C)(Cc1ccccc1)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1016/j.ejmech.2018.04.041
145992971,166340,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,443,8,5,5,3.4,O=C(Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.04.041
CHEMBL4288842,166340,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,443,8,5,5,3.4,O=C(Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1)c1ccccc1,10.1016/j.ejmech.2018.04.041
145989180,166528,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,409,8,5,5,2.7,CC(C)C(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4292249,166528,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,409,8,5,5,2.7,CC(C)C(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
57393116,69810,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,478,11,6,6,4.2,CC(C)(C)c1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
CHEMBL1940826,69810,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,478,11,6,6,4.2,CC(C)(C)c1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
57391349,69813,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,472,11,6,6,4,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940829,69813,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,472,11,6,6,4,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc4ccccc4c3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
10393774,120115,0,None,-1258,3,Human,5.3,pEC50,=,5.3,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,598,14,5,9,2.1,CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O,10.1021/jm000544b
CHEMBL35500,120115,0,None,-1258,3,Human,5.3,pEC50,=,5.3,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,598,14,5,9,2.1,CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O,10.1021/jm000544b
9845280,76889,0,None,-3,3,Human,6.3,pEC50,=,6.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,3,5,4.5,COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1,10.1021/jm0509445
CHEMBL208352,76889,0,None,-3,3,Human,6.3,pEC50,=,6.3,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,3,5,4.5,COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1,10.1021/jm0509445
90644146,111657,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,460,10,4,5,4.2,OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290975,111657,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,460,10,4,5,4.2,OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
135799875,185677,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,276,3,4,4,1.7,CC(C)(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4876155,185677,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,276,3,4,4,1.7,CC(C)(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
44441236,92903,0,None,-3981,3,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,416,9,4,5,4.5,O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1016/j.bmcl.2007.05.069
CHEMBL245875,92903,0,None,-3981,3,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,416,9,4,5,4.5,O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1016/j.bmcl.2007.05.069
1371669,37317,10,None,64,2,Human,6.3,pEC50,=,6.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
CHEMBL1456621,37317,10,None,64,2,Human,6.3,pEC50,=,6.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
127046950,139388,0,None,-2,3,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800303,139388,0,None,-2,3,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
141486999,165992,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,229,1,2,4,2.1,Oc1cc2c(cc1O)C(c1ccco1)=NCC2,10.1021/acs.jnatprod.7b00762
CHEMBL4282215,165992,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,229,1,2,4,2.1,Oc1cc2c(cc1O)C(c1ccco1)=NCC2,10.1021/acs.jnatprod.7b00762
1631626,27255,14,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,292,7,1,5,2.9,COc1ccccc1OCCCC(=O)Nc1nccs1,nan
CHEMBL1368804,27255,14,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,292,7,1,5,2.9,COc1ccccc1OCCCC(=O)Nc1nccs1,nan
46232815,197350,0,None,-5,2,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,412,6,4,5,3.7,CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL606208,197350,0,None,-5,2,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,412,6,4,5,3.7,CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
145984584,165188,0,None,-102,3,Human,7.3,pEC50,=,7.3,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,444,10,5,4,4.4,O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4249564,165188,0,None,-102,3,Human,7.3,pEC50,=,7.3,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,444,10,5,4,4.4,O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1,10.1016/j.ejmech.2018.03.032
11074,482,4,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassay,ChEMBL,314,2,2,4,3.7,Brc1ccc2c(c1)c(N)nc(n2)Nc1ccccc1,10.1021/acs.jmedchem.0c01195
145998261,482,4,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassay,ChEMBL,314,2,2,4,3.7,Brc1ccc2c(c1)c(N)nc(n2)Nc1ccccc1,10.1021/acs.jmedchem.0c01195
CHEMBL4869271,482,4,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinsf9cellsassessedasreversalofnorepinephrineinhibitionof[3H]DHAPbindingtobeta2adrenoceptorbyradioligandbindingassay,ChEMBL,314,2,2,4,3.7,Brc1ccc2c(c1)c(N)nc(n2)Nc1ccccc1,10.1021/acs.jmedchem.0c01195
20950665,66808,4,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,418,6,1,4,2.8,CC1CCC(NC(=O)CCS(=O)(=O)c2ccc3c(c2)CCN3C(=O)C2CC2)CC1,nan
CHEMBL1878737,66808,4,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,418,6,1,4,2.8,CC1CCC(NC(=O)CCS(=O)(=O)c2ccc3c(c2)CCN3C(=O)C2CC2)CC1,nan
24817062,28530,7,None,-,1,Human,5.3,pEC50,=,5.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,382,5,0,3,4.1,O=C(c1ccc(OC2CCN(Cc3ccc(F)cc3)CC2)cc1)N1CCCC1,nan
CHEMBL1378531,28530,7,None,-,1,Human,5.3,pEC50,=,5.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,382,5,0,3,4.1,O=C(c1ccc(OC2CCN(Cc3ccc(F)cc3)CC2)cc1)N1CCCC1,nan
76322965,84811,0,None,-52,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,511,9,3,7,4.5,C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL2260989,84811,0,None,-52,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,511,9,3,7,4.5,C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
4625323,197006,8,None,46,2,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,419,8,1,6,5.6,CCCc1ccc(OCc2nc(-c3ccc(NC(=O)c4cccs4)cc3)no2)cc1,nan
CHEMBL604311,197006,8,None,46,2,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,419,8,1,6,5.6,CCCc1ccc(OCc2nc(-c3ccc(NC(=O)c4cccs4)cc3)no2)cc1,nan
44396577,66547,0,None,-25,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,561,12,4,6,5.9,C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL186676,66547,0,None,-25,3,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,561,12,4,6,5.9,C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
145971070,164302,2,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsassessedasincreaseinisoproterenol-inducedcAMPproductionpreincubatedfor20minsfollowedbyisoproterenolstimulationandmeasuredafter5minsbychemiluminescence-basedassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsassessedasincreaseinisoproterenol-inducedcAMPproductionpreincubatedfor20minsfollowedbyisoproterenolstimulationandmeasuredafter5minsbychemiluminescence-basedassay,ChEMBL,646,12,4,4,4.4,CNC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)[C@H](Cc1ccc(C(N)=O)cc1)NC(=O)C(c1ccccc1)C1CCCCC1,10.1021/acs.jmedchem.0c01195
CHEMBL4225747,164302,2,None,-,1,Human,5.3,pEC50,=,5.3,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsassessedasincreaseinisoproterenol-inducedcAMPproductionpreincubatedfor20minsfollowedbyisoproterenolstimulationandmeasuredafter5minsbychemiluminescence-basedassayAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinHEK293cellsassessedasincreaseinisoproterenol-inducedcAMPproductionpreincubatedfor20minsfollowedbyisoproterenolstimulationandmeasuredafter5minsbychemiluminescence-basedassay,ChEMBL,646,12,4,4,4.4,CNC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)[C@H](Cc1ccc(C(N)=O)cc1)NC(=O)C(c1ccccc1)C1CCCCC1,10.1021/acs.jmedchem.0c01195
24817832,66755,3,None,-,1,Human,5.3,pEC50,=,5.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,412,6,0,4,4.1,COc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)c(F)c1,nan
CHEMBL1876406,66755,3,None,-,1,Human,5.3,pEC50,=,5.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,412,6,0,4,4.1,COc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)c(F)c1,nan
24790337,22523,5,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,417,7,0,7,3.7,Cc1ccc(OCc2cc(C(=O)N(C)Cc3cnn(-c4ccccc4C)c3)no2)cn1,nan
CHEMBL1327806,22523,5,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,417,7,0,7,3.7,Cc1ccc(OCc2cc(C(=O)N(C)Cc3cnn(-c4ccccc4C)c3)no2)cn1,nan
193350,67249,6,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c(O)c1,nan
CHEMBL1902287,67249,6,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c(O)c1,nan
CHEMBL1906949,67249,6,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,303,6,5,5,2.1,CC(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c(O)c1,nan
4378441,54445,8,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,3,1,5,5.7,O=C(Nc1ccc2oc(-c3ccc4ccccc4c3)nc2c1)c1ccc2c(c1)OCCO2,nan
CHEMBL1612392,54445,8,None,-,1,Human,5.3,pEC50,=,5.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,3,1,5,5.7,O=C(Nc1ccc2oc(-c3ccc4ccccc4c3)nc2c1)c1ccc2c(c1)OCCO2,nan
16189131,27520,6,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,391,6,0,5,4.7,CSc1ccc(C(=O)C2CCCN(Cc3cccn3-c3cccnc3)C2)cc1,nan
CHEMBL1370616,27520,6,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,391,6,0,5,4.7,CSc1ccc(C(=O)C2CCCN(Cc3cccn3-c3cccnc3)C2)cc1,nan
90666114,108764,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,734,18,6,9,7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3cc(F)ccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219047,108764,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,734,18,6,9,7,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3cc(F)ccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O,10.1039/C1MD00140J
12005176,48520,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,458,6,1,7,4.5,CCOC(=O)c1ccc(N2C(=O)c3[nH]nc(-c4ccco4)c3C2c2cccc([N+](=O)[O-])c2)cc1,nan
CHEMBL1559039,48520,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,458,6,1,7,4.5,CCOC(=O)c1ccc(N2C(=O)c3[nH]nc(-c4ccco4)c3C2c2cccc([N+](=O)[O-])c2)cc1,nan
2957284,37670,10,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,360,7,1,4,3.2,CCCCC(=O)Nc1ccc(C(=O)N2CCCC(C(=O)OCC)C2)cc1,nan
CHEMBL1459608,37670,10,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,360,7,1,4,3.2,CCCCC(=O)Nc1ccc(C(=O)N2CCCC(C(=O)OCC)C2)cc1,nan
16299699,41213,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,449,7,2,4,3.7,CN(c1ccccc1)S(=O)(=O)c1cccc(C(=O)Nc2cccc(C(=O)NC3CC3)c2)c1,nan
CHEMBL1490889,41213,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,449,7,2,4,3.7,CN(c1ccccc1)S(=O)(=O)c1cccc(C(=O)Nc2cccc(C(=O)NC3CC3)c2)c1,nan
76315637,84806,0,None,-47,3,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,607,12,4,10,4.2,CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
CHEMBL2260984,84806,0,None,-47,3,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,607,12,4,10,4.2,CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1007/s00044-009-9257-x
11632691,197211,0,None,3,2,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,398,7,4,5,3.5,CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
CHEMBL605372,197211,0,None,3,2,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,398,7,4,5,3.5,CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
9832011,104908,0,None,-19,3,Human,6.2,pEC50,=,6.2,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,644,13,6,7,6.5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL312074,104908,0,None,-19,3,Human,6.2,pEC50,=,6.2,Functional,Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR)Compoundwasevaluatedforitsinhibitoryactivityagainsthumanbeta-2adrenergicreceptor(AR),ChEMBL,644,13,6,7,6.5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
24823464,97081,0,None,-2041,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,418,10,4,4,4.7,CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O,10.1021/jm9000709
CHEMBL270964,97081,0,None,-2041,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassayAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationbyenzymeimmunoassay,ChEMBL,418,10,4,4,4.7,CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O,10.1021/jm9000709
5350331,108336,7,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,12,0,8,3.8,C=CCc1ccc(OCCOc2ccc(/C=N/n3cnnc3)cc2OCC)c(OC)c1,nan
CHEMBL3211107,108336,7,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,12,0,8,3.8,C=CCc1ccc(OCCOc2ccc(/C=N/n3cnnc3)cc2OCC)c(OC)c1,nan
1329577,53057,6,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,4,0,3,3.5,O=C(c1cccc(Cl)c1)N1CCC(C(=O)N2CCN(Cc3ccccc3)CC2)CC1,nan
CHEMBL1600429,53057,6,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,4,0,3,3.5,O=C(c1cccc(Cl)c1)N1CCC(C(=O)N2CCN(Cc3ccccc3)CC2)CC1,nan
44589400,190337,0,None,-2,3,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityatadrenergicbeta-2receptorAgonistactivityatadrenergicbeta-2receptor,ChEMBL,446,11,2,5,4.2,COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1,10.1016/j.bmc.2008.11.030
CHEMBL530556,190337,0,None,-2,3,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityatadrenergicbeta-2receptorAgonistactivityatadrenergicbeta-2receptor,ChEMBL,446,11,2,5,4.2,COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1,10.1016/j.bmc.2008.11.030
2234461,43485,9,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
CHEMBL1510834,43485,9,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,432,7,1,6,2.7,COC(=O)c1ccc(NC(=O)COc2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,nan
24177540,183957,1,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrsAgonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrs,ChEMBL,362,9,5,6,2.5,COc1cc(CCC(O)CC(O)CCc2ccc(O)c(O)c2)ccc1O,10.1021/acs.jmedchem.0c01195
CHEMBL4850211,183957,1,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrsAgonistactivityatbeta2adrenoceptorinhumanA431cellsmeasuredfor24hrs,ChEMBL,362,9,5,6,2.5,COc1cc(CCC(O)CC(O)CCc2ccc(O)c(O)c2)ccc1O,10.1021/acs.jmedchem.0c01195
59548089,124563,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,818,18,6,10,6.1,COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
CHEMBL3645279,124563,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPAssay:cAMPassayswereperformedinaradioimmunoassayformatusingtheFlashplateAdenylylCyclaseActivationAssaySystemwith[125I]-cAMP(NENSMP004,PerkinElmerLifeSciencesInc.,Boston,Mass.),accordingtothemanufacturersinstructions.Forthisassay,HEK-293celllinesstablyexpressingclonedhumanβ1orβ2receptorsweregrowntonearconfluencyinDMEMsupplementedwith10%FBSandGeneticin(500μg/mL)",ChEMBL,818,18,6,10,6.1,COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,nan
102262219,139402,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,488,12,4,6,4.1,COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800400,139402,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,488,12,4,6,4.1,COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
44396513,66319,0,None,-30,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,577,12,4,8,4.4,CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL185660,66319,0,None,-30,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,577,12,4,8,4.4,CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
16035377,110677,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,500,15,3,7,2.5,CN(C)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL3265160,110677,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,500,15,3,7,2.5,CN(C)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
16035379,110688,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,562,17,3,7,3.9,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
CHEMBL3265171,110688,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,562,17,3,7,3.9,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1,10.1021/ml4005232
16035068,112118,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,3,7,4.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc2ccccc12,10.1021/ml4005232
CHEMBL3265167,112118,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,3,7,4.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc2ccccc12,10.1021/ml4005232
CHEMBL3304488,112118,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,578,17,3,7,4.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc2ccccc12,10.1021/ml4005232
56943517,111916,0,None,3,3,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,621,13,5,9,2.8,CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1,10.1016/j.bmcl.2014.04.095
CHEMBL3298832,111916,0,None,3,3,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassayAgonistactivityathumanbeta2adrenergicreceptorinhumanBEAS-2BcellsbycAMPaccumulationassay,ChEMBL,621,13,5,9,2.8,CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1,10.1016/j.bmcl.2014.04.095
59119466,111680,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,436,10,5,7,3.3,COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290996,111680,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,436,10,5,7,3.3,COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2014.04.069
57391345,69807,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,482,13,6,8,2.9,COc1ccc(OC)c(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1,10.1016/j.bmcl.2011.11.072
CHEMBL1940823,69807,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,482,13,6,8,2.9,COc1ccc(OC)c(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1,10.1016/j.bmcl.2011.11.072
1165076,39670,5,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,466,5,1,7,4.8,Cc1ccc(Cn2ccc(NC(=O)c3cc4nc(-c5ccco5)cc(C(F)(F)F)n4n3)n2)cc1,nan
CHEMBL1478198,39670,5,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,466,5,1,7,4.8,Cc1ccc(Cn2ccc(NC(=O)c3cc4nc(-c5ccco5)cc(C(F)(F)F)n4n3)n2)cc1,nan
44396577,66547,0,None,-25,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,561,12,4,6,5.9,C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL186676,66547,0,None,-25,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,561,12,4,6,5.9,C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
44396596,122663,0,None,-25,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,485,10,4,6,4.3,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL361505,122663,0,None,-25,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,485,10,4,6,4.3,COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
44396488,66327,0,None,-5,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,556,12,4,7,3.8,C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL185703,66327,0,None,-5,3,Human,8.2,pEC50,=,8.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,556,12,4,7,3.8,C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
1287365,37544,9,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,373,5,2,3,5.3,Cc1ccc(SCC(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc1,nan
CHEMBL1458579,37544,9,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,373,5,2,3,5.3,Cc1ccc(SCC(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc1,nan
666902,24745,9,None,213,2,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,451,8,1,7,5.3,Clc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
CHEMBL1346316,24745,9,None,213,2,Human,8.2,pEC50,=,8.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,451,8,1,7,5.3,Clc1ccc(OCc2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)cc1,nan
44396738,123243,0,None,-54,3,Human,7.2,pEC50,=,7.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,655,13,5,9,4.8,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
CHEMBL362763,123243,0,None,-54,3,Human,7.2,pEC50,=,7.2,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,655,13,5,9,4.8,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1016/j.bmcl.2004.10.035
10233153,4141,0,None,-6,3,Human,7.2,pEC50,=,7.2,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,642,11,5,9,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
CHEMBL100351,4141,0,None,-6,3,Human,7.2,pEC50,=,7.2,Functional,Beta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptorBeta-2adrenergicreceptoragonistactivityasincreasedcAMPlevelsinCHOcellsexpressinghumanBeta-2-adrenoceptor,ChEMBL,642,11,5,9,3.1,CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00608-x
10076548,162566,0,None,-6,3,Human,7.2,pEC50,=,7.2,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,13,5,8,2.7,CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
CHEMBL418600,162566,0,None,-6,3,Human,7.2,pEC50,=,7.2,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,13,5,8,2.7,CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1021/jm000544b
123686,1928,42,None,-74,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
12581,1928,42,None,-74,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
CHEMBL11268,1928,42,None,-74,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
2953239,30991,5,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
CHEMBL1401186,30991,5,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,388,5,0,5,1.4,Cc1ccc(S(=O)(=O)N(C)CC(=O)N2CCN(c3ccccn3)CC2)cc1,nan
20954905,22889,5,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,398,7,2,5,3.6,CCOc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
CHEMBL1330871,22889,5,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,398,7,2,5,3.6,CCOc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
1025603,28196,11,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,430,8,1,4,3.4,CN(Cc1ccccc1)S(=O)(=O)c1ccc(NS(=O)(=O)Cc2ccccc2)cc1,nan
CHEMBL1375364,28196,11,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,430,8,1,4,3.4,CN(Cc1ccccc1)S(=O)(=O)c1ccc(NS(=O)(=O)Cc2ccccc2)cc1,nan
10601234,111419,0,None,-91,3,Human,5.2,pEC50,=,5.2,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,493,11,5,8,1.7,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL32888,111419,0,None,-91,3,Human,5.2,pEC50,=,5.2,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,493,11,5,8,1.7,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
145984792,165030,0,None,-776,3,Human,5.2,pEC50,=,5.2,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,461,12,4,5,3.1,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
CHEMBL4246134,165030,0,None,-776,3,Human,5.2,pEC50,=,5.2,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,461,12,4,5,3.1,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
2458483,50159,6,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,0,4,4.5,CN(Cc1ccccc1F)c1nc(-c2cccnc2)nc2ccccc12,nan
CHEMBL1573444,50159,6,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,344,4,0,4,4.5,CN(Cc1ccccc1F)c1nc(-c2cccnc2)nc2ccccc12,nan
1094286,50515,15,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
CHEMBL1577023,50515,15,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,359,5,1,5,4.2,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)cc1,nan
73056759,103708,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,8,4,5,3,COc1ccc(C[C@@H](NC[C@H](O)c2cc(O)cc(O)c2)C(C)C)cc1,10.1016/j.bmc.2013.11.030
CHEMBL3099662,103708,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,8,4,5,3,COc1ccc(C[C@@H](NC[C@H](O)c2cc(O)cc(O)c2)C(C)C)cc1,10.1016/j.bmc.2013.11.030
73057082,103710,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,9,4,5,3.1,CCC[C@@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
CHEMBL3099664,103710,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,345,9,4,5,3.1,CCC[C@@H](Cc1ccc(OC)cc1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2013.11.030
1854978,37441,8,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,5,1,7,5.5,CC(C)Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2,nan
CHEMBL1457704,37441,8,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,422,5,1,7,5.5,CC(C)Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2,nan
135799890,185044,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,304,8,4,4,2.4,CCCCCCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4866730,185044,0,None,-,1,Human,5.2,pEC50,=,5.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,304,8,4,4,2.4,CCCCCCNC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
44377771,164849,0,None,-102,3,Human,6.2,pEC50,=,6.2,Functional,AgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptorAgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptor,ChEMBL,596,10,5,9,3.4,O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1,10.1016/s0960-894x(01)00063-4
CHEMBL424167,164849,0,None,-102,3,Human,6.2,pEC50,=,6.2,Functional,AgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptorAgonisticactivitywasassessedbymeasurementofcAMPaccumulationlevelsinCHOcellsexpressinghumanbeta-2-adrenergicreceptor,ChEMBL,596,10,5,9,3.4,O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1,10.1016/s0960-894x(01)00063-4
1090196,53531,15,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,378,5,1,6,3.2,CCN1CCN(c2ccc(NC(=O)c3ccc([N+](=O)[O-])o3)cc2Cl)CC1,nan
CHEMBL1604735,53531,15,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,378,5,1,6,3.2,CCN1CCN(c2ccc(NC(=O)c3ccc([N+](=O)[O-])o3)cc2Cl)CC1,nan
1288829,24897,10,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,391,6,1,6,5,Cc1ccc(SCC(=O)Nc2ccc(-c3nnc(-c4ccco4)o3)cc2)cc1,nan
CHEMBL1347493,24897,10,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,391,6,1,6,5,Cc1ccc(SCC(=O)Nc2ccc(-c3nnc(-c4ccco4)o3)cc2)cc1,nan
57396616,69811,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,492,14,6,6,4.5,CC(C)CCc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
CHEMBL1940827,69811,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,492,14,6,6,4.5,CC(C)CCc1ccc(C(O)CNc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1,10.1016/j.bmcl.2011.11.072
9823696,75342,0,None,-398,3,Human,6.2,pEC50,=,6.2,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.7,Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1021/jm0509445
CHEMBL204827,75342,0,None,-398,3,Human,6.2,pEC50,=,6.2,Functional,Activityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproductionActivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsbystimulationofcAMPproduction,ChEMBL,424,9,4,4,4.7,Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1,10.1021/jm0509445
44441235,150322,0,None,-1584,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,430,9,4,5,4.9,C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL395834,150322,0,None,-1584,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,430,9,4,5,4.9,C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
145991502,166151,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,400,7,4,4,3.7,O=c1ccc2c(C(CO)NCC(c3ccccc3)c3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4285474,166151,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,400,7,4,4,3.7,O=c1ccc2c(C(CO)NCC(c3ccccc3)c3ccccc3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
145992059,166273,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)CC(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4287518,166273,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,423,9,5,5,3.1,CC(C)CC(=O)Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
90644150,111661,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,491,11,4,7,3.1,COc1ccc(CN2CCN(c3ccc(CCNCC(O)c4ccc(O)c(CO)c4)cc3)CC2)cc1,10.1016/j.bmcl.2014.04.069
CHEMBL3290979,111661,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,491,11,4,7,3.1,COc1ccc(CN2CCN(c3ccc(CCNCC(O)c4ccc(O)c(CO)c4)cc3)CC2)cc1,10.1016/j.bmcl.2014.04.069
1104203,44576,13,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,350,4,1,7,3.6,O=C(Nc1ccc(-c2nc3ncccc3o2)cc1)c1ccc([N+](=O)[O-])o1,nan
CHEMBL1522618,44576,13,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,350,4,1,7,3.6,O=C(Nc1ccc(-c2nc3ncccc3o2)cc1)c1ccc([N+](=O)[O-])o1,nan
9169702,66868,6,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,423,8,1,5,2.7,CCC(=O)c1ccc(OCC(=O)N2CCN(CC(=O)Nc3ccc(C)cc3)CC2)cc1,nan
CHEMBL1881705,66868,6,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,423,8,1,5,2.7,CCC(=O)c1ccc(OCC(=O)N2CCN(CC(=O)Nc3ccc(C)cc3)CC2)cc1,nan
90666109,108756,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,700,18,6,9,6.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(O)cc(F)c3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219039,108756,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,700,18,6,9,6.3,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(O)cc(F)c3)CC2)ccc1O,10.1039/C1MD00140J
160510,100567,30,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
CHEMBL1506260,100567,30,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
CHEMBL295234,100567,30,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,184,0,1,1,2.5,CC1=NCCc2c1[nH]c1ccccc21,nan
6619041,21016,6,None,6,2,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,502,9,2,8,3.2,CCOc1ccc(NC(=O)CNC(=O)c2nn(-c3ccc(OC)c(OC)c3)c(=O)c3ccccc23)cc1,nan
CHEMBL1313270,21016,6,None,6,2,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,502,9,2,8,3.2,CCOc1ccc(NC(=O)CNC(=O)c2nn(-c3ccc(OC)c(OC)c3)c(=O)c3ccccc23)cc1,nan
44396532,66352,0,None,-42,3,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,455,9,4,5,4.3,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL185836,66352,0,None,-42,3,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,455,9,4,5,4.3,C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
655791,20361,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,462,7,1,8,4.2,Cn1c(CNc2nc(-c3ccccc3)cs2)nnc1SCC(=O)N1CCc2ccccc21,nan
CHEMBL1308099,20361,5,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,462,7,1,8,4.2,Cn1c(CNc2nc(-c3ccccc3)cs2)nnc1SCC(=O)N1CCc2ccccc21,nan
1369799,44172,8,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,401,5,1,5,5.2,CC(C)(C)c1ccc(OCC(=O)Nc2ccc(-c3nc4cccnc4o3)cc2)cc1,nan
CHEMBL1519042,44172,8,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,401,5,1,5,5.2,CC(C)(C)c1ccc(OCC(=O)Nc2ccc(-c3nc4cccnc4o3)cc2)cc1,nan
105,3375,81,None,-23,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/jm100068m
2083,3375,81,None,-23,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/jm100068m
558,3375,81,None,-23,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/jm100068m
CHEMBL714,3375,81,None,-23,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/jm100068m
DB01001,3375,81,None,-23,3,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassayAgonistactivityathumanbeta2adrenergicreceptorassessedasincreaseincAMPlevelbywholecellassay,ChEMBL,239,4,4,4,1.3,OCc1cc(ccc1O)C(CNC(C)(C)C)O,10.1021/jm100068m
46232816,196623,0,None,3,2,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,432,7,4,5,4,CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
CHEMBL601858,196623,0,None,3,2,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,432,7,4,5,4,CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.12.087
10305108,110860,0,None,-134,3,Human,6.2,pEC50,=,6.2,Functional,InvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptorInvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,659,17,6,8,4.2,CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1,10.1016/s0960-894x(02)00607-8
CHEMBL327519,110860,0,None,-134,3,Human,6.2,pEC50,=,6.2,Functional,InvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptorInvitroagonistactivitymeasuredbyincreaseincAMPlevelsinchinesehamsterovarycells(CHO)cellsexpressinghumanBeta-2adrenergicreceptor,ChEMBL,659,17,6,8,4.2,CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1,10.1016/s0960-894x(02)00607-8
44392490,64846,0,None,1,3,Human,7.2,pEC50,=,7.2,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,507,10,4,6,4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL182708,64846,0,None,1,3,Human,7.2,pEC50,=,7.2,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,507,10,4,6,4,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1,10.1016/j.bmcl.2004.12.033
1253647,36819,10,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,448,3,0,8,2.6,O=C(c1cc2c(=O)n3ccccc3nc2s1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,nan
CHEMBL1452334,36819,10,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,448,3,0,8,2.6,O=C(c1cc2c(=O)n3ccccc3nc2s1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,nan
24794013,51078,1,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,404,5,1,4,4.4,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)cn1,nan
CHEMBL1581826,51078,1,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,404,5,1,4,4.4,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)cn1,nan
127045853,139136,0,None,117,2,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3798748,139136,0,None,117,2,Human,8.2,pEC50,=,8.2,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
16735261,85222,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
CHEMBL228998,85222,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2009.11.062
16735261,85222,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
CHEMBL228998,85222,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulation,ChEMBL,317,7,4,5,2.4,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,10.1016/j.bmc.2013.11.030
44396737,66453,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,683,14,4,10,5.2,CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1,10.1016/j.bmcl.2004.10.035
CHEMBL186236,66453,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,683,14,4,10,5.2,CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1,10.1016/j.bmcl.2004.10.035
44396530,66682,0,None,-23,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,591,14,4,8,4.8,CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL187317,66682,0,None,-23,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,591,14,4,8,4.8,CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
658782,49794,10,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,465,4,0,9,1.9,Cn1c(N2CCN(c3ccccn3)CC2)nc2c1c(=O)n(Cc1ccc(Cl)cc1)c(=O)n2C,nan
CHEMBL1570111,49794,10,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,465,4,0,9,1.9,Cn1c(N2CCN(c3ccccn3)CC2)nc2c1c(=O)n(Cc1ccc(Cl)cc1)c(=O)n2C,nan
42629372,63251,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL1800962,63251,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,337,6,4,4,3.5,C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
44392542,65460,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,543,11,4,6,5.5,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1,10.1016/j.bmcl.2004.12.033
CHEMBL183552,65460,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,543,11,4,6,5.5,C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1,10.1016/j.bmcl.2004.12.033
44396559,66443,0,None,-7,2,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,499,11,4,6,4.7,CCOc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
CHEMBL186196,66443,0,None,-7,2,Human,8.1,pEC50,=,8.1,Functional,AgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptorAgonisticactivitywasdeterminedbymeasuringcAMPaccumulationinCHOcellsexpressingclonedhumanBeta-2adrenergicreceptor,ChEMBL,499,11,4,6,4.7,CCOc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12,10.1016/j.bmcl.2004.10.035
4191632,45272,9,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,8,2,6,3.7,O=C(CCCCCn1c(=S)[nH]c2ccccc2c1=O)NCc1ccc2c(c1)OCO2,nan
CHEMBL1528906,45272,9,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,8,2,6,3.7,O=C(CCCCCn1c(=S)[nH]c2ccccc2c1=O)NCc1ccc2c(c1)OCO2,nan
1016754,22459,12,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,395,5,1,5,5.3,O=C(CSc1ccc(Cl)cc1)Nc1ccc(-c2nc3ncccc3o2)cc1,nan
CHEMBL1327325,22459,12,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,395,5,1,5,5.3,O=C(CSc1ccc(Cl)cc1)Nc1ccc(-c2nc3ncccc3o2)cc1,nan
11134054,46677,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,444,10,4,6,4.1,C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
CHEMBL154150,46677,0,None,-6,3,Human,8.1,pEC50,=,8.1,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,444,10,4,6,4.1,C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1021/jm0101500
1239,1626,45,None,-1,5,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2010.06.136
3410,1626,45,None,-1,5,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2010.06.136
3465,1626,45,None,-1,5,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2010.06.136
CHEMBL1256786,1626,45,None,-1,5,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2010.06.136
DB00983,1626,45,None,-1,5,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulationAgonistactivityatbeta2inhumanA431cellsadrenoceptorassessedascAMPaccumulation,ChEMBL,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,10.1016/j.bmcl.2010.06.136
56683262,63155,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,457,12,4,6,3,CC(C)(CNCCc1ccc(O)c2[nH]c(=O)sc12)NC(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800474,63155,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,457,12,4,6,3,CC(C)(CNCCc1ccc(O)c2[nH]c(=O)sc12)NC(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
56666341,63165,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,471,14,3,6,3.3,CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800657,63165,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,471,14,3,6,3.3,CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
56659408,63166,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,471,13,3,6,3.3,CC(C)N(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
CHEMBL1800658,63166,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hrAgonistactivityathumanadrenergicbeta2receptorexpressedinH292cellsassessedasintracellularcAMPaccumulationafter1hr,ChEMBL,471,13,3,6,3.3,CC(C)N(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1016/j.bmcl.2011.04.135
16035375,110674,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,528,17,3,7,3.2,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
CHEMBL3265157,110674,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,528,17,3,7,3.2,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1ccccc1,10.1021/ml4005232
90655868,110682,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,574,17,3,7,4,CN(CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1)C1CC1,10.1021/ml4005232
CHEMBL3265165,110682,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,574,17,3,7,4,CN(CCCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(Cl)c1)C1CC1,10.1021/ml4005232
16035175,110685,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,546,17,3,7,3.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(F)c1,10.1021/ml4005232
CHEMBL3265169,110685,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,546,17,3,7,3.4,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(F)c1,10.1021/ml4005232
16035281,110687,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,558,18,3,8,3.3,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(OC)c1,10.1021/ml4005232
CHEMBL3265170,110687,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassayAgonistactivityathumanbeta-2adrenergicreceptorexpressedinhumanH292cellsassessedasaccumulationofintracellularcAMPafter1hrbyAlphaScreenassay,ChEMBL,558,18,3,8,3.3,CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc(OC)c1,10.1021/ml4005232
57401436,69984,0,None,1,4,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
CHEMBL1945504,69984,0,None,1,4,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,479,11,5,7,3.5,COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,10.1016/j.bmcl.2011.10.049
11318107,105812,0,None,251,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,505,16,4,7,3.4,O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
CHEMBL3126386,105812,0,None,251,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,505,16,4,7,3.4,O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
CHEMBL3139364,105812,0,None,251,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassayAgonistactivityathumanbeta2adrenoceptortransfectedinCHOcellsassessedascyclicAMPaccumulationafter45minsbyfluorescencepolarizationassay,ChEMBL,505,16,4,7,3.4,O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21,10.1021/jm401532g
42625741,12461,0,None,158,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL1186940,12461,0,None,158,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
CHEMBL483202,12461,0,None,158,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassayAgonistactivityathumanclonedbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationbybeta-galactosidasebasedwholecellassay,ChEMBL,494,17,5,7,2.8,NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1,10.1021/jm801016j
46833103,7305,0,None,7,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,433,16,5,7,3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O,10.1021/jm100326d
CHEMBL1086535,7305,0,None,7,3,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45minsAgonistactivityathumanrecombinantbeta2adrenergicreceptorexpressedinCHOcellsassessedasinductionofintracellularcAMPaccumulationafter30to45mins,ChEMBL,433,16,5,7,3,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O,10.1021/jm100326d
59119472,111669,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,418,9,5,5,4,OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290986,111669,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,418,9,5,5,4,OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
59119417,111670,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,454,10,5,5,5.2,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
CHEMBL3290987,111670,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassayAgonistactivityathumanrecombinantbeta2receptorassessedascAMPaccumulationbyradioimmunoassayandcellbasedassay,ChEMBL,454,10,5,5,5.2,OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O,10.1016/j.bmcl.2014.04.069
57391346,69808,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,438,11,7,7,2.6,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(O)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
CHEMBL1940824,69808,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassayAgonistactivityatrecombinanthumanbeta2-adrenoceptorexpressedinwholecellsassessedascAMPaccumulationbyhomogeneousradioimmunoassay,ChEMBL,438,11,7,7,2.6,OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(O)cc3)cc2)ccc1O,10.1016/j.bmcl.2011.11.072
45483825,192946,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,315,7,4,4,2.5,CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
CHEMBL568511,192946,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,Agonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulationAgonistactivityathumanadrenergicbeta2expressedinCHO-K1cellsassessedasintracellularcAMPaccumulation,ChEMBL,315,7,4,4,2.5,CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c(CO)c1,10.1016/j.bmcl.2009.10.013
2952777,190352,7,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,443,6,1,6,6,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccco3)cc2)no1,nan
CHEMBL531401,190352,7,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,443,6,1,6,6,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccco3)cc2)no1,nan
155774,4005,31,None,-64,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
2848,4005,31,None,-64,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
538,4005,31,None,-64,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
CHEMBL75753,4005,31,None,-64,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
DB13781,4005,31,None,-64,3,Human,6.2,pEC50,=,6.2,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrsAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinductionof[3H]cAMPaccumulationafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
1288829,24897,10,None,-,1,Human,6.2,pEC50,=,6.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,391,6,1,6,5,Cc1ccc(SCC(=O)Nc2ccc(-c3nnc(-c4ccco4)o3)cc2)cc1,nan
CHEMBL1347493,24897,10,None,-,1,Human,6.2,pEC50,=,6.2,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,391,6,1,6,5,Cc1ccc(SCC(=O)Nc2ccc(-c3nnc(-c4ccco4)o3)cc2)cc1,nan
3105,14303,26,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,351,5,2,6,2.8,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,nan
CHEMBL1200833,14303,26,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,351,5,2,6,2.8,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,nan
CHEMBL1201262,14303,26,None,-,1,Human,5.2,pEC50,=,5.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,351,5,2,6,2.8,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,nan
24789167,58919,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,502,8,2,7,3.3,Cc1cc(C)cc(C(=O)NC(CC(N)=O)c2ccc(N3CCN(c4ccccn4)CC3)c([N+](=O)[O-])c2)c1,nan
CHEMBL1705007,58919,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,502,8,2,7,3.3,Cc1cc(C)cc(C(=O)NC(CC(N)=O)c2ccc(N3CCN(c4ccccn4)CC3)c([N+](=O)[O-])c2)c1,nan
44396779,66655,0,None,-17,3,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,611,12,4,8,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
CHEMBL187209,66655,0,None,-17,3,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatHomosapiens(human)beta2adrenoreceptorAgonistactivityatHomosapiens(human)beta2adrenoreceptor,ChEMBL,611,12,4,8,5.1,C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1,10.1007/s00044-009-9257-x
127047996,138989,0,None,-28,2,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,303,8,3,5,2.3,COc1ccccc1OCCNCCc1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
CHEMBL3797758,138989,0,None,-28,2,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,303,8,3,5,2.3,COc1ccccc1OCCNCCc1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
1132508,27893,15,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,419,3,1,5,6.3,Cc1ccc(-c2nc3ncccc3o2)cc1NC(=O)c1sc2ccccc2c1Cl,nan
CHEMBL1373276,27893,15,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,419,3,1,5,6.3,Cc1ccc(-c2nc3ncccc3o2)cc1NC(=O)c1sc2ccccc2c1Cl,nan
4117484,48392,2,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,386,5,2,5,3,CCc1ccccc1N(C)S(=O)(=O)c1ccc2ncc(C(=O)O)c(O)c2c1,nan
CHEMBL1557985,48392,2,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,386,5,2,5,3,CCc1ccccc1N(C)S(=O)(=O)c1ccc2ncc(C(=O)O)c(O)c2c1,nan
24820094,59339,1,None,-,1,Human,6.1,pEC50,=,6.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,409,5,1,4,5.1,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)s1,nan
CHEMBL1723653,59339,1,None,-,1,Human,6.1,pEC50,=,6.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,409,5,1,4,5.1,Cc1ncc(CN2CCCC(C(=O)Nc3ccc(-c4cccc(F)c4)cc3)C2)s1,nan
90666101,108749,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,666,18,5,8,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219031,108749,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,666,18,5,8,6.5,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O,10.1039/C1MD00140J
878337,44751,4,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,309,4,2,2,4.1,O=C(NC1(Cc2ccc(O)cc2)CCCCC1)c1ccccc1,nan
CHEMBL1524289,44751,4,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,309,4,2,2,4.1,O=C(NC1(Cc2ccc(O)cc2)CCCCC1)c1ccccc1,nan
567055,23169,10,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,323,5,2,2,4,O=C(Cc1ccccc1)NC1(Cc2ccc(O)cc2)CCCCC1,nan
CHEMBL1332942,23169,10,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,323,5,2,2,4,O=C(Cc1ccccc1)NC1(Cc2ccc(O)cc2)CCCCC1,nan
2816337,46143,5,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,6,1,7,5.9,C=CCn1c(SCc2ccccc2Cl)nnc1-c1sc2nc(C)cc(C)c2c1N,nan
CHEMBL1537056,46143,5,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,441,6,1,7,5.9,C=CCn1c(SCc2ccccc2Cl)nnc1-c1sc2nc(C)cc(C)c2c1N,nan
2481225,34538,6,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,363,5,1,4,4.3,CCOC(=O)c1ccc(NC(=O)Cc2coc3cc4c(cc23)CCC4)cc1,nan
CHEMBL1431082,34538,6,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,363,5,1,4,4.3,CCOC(=O)c1ccc(NC(=O)Cc2coc3cc4c(cc23)CCC4)cc1,nan
135799865,185847,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,262,4,4,4,1.3,CC(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
CHEMBL4878555,185847,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassayAgonistactivityathumanbeta2adrenoceptorexpressedinCHOcellsharboringbeta2-beta-arrassessedasinductionofbeta-arrestin2recruitmentusingbeta-galactosidaseassubstratepreincubatedfor90minsfollowedbysubstrateadditionandmeasuredafter60minsbyluminescenceassay,ChEMBL,262,4,4,4,1.3,CC(C)NC(CO)c1ccc(O)c2[nH]c(=O)ccc12,10.1021/acs.jmedchem.0c01195
9551438,59013,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,389,8,2,5,2.8,O=C(CCCCCn1c(=O)[nH]c2ccsc2c1=O)NCc1ccc(F)cc1,nan
CHEMBL1709014,59013,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,389,8,2,5,2.8,O=C(CCCCCn1c(=O)[nH]c2ccsc2c1=O)NCc1ccc(F)cc1,nan
10346448,119211,0,None,-501,3,Human,7.1,pEC50,=,7.1,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,515,11,4,6,3.8,Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
CHEMBL348501,119211,0,None,-501,3,Human,7.1,pEC50,=,7.1,Functional,AbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentrationAbilitytocausecAMPaccumulationinCHOcellsexpressinghumanbeta-2ARexpressedasthenegativelogarithmofthemolardrugconcentration,ChEMBL,515,11,4,6,3.8,Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1,10.1021/jm0101500
44441234,93269,0,None,-251,3,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,414,9,4,5,4.4,C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL247520,93269,0,None,-251,3,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,414,9,4,5,4.4,C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
145982386,165931,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,339,6,5,5,1.7,Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
CHEMBL4280939,165931,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,339,6,5,5,1.7,Nc1ccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)cc1,10.1016/j.ejmech.2018.04.041
57395240,70079,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,465,11,4,5,4.1,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,10.1016/j.bmcl.2011.10.049
CHEMBL1946762,70079,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometryAgonistactivityathumanbeta2adrenoceptorexpressedinH292cellsassessedasincreaseincAMPaccumulationafter60minsbyspectrophotometry,ChEMBL,465,11,4,5,4.1,O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,10.1016/j.bmcl.2011.10.049
4611324,21536,6,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,401,7,1,4,4.1,CCCCC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
CHEMBL1319108,21536,6,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,401,7,1,4,4.1,CCCCC(=O)Nc1ccc(S(=O)(=O)N2CCCCC2c2cccnc2)cc1,nan
24817704,43011,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,407,7,1,6,3.8,Cc1ccc(OCc2cc(C(=O)NCc3ccc(OC(F)(F)F)cc3)no2)cn1,nan
CHEMBL1506675,43011,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,407,7,1,6,3.8,Cc1ccc(OCc2cc(C(=O)NCc3ccc(OC(F)(F)F)cc3)no2)cn1,nan
23661589,92901,0,None,-12589,3,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,430,9,4,5,4.9,C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
CHEMBL245873,92901,0,None,-12589,3,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanbeta-2adrenergicreceptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,430,9,4,5,4.9,C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1,10.1016/j.bmcl.2007.05.069
145987609,166502,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
CHEMBL4291538,166502,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,340,6,5,5,1.8,O=c1ccc2c(C(CO)NCCc3cccc(O)c3)ccc(O)c2[nH]1,10.1016/j.ejmech.2018.04.041
54580129,61403,0,None,-3,2,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,786,21,6,8,7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
CHEMBL1773197,61403,0,None,-3,2,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionafter30minsofwashingbywash-offassay,ChEMBL,786,21,6,8,7,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)c2)ccc1O)C(C)C,10.1016/j.bmcl.2010.10.132
3224430,35850,6,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,6,2,6,3.2,O=C(Cn1nc(-c2ccccc2)ccc1=O)Nc1ccc(NC(=O)c2ccccn2)cc1,nan
CHEMBL1444240,35850,6,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,425,6,2,6,3.2,O=C(Cn1nc(-c2ccccc2)ccc1=O)Nc1ccc(NC(=O)c2ccccn2)cc1,nan
10484263,58175,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,639,16,6,6,6.5,O=C(Nc1ccccc1-c1ccccc1)NC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
CHEMBL1683940,58175,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,639,16,6,6,6.5,O=C(Nc1ccccc1-c1ccccc1)NC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1,10.1016/j.bmcl.2011.01.043
667688,85288,3,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
CHEMBL229477,85288,3,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasstimulationofcAMPaccumulationbyproteinkinasebindingassay,ChEMBL,303,6,5,5,2.1,C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,10.1016/j.bmc.2009.11.062
53319789,58176,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,667,16,5,6,7.1,O=C(Nc1ccccc1-c1ccccc1)O[C@H]1C[N+]2(CCCCCCCCCNCC(O)c3ccc(O)c4[nH]c(=O)ccc34)CCC1CC2,10.1016/j.bmcl.2011.01.043
CHEMBL1683941,58176,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassayAgonistactivityathumanbeta2-adrenoceptorexpressedinHEKcellsassessedasincreaseofcAMPlevelafter10minsbyradioimmunoassay,ChEMBL,667,16,5,6,7.1,O=C(Nc1ccccc1-c1ccccc1)O[C@H]1C[N+]2(CCCCCCCCCNCC(O)c3ccc(O)c4[nH]c(=O)ccc34)CCC1CC2,10.1016/j.bmcl.2011.01.043
10008017,99319,2,None,-10,3,Human,7.1,pEC50,=,7.1,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,12,6,8,2.3,CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O,10.1021/jm000544b
CHEMBL285881,99319,2,None,-10,3,Human,7.1,pEC50,=,7.1,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,562,12,6,8,2.3,CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O,10.1021/jm000544b
648074,26818,4,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,494,7,2,6,3.4,COc1ccc(S(=O)(=O)N2CCCC(C(=O)Nc3ccc(NC(=O)c4ccccn4)cc3)C2)cc1,nan
CHEMBL1365203,26818,4,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,494,7,2,6,3.4,COc1ccc(S(=O)(=O)N2CCCC(C(=O)Nc3ccc(NC(=O)c4ccccn4)cc3)C2)cc1,nan
24789201,52118,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,517,12,3,6,3.4,NC(=O)CC(NC(=O)Cc1cccc2ccccc12)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
CHEMBL1590854,52118,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,517,12,3,6,3.4,NC(=O)CC(NC(=O)Cc1cccc2ccccc12)c1ccc(NCCCN2CCCC2=O)c([N+](=O)[O-])c1,nan
4870978,59309,9,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,462,7,2,6,3.7,CC(=O)Nc1ccc(S(=O)(=O)N(Cc2cccnc2)Cc2cc3ccccc3nc2O)cc1,nan
CHEMBL1722488,59309,9,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,462,7,2,6,3.7,CC(=O)Nc1ccc(S(=O)(=O)N(Cc2cccnc2)Cc2cc3ccccc3nc2O)cc1,nan
998685,33765,12,None,-7,3,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,4,1,7,3.3,Cc1ccc(-c2nc(NC(=O)c3nn(C)cc3[N+](=O)[O-])sc2C)cc1,nan
CHEMBL1424697,33765,12,None,-7,3,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,357,4,1,7,3.3,Cc1ccc(-c2nc(NC(=O)c3nn(C)cc3[N+](=O)[O-])sc2C)cc1,nan
667188,40294,11,None,2,2,Human,5.1,pEC50,=,5.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,421,6,1,6,5.4,Clc1cccc(-c2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)c1,nan
CHEMBL1483555,40294,11,None,2,2,Human,5.1,pEC50,=,5.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,421,6,1,6,5.4,Clc1cccc(-c2nnc(SCc3nc4ccccc4[nH]3)n2Cc2ccco2)c1,nan
658782,49794,10,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,465,4,0,9,1.9,Cn1c(N2CCN(c3ccccn3)CC2)nc2c1c(=O)n(Cc1ccc(Cl)cc1)c(=O)n2C,nan
CHEMBL1570111,49794,10,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,465,4,0,9,1.9,Cn1c(N2CCN(c3ccccn3)CC2)nc2c1c(=O)n(Cc1ccc(Cl)cc1)c(=O)n2C,nan
1480945,50387,13,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,345,4,0,5,2.7,Cc1ccc(CS(=O)(=O)c2nc3c(c(N(C)C)n2)CCCC3)cc1,nan
CHEMBL1575889,50387,13,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,345,4,0,5,2.7,Cc1ccc(CS(=O)(=O)c2nc3c(c(N(C)C)n2)CCCC3)cc1,nan
2977891,21568,8,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
CHEMBL1319376,21568,8,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,452,5,0,5,1.8,CN(CC(=O)N1CCN(c2ccccn2)CC1)S(=O)(=O)c1ccc(Br)cc1,nan
1499,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
3779,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
536,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
CHEMBL434,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
DB01064,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
1499,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
3779,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
536,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
CHEMBL434,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
DB01064,2038,40,None,-72,36,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,nan
145985242,164847,0,None,-75,3,Human,7.1,pEC50,=,7.1,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,443,11,4,4,3.9,O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4241613,164847,0,None,-75,3,Human,7.1,pEC50,=,7.1,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,443,11,4,4,3.9,O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1,10.1016/j.ejmech.2018.03.032
9266740,30547,8,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,360,3,0,8,3.7,Cn1nnnc1Sc1ncnc2scc(-c3ccc(Cl)cc3)c12,nan
CHEMBL1396351,30547,8,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,360,3,0,8,3.7,Cn1nnnc1Sc1ncnc2scc(-c3ccc(Cl)cc3)c12,nan
1266768,33763,11,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,365,6,1,7,2.5,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccc(C)cc3)n2)cc1,nan
CHEMBL1424678,33763,11,None,-,1,Human,6.1,pEC50,=,6.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,365,6,1,7,2.5,CCOC(=O)c1ccc(NC(=O)Cn2nnc(-c3ccc(C)cc3)n2)cc1,nan
127046948,139413,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,488,12,4,6,4.1,COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800468,139413,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,488,12,4,6,4.1,COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
145983266,164830,0,None,-2511,3,Human,5.1,pEC50,=,5.1,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,512,14,5,6,2.7,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
CHEMBL4241176,164830,0,None,-2511,3,Human,5.1,pEC50,=,5.1,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,512,14,5,6,2.7,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
31055126,47961,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,404,3,0,8,3.8,Cn1nnnc1Sc1ncnc2scc(-c3ccc(Br)cc3)c12,nan
CHEMBL1553183,47961,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,404,3,0,8,3.8,Cn1nnnc1Sc1ncnc2scc(-c3ccc(Br)cc3)c12,nan
1499,2038,40,None,-72,36,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2016.04.028
3779,2038,40,None,-72,36,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2016.04.028
536,2038,40,None,-72,36,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2016.04.028
CHEMBL434,2038,40,None,-72,36,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2016.04.028
DB01064,2038,40,None,-72,36,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanbeta2receptorexpressedinHEK293cellscotransfectedwithGqs5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,10.1016/j.bmc.2016.04.028
141486999,165992,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinCHO-K1cellsharboringGalpha15assessedasinductionofcalciumcurrentbyFLIPRtetramethodAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinCHO-K1cellsharboringGalpha15assessedasinductionofcalciumcurrentbyFLIPRtetramethod,ChEMBL,229,1,2,4,2.1,Oc1cc2c(cc1O)C(c1ccco1)=NCC2,10.1021/acs.jmedchem.0c01195
CHEMBL4282215,165992,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityatbeta2adrenoceptor(unknownorigin)expressedinCHO-K1cellsharboringGalpha15assessedasinductionofcalciumcurrentbyFLIPRtetramethodAgonistactivityatbeta2adrenoceptor(unknownorigin)expressedinCHO-K1cellsharboringGalpha15assessedasinductionofcalciumcurrentbyFLIPRtetramethod,ChEMBL,229,1,2,4,2.1,Oc1cc2c(cc1O)C(c1ccco1)=NCC2,10.1021/acs.jmedchem.0c01195
7334649,166558,2,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,255,2,3,3,2.5,Oc1cc2c(cc1O)[C@@H](Cc1ccccc1)NCC2,10.1021/acs.jnatprod.7b00762
CHEMBL4292818,166558,2,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassayAgonistactivityathumanbeta2-ARexpressedinCHOK1cellsco-expressingGalpha15measuredafter21secsto120secsbyCalcium-4dyebasedFLIPRassay,ChEMBL,255,2,3,3,2.5,Oc1cc2c(cc1O)[C@@H](Cc1ccccc1)NCC2,10.1021/acs.jnatprod.7b00762
4968428,24151,6,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,470,9,1,4,4.5,CCN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)NC(C)C2CC3CCC2C3)ccc1OC,nan
CHEMBL1341251,24151,6,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,470,9,1,4,4.5,CCN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)NC(C)C2CC3CCC2C3)ccc1OC,nan
664105,29531,8,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,468,4,1,9,2.8,CC1(C)Cc2c(c(N3CCCC3)nc3sc4c(N5CCN(CCO)CC5)ncnc4c23)CO1,nan
CHEMBL1387056,29531,8,None,-,1,Human,5.1,pEC50,=,5.1,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,468,4,1,9,2.8,CC1(C)Cc2c(c(N3CCCC3)nc3sc4c(N5CCN(CCO)CC5)ncnc4c23)CO1,nan
5085262,28332,1,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,454,6,1,6,5.8,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccccn3)cc2)no1,nan
CHEMBL1376574,28332,1,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,454,6,1,6,5.8,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccccn3)cc2)no1,nan
45484646,192972,0,None,1,2,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,456,10,6,7,2,CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
CHEMBL568667,192972,0,None,1,2,Human,8.1,pEC50,=,8.1,Functional,Agonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevelAgonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellassessedasincreaseofintracellularcAMPlevel,ChEMBL,456,10,6,7,2,CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2,10.1016/j.bmcl.2009.06.104
155550544,173588,0,None,1,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,388,7,4,4,3.6,O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
CHEMBL4550290,173588,0,None,1,2,Human,8,pEC50,=,8,Functional,Agonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassayAgonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsassessedasincreaseincAMPaccumulationafter60minsbyHTRFassay,ChEMBL,388,7,4,4,3.6,O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1,10.1016/j.bmc.2018.10.043
44392575,63975,0,None,-2,3,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,441,10,4,6,2.8,C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
CHEMBL181300,63975,0,None,-2,3,Human,8,pEC50,=,8,Functional,AgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptorAgonisticactivitywasassessedbymeasuringcAMPaccumulationinCHOcellsexpressinghumanbeta-2adrenergicreceptor,ChEMBL,441,10,4,6,2.8,C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1,10.1016/j.bmcl.2004.12.033
1253647,36819,10,None,-,1,Human,8,pEC50,=,8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,448,3,0,8,2.6,O=C(c1cc2c(=O)n3ccccc3nc2s1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,nan
CHEMBL1452334,36819,10,None,-,1,Human,8,pEC50,=,8,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset3.(Classofassay:confirmatory),ChEMBL,448,3,0,8,2.6,O=C(c1cc2c(=O)n3ccccc3nc2s1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,nan
90666104,108752,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3O)CC2)ccc1O,10.1039/C1MD00140J
CHEMBL3219034,108752,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,Agonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproductionAgonistactivityathumanbeta-2adrenoceptorexpressedinCHOcellsassessedasstimulationofintracellularcAMPproduction,ChEMBL,682,18,6,9,6.2,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3O)CC2)ccc1O,10.1039/C1MD00140J
10553603,99146,0,None,-8,3,Human,6.1,pEC50,=,6.1,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,506,10,6,8,1.5,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
CHEMBL284612,99146,0,None,-8,3,Human,6.1,pEC50,=,6.1,Functional,IncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptorsIncreasedcAMPlevelsofChinesehamsterovary(CHO)cellsexpressinghumanbeta2adrenergicreceptors,ChEMBL,506,10,6,8,1.5,CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O,10.1021/jm000544b
3271684,38884,9,None,-,1,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,4,1,8,4.9,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCC5CCCO5)ncnc4c23)CO1,nan
CHEMBL1469574,38884,9,None,-,1,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,436,4,1,8,4.9,CC1(C)Cc2c(c(-c3ccco3)nc3sc4c(NCC5CCCO5)ncnc4c23)CO1,nan
1371669,37317,10,None,64,2,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
CHEMBL1456621,37317,10,None,64,2,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,373,5,1,5,4.5,Cc1ccc(OCC(=O)Nc2ccc(-c3nc4ncccc4o3)cc2)c(C)c1,nan
44309523,101627,0,None,-30,3,Human,6,pEC50,=,6,Functional,Agonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcellsAgonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcells,ChEMBL,420,10,3,6,2.3,CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1,10.1016/s0960-894x(03)00387-1
CHEMBL302803,101627,0,None,-30,3,Human,6,pEC50,=,6,Functional,Agonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcellsAgonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcells,ChEMBL,420,10,3,6,2.3,CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1,10.1016/s0960-894x(03)00387-1
44309272,199534,0,None,-181,3,Human,6,pEC50,=,6,Functional,Agonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcellsAgonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcells,ChEMBL,611,14,6,8,2.9,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(03)00387-1
CHEMBL68766,199534,0,None,-181,3,Human,6,pEC50,=,6,Functional,Agonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcellsAgonisticactivityagainstclonedhumanbeta1-AR(beta-2-adrenergicreceptor)inCHOcells,ChEMBL,611,14,6,8,2.9,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1,10.1016/s0960-894x(03)00387-1
536369,42357,15,None,1,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,293,1,0,1,4.5,CC(=O)N1c2ccccc2C(C)(c2ccccc2)CC1(C)C,nan
CHEMBL1500954,42357,15,None,1,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,293,1,0,1,4.5,CC(=O)N1c2ccccc2C(C)(c2ccccc2)CC1(C)C,nan
3238021,45030,7,None,2,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,445,8,1,6,3.3,COc1ccccc1-c1cc(C(F)(F)F)nc(S(=O)(=O)CCCC(=O)NC(C)C)n1,nan
CHEMBL1526751,45030,7,None,2,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,445,8,1,6,3.3,COc1ccccc1-c1cc(C(F)(F)F)nc(S(=O)(=O)CCCC(=O)NC(C)C)n1,nan
24791686,29697,1,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,392,6,0,3,4.5,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
CHEMBL1388401,29697,1,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,392,6,0,3,4.5,CCc1ccc(CN2CCC(Oc3ccc(C(=O)N4CCCC4)cc3)CC2)cc1,nan
20954918,23375,5,None,-,1,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,6,2,4,3.7,CCc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
CHEMBL1334494,23375,5,None,-,1,Human,7,pEC50,=,7,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,382,6,2,4,3.7,CCc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1,nan
145983355,165102,0,None,-85,3,Human,6,pEC50,=,6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,454,12,3,5,3.6,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
CHEMBL4248093,165102,0,None,-85,3,Human,6,pEC50,=,6,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,454,12,3,5,3.6,CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1,10.1016/j.ejmech.2018.03.032
4296505,37541,13,None,1,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,345,5,1,6,2.2,CCCNC(=O)c1nnsc1S(=O)(=O)c1ccc(Cl)cc1,nan
CHEMBL1458548,37541,13,None,1,2,Human,5,pEC50,=,5,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,345,5,1,6,2.2,CCCNC(=O)c1nnsc1S(=O)(=O)c1ccc(Cl)cc1,nan
46232974,196479,5,None,27,2,Human,7,pEC50,=,7,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
CHEMBL600817,196479,5,None,27,2,Human,7,pEC50,=,7,Functional,Agonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulationAgonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedascAMPaccumulation,ChEMBL,386,7,4,6,2.4,COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,10.1016/j.bmcl.2009.12.087
5085262,28332,1,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,454,6,1,6,5.8,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccccn3)cc2)no1,nan
CHEMBL1376574,28332,1,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,454,6,1,6,5.8,CC(Oc1ccc(Cl)cc1Cl)c1nc(-c2ccc(NC(=O)c3ccccn3)cc2)no1,nan
145983711,164685,0,None,-2089,3,Human,5,pEC50,=,5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,476,12,5,5,3.5,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
CHEMBL4237802,164685,0,None,-2089,3,Human,5,pEC50,=,5,Functional,Antagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassayAntagonistactivityathumanbeta2adrenergicreceptorexpressedinHEK293cellsco-expressingGalpha16assessedasinhibitionofisoproterenol-inducedintercellularcalciummobilizationpre-incubatedfor10minsbeforeisoproterenoladditionbyFluo-4AMdye-basedfluorescenceassay,ChEMBL,476,12,5,5,3.5,CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1,10.1016/j.ejmech.2018.03.032
1073012,33463,15,None,-,1,Human,6,pEC50,=,6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,403,5,0,5,1.3,CCOC(=O)N1CCN(C(=O)CN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1,nan
CHEMBL1422244,33463,15,None,-,1,Human,6,pEC50,=,6,Functional,PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory)PubChemBioAssay.DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromPowderset1.(Classofassay:confirmatory),ChEMBL,403,5,0,5,1.3,CCOC(=O)N1CCN(C(=O)CN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1,nan
6491897,25323,3,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,444,7,1,5,2.8,O=C(NCCCn1ccnc1)C1CCCN(S(=O)(=O)c2cc(Cl)ccc2Cl)C1,nan
CHEMBL1351178,25323,3,None,-,1,Human,6,pEC50,=,6,Functional,"PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]PUBCHEM_BIOASSAY:DoseresponseforHTSforBeta-2ARagonistsviaFAPmethodfromCP1.(Classofassay:confirmatory)[Relatedpubchemassays(depositordefined):AID485366,AID492947,AID504448]",ChEMBL,444,7,1,5,2.8,O=C(NCCCn1ccnc1)C1CCCN(S(=O)(=O)c2cc(Cl)ccc2Cl)C1,nan
165193,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
2303,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
4946,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
564,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
62882,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
63,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
66366,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
91536,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
CHEMBL27,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
CHEMBL452861,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
DB00571,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
165193,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
2303,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
4946,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
564,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
62882,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
63,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
66366,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
91536,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
CHEMBL27,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
CHEMBL452861,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
DB00571,3109,59,None,6,13,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.0c00831
204665,10112,6,None,4,2,Human,9.1,pIC50,=,9.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL1160734,10112,6,None,4,2,Human,9.1,pIC50,=,9.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
137,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
2119,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
563,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
66368,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
CHEMBL266195,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
DB00866,367,39,None,1,4,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
155539613,172127,0,None,2,2,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,677,24,5,13,2.9,CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4514723,172127,0,None,2,2,Human,8.9,pIC50,=,8.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,677,24,5,13,2.9,CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
155569481,175492,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4594173,175492,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155518547,169574,0,None,107,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,558,20,6,7,3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4446394,169574,0,None,107,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,558,20,6,7,3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155559960,174173,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,586,22,6,7,3.8,CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4564189,174173,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,586,22,6,7,3.8,CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4633760,176400,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,370,9,3,6,3.8,CC(=O)Nc1ccc(/N=N/c2ccccc2OC[C@@H](O)CNC(C)C)cc1,10.1021/acs.jmedchem.0c00831
155530927,170881,0,None,3,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,24,6,7,4.6,CC(C)NC[C@H](O)COc1ccccc1CCCCCNC(=O)NCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4465278,170881,0,None,3,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,24,6,7,4.6,CC(C)NC[C@H](O)COc1ccccc1CCCCCNC(=O)NCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155559960,174173,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,586,22,6,7,3.8,CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4564189,174173,0,None,8,2,Human,8.8,pIC50,=,8.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,586,22,6,7,3.8,CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
127034967,135841,0,None,1,3,Human,7,pIC50,=,7,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,260,5,2,4,1.6,CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1,10.1021/acs.jmedchem.5b01088
CHEMBL3736156,135841,0,None,1,3,Human,7,pIC50,=,7,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,260,5,2,4,1.6,CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1,10.1021/acs.jmedchem.5b01088
24936881,17301,0,None,-173,3,Human,7,pIC50,=,7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,476,8,3,8,4.1,Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
CHEMBL1257913,17301,0,None,-173,3,Human,7,pIC50,=,7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,476,8,3,8,4.1,Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
155535986,171385,0,None,16,2,Human,8,pIC50,=,8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,642,25,6,8,3.5,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4472564,171385,0,None,16,2,Human,8,pIC50,=,8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,642,25,6,8,3.5,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155545790,172763,0,None,79,2,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,593,18,5,13,1.6,CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4530266,172763,0,None,79,2,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,593,18,5,13,1.6,CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
46889771,6889,0,None,-1,3,Human,6.9,pIC50,=,6.9,Functional,Antagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassayAntagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassay,ChEMBL,549,7,3,6,4.9,O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1,10.1016/j.bmcl.2010.04.009
CHEMBL1084706,6889,0,None,-1,3,Human,6.9,pIC50,=,6.9,Functional,Antagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassayAntagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassay,ChEMBL,549,7,3,6,4.9,O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1,10.1016/j.bmcl.2010.04.009
52948056,17303,0,None,-18,3,Human,6.9,pIC50,=,6.9,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,478,8,2,7,4.5,OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1,10.1016/j.bmcl.2010.08.039
CHEMBL1257915,17303,0,None,-18,3,Human,6.9,pIC50,=,6.9,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,478,8,2,7,4.5,OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1,10.1016/j.bmcl.2010.08.039
52943968,17578,0,None,-11,3,Human,5.9,pIC50,=,5.9,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,518,9,4,8,3.8,NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
CHEMBL1258824,17578,0,None,-11,3,Human,5.9,pIC50,=,5.9,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,518,9,4,8,3.8,NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
155510718,168799,0,None,1,2,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,556,23,4,6,6.1,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4434772,168799,0,None,1,2,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,556,23,4,6,6.1,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155568878,175443,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,457,15,4,5,3.3,COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4593049,175443,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,457,15,4,5,3.3,COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155559932,174186,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,427,14,4,4,3.3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1,10.1021/acs.jmedchem.9b00595
CHEMBL4564495,174186,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,427,14,4,4,3.3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1,10.1021/acs.jmedchem.9b00595
155563970,174638,0,None,20,2,Human,7.8,pIC50,=,7.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,530,18,6,7,2.2,CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4574652,174638,0,None,20,2,Human,7.8,pIC50,=,7.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,530,18,6,7,2.2,CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
9832011,104908,0,None,-19,3,Human,6.8,pIC50,=,6.8,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,644,13,6,7,6.5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL312074,104908,0,None,-19,3,Human,6.8,pIC50,=,6.8,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,644,13,6,7,6.5,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL4634403,176439,0,None,-,1,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,370,9,3,6,3.8,CC(=O)Nc1ccc(/N=N/c2cccc(OC[C@@H](O)CNC(C)C)c2)cc1,10.1021/acs.jmedchem.0c00831
155545790,172763,0,None,79,2,Human,6.8,pIC50,=,6.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,593,18,5,13,1.6,CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4530266,172763,0,None,79,2,Human,6.8,pIC50,=,6.8,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,593,18,5,13,1.6,CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
155528927,170680,0,None,6,2,Human,8.7,pIC50,=,8.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,649,22,5,13,2.1,CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4462252,170680,0,None,6,2,Human,8.7,pIC50,=,8.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,649,22,5,13,2.1,CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
155563970,174638,0,None,20,2,Human,8.7,pIC50,=,8.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,530,18,6,7,2.2,CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4574652,174638,0,None,20,2,Human,8.7,pIC50,=,8.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,530,18,6,7,2.2,CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
204665,10112,6,None,4,2,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL1160734,10112,6,None,4,2,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
203685,30505,7,None,33,4,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL1395661,30505,7,None,33,4,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155544582,172658,0,None,5,2,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,528,21,4,6,5.3,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4527821,172658,0,None,5,2,Human,8.6,pIC50,=,8.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,528,21,4,6,5.3,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155539613,172127,0,None,2,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,677,24,5,13,2.9,CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4514723,172127,0,None,2,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,677,24,5,13,2.9,CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
52949488,17330,0,None,-81,3,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,2,8,4.4,COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1,10.1016/j.bmcl.2010.08.039
CHEMBL1258023,17330,0,None,-81,3,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,2,8,4.4,COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1,10.1016/j.bmcl.2010.08.039
155537285,171567,0,None,14,2,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,558,19,6,8,1.2,CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4474813,171567,0,None,14,2,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,558,19,6,8,1.2,CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155557081,173819,0,None,20,2,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4556017,173819,0,None,20,2,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
53326195,58286,0,None,-144,3,Human,5.7,pIC50,=,5.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684577,58286,0,None,-144,3,Human,5.7,pIC50,=,5.7,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
52944986,17397,0,None,-26,3,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,478,8,2,7,4.5,OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F,10.1016/j.bmcl.2010.08.039
CHEMBL1258257,17397,0,None,-26,3,Human,6.7,pIC50,=,6.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,478,8,2,7,4.5,OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F,10.1016/j.bmcl.2010.08.039
24936626,17193,0,None,-112201,3,Human,5.7,pIC50,=,5.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,506,9,4,9,3.6,OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O,10.1016/j.bmcl.2010.08.039
CHEMBL1257555,17193,0,None,-112201,3,Human,5.7,pIC50,=,5.7,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,506,9,4,9,3.6,OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O,10.1016/j.bmcl.2010.08.039
24937269,17431,0,None,-9,3,Human,6.6,pIC50,=,6.6,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,3,8,3.8,OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
CHEMBL1258371,17431,0,None,-9,3,Human,6.6,pIC50,=,6.6,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,3,8,3.8,OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
155515551,169259,0,None,1,2,Human,7.6,pIC50,=,7.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,584,25,4,6,6.8,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4441975,169259,0,None,1,2,Human,7.6,pIC50,=,7.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,584,25,4,6,6.8,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
52949489,17331,0,None,-12,3,Human,6.6,pIC50,=,6.6,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,2,8,4.4,COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
CHEMBL1258024,17331,0,None,-12,3,Human,6.6,pIC50,=,6.6,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,490,9,2,8,4.4,COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1,10.1016/j.bmcl.2010.08.039
51346867,58291,0,None,-616,3,Human,5.6,pIC50,=,5.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684583,58291,0,None,-616,3,Human,5.6,pIC50,=,5.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
155537285,171567,0,None,14,2,Human,5.6,pIC50,=,5.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,558,19,6,8,1.2,CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4474813,171567,0,None,14,2,Human,5.6,pIC50,=,5.6,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,558,19,6,8,1.2,CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
10283539,167155,0,None,-346,3,Human,6.6,pIC50,=,6.6,Functional,CompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptorCompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptor,ChEMBL,697,14,6,9,2.8,CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00607-8
CHEMBL431048,167155,0,None,-346,3,Human,6.6,pIC50,=,6.6,Functional,CompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptorCompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptor,ChEMBL,697,14,6,9,2.8,CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O,10.1016/s0960-894x(02)00607-8
53319639,58290,0,None,-2,3,Human,5.6,pIC50,=,5.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684582,58290,0,None,-2,3,Human,5.6,pIC50,=,5.6,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL4633760,176400,0,None,-,1,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderconstantvioletlightconditionsbyFRETassay,ChEMBL,370,9,3,6,3.8,CC(=O)Nc1ccc(/N=N/c2ccccc2OC[C@@H](O)CNC(C)C)cc1,10.1021/acs.jmedchem.0c00831
53326197,58292,0,None,-35,3,Human,6.5,pIC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684584,58292,0,None,-35,3,Human,6.5,pIC50,=,6.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
155536373,171460,0,None,7,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,500,19,4,6,4.5,CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4473518,171460,0,None,7,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,500,19,4,6,4.5,CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155521390,169871,0,None,128,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,586,21,6,8,2,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4450606,169871,0,None,128,2,Human,8.5,pIC50,=,8.5,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,586,21,6,8,2,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155510718,168799,0,None,1,2,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,556,23,4,6,6.1,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4434772,168799,0,None,1,2,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,556,23,4,6,6.1,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155536373,171460,0,None,7,2,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,500,19,4,6,4.5,CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4473518,171460,0,None,7,2,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,500,19,4,6,4.5,CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155546387,172832,0,None,-,1,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,513,18,4,6,3,COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4532142,172832,0,None,-,1,Human,8.4,pIC50,=,8.4,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,513,18,4,6,3,COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
24936491,17304,0,None,-977,3,Human,5.5,pIC50,=,5.5,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,494,8,3,8,4.2,Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1,10.1016/j.bmcl.2010.08.039
CHEMBL1257916,17304,0,None,-977,3,Human,5.5,pIC50,=,5.5,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,494,8,3,8,4.2,Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1,10.1016/j.bmcl.2010.08.039
46889854,7200,0,None,9,3,Human,7.5,pIC50,=,7.5,Functional,Antagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassayAntagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassay,ChEMBL,446,7,2,4,4.8,O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1,10.1016/j.bmcl.2010.04.009
CHEMBL1086077,7200,0,None,9,3,Human,7.5,pIC50,=,7.5,Functional,Antagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassayAntagonistactivityathumanadrenergicbeta2receptorexpressedinCHOK1cellsassessedasinhibitionofcAMPaccumulationbyHTRFassay,ChEMBL,446,7,2,4,4.8,O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1,10.1016/j.bmcl.2010.04.009
9896817,102318,0,None,-44,3,Human,4.5,pIC50,=,4.5,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL305891,102318,0,None,-44,3,Human,4.5,pIC50,=,4.5,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1,10.1016/s0960-894x(00)00459-5
24936492,17333,0,None,-323,3,Human,6.5,pIC50,=,6.5,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,482,8,3,9,4.1,Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1,10.1016/j.bmcl.2010.08.039
CHEMBL1258026,17333,0,None,-323,3,Human,6.5,pIC50,=,6.5,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,482,8,3,9,4.1,Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1,10.1016/j.bmcl.2010.08.039
9853471,200499,0,None,-177,3,Human,5.5,pIC50,=,5.5,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
CHEMBL75604,200499,0,None,-177,3,Human,5.5,pIC50,=,5.5,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,628,12,6,6,6.7,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1,10.1016/s0960-894x(00)00459-5
53326196,58288,0,None,-1,3,Human,5.5,pIC50,=,5.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684580,58288,0,None,-1,3,Human,5.5,pIC50,=,5.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
53326839,58289,0,None,-43,3,Human,5.5,pIC50,=,5.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684581,58289,0,None,-43,3,Human,5.5,pIC50,=,5.5,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,649,9,3,6,7.7,O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
9873245,4425,0,None,12,3,Human,8.4,pIC50,=,8.4,Functional,CompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptorCompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptor,ChEMBL,590,17,5,7,4.3,CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1,10.1016/s0960-894x(02)00607-8
CHEMBL102194,4425,0,None,12,3,Human,8.4,pIC50,=,8.4,Functional,CompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptorCompoundwastestedfortheantagonisticactivityagainstBeta-2adrenergicreceptor,ChEMBL,590,17,5,7,4.3,CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1,10.1016/s0960-894x(02)00607-8
155528927,170680,0,None,6,2,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,649,22,5,13,2.1,CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4462252,170680,0,None,6,2,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,649,22,5,13,2.1,CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
13208878,160546,0,None,5,2,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,520,20,4,9,2.6,CC(C)NC[C@H](O)COc1ccccc1OCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL41189,160546,0,None,5,2,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,520,20,4,9,2.6,CC(C)NC[C@H](O)COc1ccccc1OCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155544582,172658,0,None,5,2,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,528,21,4,6,5.3,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4527821,172658,0,None,5,2,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,528,21,4,6,5.3,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
137,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
2119,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
563,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
66368,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
CHEMBL266195,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
DB00866,367,39,None,1,4,Human,8.3,pIC50,=,8.3,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/acs.jmedchem.9b00595
155539979,172165,0,None,-,1,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,483,17,4,5,3,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1,10.1021/acs.jmedchem.9b00595
CHEMBL4515576,172165,0,None,-,1,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,483,17,4,5,3,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1,10.1021/acs.jmedchem.9b00595
165193,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
2303,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
4946,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
564,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
62882,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
63,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
66366,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
91536,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
CHEMBL27,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
CHEMBL452861,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
DB00571,3109,59,None,6,13,Human,7.3,pIC50,=,7.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/acs.jmedchem.5b01088
127034966,135879,0,None,1,2,Human,6.3,pIC50,=,6.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,260,5,2,4,1.6,CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1,10.1021/acs.jmedchem.5b01088
CHEMBL3736433,135879,0,None,1,2,Human,6.3,pIC50,=,6.3,Functional,Antagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassayAntagonistactivityathumanbeta2receptorexpressedinCHO-K1cellsassessedasisoproterenol-inducedcAMPlevelbyHTRFassay,ChEMBL,260,5,2,4,1.6,CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1,10.1021/acs.jmedchem.5b01088
24936488,17433,0,None,-275,3,Human,5.3,pIC50,=,5.3,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,414,7,3,8,2.7,Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12,10.1016/j.bmcl.2010.08.039
CHEMBL1258373,17433,0,None,-275,3,Human,5.3,pIC50,=,5.3,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,414,7,3,8,2.7,Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12,10.1016/j.bmcl.2010.08.039
CHEMBL4634403,176439,0,None,-,1,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassayAntagonistactivityatADRB2endogenouslyexpressedinHEK293cellstransfectedwithcAMPFRETbiosensorassessedasinhibitionofcimaterol-inducedresponsepre-incubatedfor45minsunderdarkconditionsbyFRETassay,ChEMBL,370,9,3,6,3.8,CC(=O)Nc1ccc(/N=N/c2cccc(OC[C@@H](O)CNC(C)C)c2)cc1,10.1021/acs.jmedchem.0c00831
5581,101097,7,None,-2,6,Human,8.2,pIC50,=,8.2,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,345,5,3,6,2.6,COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
CHEMBL299175,101097,7,None,-2,6,Human,8.2,pIC50,=,8.2,Functional,CompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindololCompoundwasevaluatedforitsinhibitoryactivityagainstCHOcellsexpressingtheclonedhumanbeta-2adrenergicreceptor(AR)inthepresenceof[125I]-iodocyanopindolol,ChEMBL,345,5,3,6,2.6,COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,10.1016/s0960-894x(00)00459-5
155515823,169307,0,None,24,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,621,20,5,13,1.7,CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4442559,169307,0,None,24,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15minsAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)expressedinHEK293cellassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter15mins,ChEMBL,621,20,5,13,1.7,CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
155565922,175069,0,None,4,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,628,24,6,8,3.1,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4584173,175069,0,None,4,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,628,24,6,8,3.1,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155569481,175492,0,None,8,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4594173,175492,0,None,8,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,614,23,6,8,2.7,CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
145990586,166144,0,None,1,3,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityathumanbeta2-adrenergicreceptorexpressedinCHO-K1cellsassessedasdecreaseinprocaterol-inducedcAMPaccumulationafter20minsbyHTRFassayAntagonistactivityathumanbeta2-adrenergicreceptorexpressedinCHO-K1cellsassessedasdecreaseinprocaterol-inducedcAMPaccumulationafter20minsbyHTRFassay,ChEMBL,297,2,2,4,2.6,COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2,10.1039/C7MD00656J
CHEMBL4285281,166144,0,None,1,3,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityathumanbeta2-adrenergicreceptorexpressedinCHO-K1cellsassessedasdecreaseinprocaterol-inducedcAMPaccumulationafter20minsbyHTRFassayAntagonistactivityathumanbeta2-adrenergicreceptorexpressedinCHO-K1cellsassessedasdecreaseinprocaterol-inducedcAMPaccumulationafter20minsbyHTRFassay,ChEMBL,297,2,2,4,2.6,COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2,10.1039/C7MD00656J
155515551,169259,0,None,1,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,584,25,4,6,6.8,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4441975,169259,0,None,1,2,Human,8.2,pIC50,=,8.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,584,25,4,6,6.8,CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155515823,169307,0,None,24,2,Human,7.2,pIC50,=,7.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,621,20,5,13,1.7,CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
CHEMBL4442559,169307,0,None,24,2,Human,7.2,pIC50,=,7.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,621,20,5,13,1.7,CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1,10.1021/acs.jmedchem.9b00595
155564992,174793,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,407,15,4,5,1.8,CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4578042,174793,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,407,15,4,5,1.8,CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155518547,169574,0,None,107,2,Human,8.1,pIC50,=,8.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,558,20,6,7,3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4446394,169574,0,None,107,2,Human,8.1,pIC50,=,8.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,558,20,6,7,3,CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
13208884,173914,0,None,1,2,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,564,23,4,10,2.7,CC(C)NC[C@H](O)COc1ccccc1OCCOCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4557995,173914,0,None,1,2,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,564,23,4,10,2.7,CC(C)NC[C@H](O)COc1ccccc1OCCOCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
203685,30505,7,None,33,4,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL1395661,30505,7,None,33,4,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OC[C@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155521390,169871,0,None,128,2,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,586,21,6,8,2,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4450606,169871,0,None,128,2,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,586,21,6,8,2,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
53318280,58287,0,None,-70,3,Human,6.1,pIC50,=,6.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,623,11,3,6,7.2,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
CHEMBL1684578,58287,0,None,-70,3,Human,6.1,pIC50,=,6.1,Functional,Agonistactivityathumanbeta2adrenergicreceptorAgonistactivityathumanbeta2adrenergicreceptor,ChEMBL,623,11,3,6,7.2,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,10.1016/j.bmcl.2010.12.087
155527605,170529,0,None,213,2,Human,8.1,pIC50,=,8.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,600,22,6,8,2.4,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4459989,170529,0,None,213,2,Human,8.1,pIC50,=,8.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,600,22,6,8,2.4,CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
155532901,171095,0,None,-,1,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,351,12,4,4,2.1,CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
CHEMBL4468271,171095,0,None,-,1,Human,7.1,pIC50,=,7.1,Functional,Antagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassayAntagonistactivityatbeta2adrenergicreceptor(unknownorigin)stablyexpressedinHEK293cellmembranesassessedasinhibitionofisoproterenol-inducedcAMPproductionpreincubatedfor15minsfollowedbyisoproterenoladditionandmeasuredafter30minsbyTR-FRETassay,ChEMBL,351,12,4,4,2.1,CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C,10.1021/acs.jmedchem.9b00595
52947562,17471,0,None,-173,3,Human,6.1,pIC50,=,6.1,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,384,7,2,7,2.7,OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1,10.1016/j.bmcl.2010.08.039
CHEMBL1258486,17471,0,None,-173,3,Human,6.1,pIC50,=,6.1,Functional,Antagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassayAntagonistactivityathumanrecombinantadrenergicbeta2receptorexpressedinCHOcellsassessedasinhibitionofisoproterenol-inducedcyclicAMPformationbyHTRFassay,ChEMBL,384,7,2,7,2.7,OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1,10.1016/j.bmcl.2010.08.039
25271869,157939,1,None,-,0,Human,10.7,pKd,=,10.7,Functional,Partialagonistactivityathumanbeta2-ARexpressedinCHOK1cellsassessedasinhibitionofcimaterol-inducedCRE-SPAPproductionafter5hrsPartialagonistactivityathumanbeta2-ARexpressedinCHOK1cellsassessedasinhibitionofcimaterol-inducedCRE-SPAPproductionafter5hrs,ChEMBL,299,6,2,3,3.5,CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1,10.1021/acsmedchemlett.6b00363
CHEMBL4092412,157939,1,None,-,0,Human,10.7,pKd,=,10.7,Functional,Partialagonistactivityathumanbeta2-ARexpressedinCHOK1cellsassessedasinhibitionofcimaterol-inducedCRE-SPAPproductionafter5hrsPartialagonistactivityathumanbeta2-ARexpressedinCHOK1cellsassessedasinhibitionofcimaterol-inducedCRE-SPAPproductionafter5hrs,ChEMBL,299,6,2,3,3.5,CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1,10.1021/acsmedchemlett.6b00363
165193,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
2303,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
4946,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
564,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
62882,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
63,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
66366,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
91536,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
CHEMBL27,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
CHEMBL452861,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
DB00571,3109,59,None,6,13,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,259,6,2,3,2.6,OC(COc1cccc2c1cccc2)CNC(C)C,10.1021/jm2008562
54756927,65088,0,None,-,0,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,833,22,4,8,7.5,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830486,65088,0,None,-,0,Human,9.6,pKd,=,9.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,833,22,4,8,7.5,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
137,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
2119,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
563,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
66368,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
CHEMBL266195,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
DB00866,367,39,None,1,4,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,249,8,2,3,2.2,C=CCc1ccccc1OCC(CNC(C)C)O,10.1021/jm2008562
54669764,65093,0,None,-,0,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,893,26,4,10,6.8,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830491,65093,0,None,-,0,Human,9.5,pKd,=,9.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,893,26,4,10,6.8,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
54758417,65087,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,805,20,4,8,6.7,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830485,65087,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,805,20,4,8,6.7,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
54757232,65117,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,883,28,4,10,6.3,C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
CHEMBL1830618,65117,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,883,28,4,10,6.3,C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
54757126,65094,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,893,26,4,10,6.8,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830492,65094,0,None,-,0,Human,9.4,pKd,=,9.4,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,893,26,4,10,6.8,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
54757331,65118,0,None,-,0,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,883,28,4,10,6.3,C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
CHEMBL1830619,65118,0,None,-,0,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,883,28,4,10,6.3,C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
2176,3048,62,None,1,6,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,248,6,3,3,1.9,OC(COc1cccc2c1cc[nH]2)CNC(C)C,10.1021/jm2008562
4828,3048,62,None,1,6,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,248,6,3,3,1.9,OC(COc1cccc2c1cc[nH]2)CNC(C)C,10.1021/jm2008562
91,3048,62,None,1,6,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,248,6,3,3,1.9,OC(COc1cccc2c1cc[nH]2)CNC(C)C,10.1021/jm2008562
CHEMBL500,3048,62,None,1,6,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,248,6,3,3,1.9,OC(COc1cccc2c1cc[nH]2)CNC(C)C,10.1021/jm2008562
DB00960,3048,62,None,1,6,Human,9.2,pKd,=,9.2,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,248,6,3,3,1.9,OC(COc1cccc2c1cc[nH]2)CNC(C)C,10.1021/jm2008562
54757026,65091,0,None,-,0,Human,9.1,pKd,=,9.1,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,833,22,4,8,7.5,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830489,65091,0,None,-,0,Human,9.1,pKd,=,9.1,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,833,22,4,8,7.5,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
54757229,65116,0,None,-,0,Human,8.8,pKd,=,8.8,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,795,22,4,8,6.3,C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
CHEMBL1830617,65116,0,None,-,0,Human,8.8,pKd,=,8.8,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,795,22,4,8,6.3,C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
54756928,65089,0,None,-,0,Human,8.8,pKd,=,8.8,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,889,26,4,8,9.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830487,65089,0,None,-,0,Human,8.8,pKd,=,8.8,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,889,26,4,8,9.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12,10.1021/jm2008562
54757129,65095,0,None,-,0,Human,8.7,pKd,=,8.7,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,795,22,4,8,6.3,C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
CHEMBL1830493,65095,0,None,-,0,Human,8.7,pKd,=,8.7,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,795,22,4,8,6.3,C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,10.1021/jm2008562
2685,871,12,None,-,1,Human,6,pKd,=,6,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
541,871,12,None,-,1,Human,6,pKd,=,6,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
CHEMBL280822,871,12,None,-,1,Human,6,pKd,=,6,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,494,11,4,8,2.3,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O,10.1021/jm400348g
56598967,87748,0,None,-2238,3,Human,5.9,pKd,=,5.9,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,457,14,4,6,3.2,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1,10.1021/jm400348g
CHEMBL2348211,87748,0,None,-2238,3,Human,5.9,pKd,=,5.9,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,457,14,4,6,3.2,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1,10.1021/jm400348g
56597179,87756,0,None,-2754,3,Human,5.8,pKd,=,5.8,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,473,14,5,7,2.9,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348219,87756,0,None,-2754,3,Human,5.8,pKd,=,5.8,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,473,14,5,7,2.9,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
54757027,65092,0,None,-,0,Human,8.6,pKd,=,8.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,889,26,4,8,9.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830490,65092,0,None,-,0,Human,8.6,pKd,=,8.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,889,26,4,8,9.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
54756929,65090,0,None,-,0,Human,8.6,pKd,=,8.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,805,20,4,8,6.7,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
CHEMBL1830488,65090,0,None,-,0,Human,8.6,pKd,=,8.6,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,805,20,4,8,6.7,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12,10.1021/jm2008562
5311116,2281,5,None,-4365,3,Human,5.5,pKd,=,5.5,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
544,2281,5,None,-4365,3,Human,5.5,pKd,=,5.5,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
CHEMBL207802,2281,5,None,-4365,3,Human,5.5,pKd,=,5.5,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,484,15,5,8,2.2,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O,10.1021/jm400348g
54758320,65119,0,None,-,0,Human,7.5,pKd,=,7.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,794,20,5,8,6.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12,10.1021/jm2008562
CHEMBL1830620,65119,0,None,-,0,Human,7.5,pKd,=,7.5,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,794,20,5,8,6.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12,10.1021/jm2008562
123686,1928,42,None,-74,3,Human,7.3,pKd,=,7.3,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
12581,1928,42,None,-74,3,Human,7.3,pKd,=,7.3,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
CHEMBL11268,1928,42,None,-74,3,Human,7.3,pKd,=,7.3,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,354,9,4,5,1.7,C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O,10.1021/jm400348g
155774,4005,31,None,-64,3,Human,6.2,pKd,=,6.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
2848,4005,31,None,-64,3,Human,6.2,pKd,=,6.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
538,4005,31,None,-64,3,Human,6.2,pKd,=,6.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
CHEMBL75753,4005,31,None,-64,3,Human,6.2,pKd,=,6.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
DB13781,4005,31,None,-64,3,Human,6.2,pKd,=,6.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,339,8,4,6,-0.2,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1,10.1021/jm400348g
54758415,65120,0,None,-,0,Human,8.1,pKd,=,8.1,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,882,26,5,10,6.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12,10.1021/jm2008562
CHEMBL1830621,65120,0,None,-,0,Human,8.1,pKd,=,8.1,Functional,Antagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysisAntagonistactivityathumanbeta-2adrenergicreceptorexpressedinsalbutamol-stimulatedCHO-K1cellsassessedasCRE-SPAPlevelbyfluorescencecorrelationspectroscopicanalysis,ChEMBL,882,26,5,10,6.1,O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12,10.1021/jm2008562
56598831,88627,0,None,-1023,3,Human,5.2,pKd,=,5.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348220,88627,0,None,-1023,3,Human,5.2,pKd,=,5.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2365796,88627,0,None,-1023,3,Human,5.2,pKd,=,5.2,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,459,15,5,7,2.3,O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
66653268,87738,0,None,-3311,3,Human,6.1,pKd,=,6.1,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,491,14,4,6,3.8,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1,10.1021/jm400348g
CHEMBL2348201,87738,0,None,-3311,3,Human,6.1,pKd,=,6.1,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,491,14,4,6,3.8,O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1,10.1021/jm400348g
56598832,87755,0,None,-4365,3,Human,6.1,pKd,=,6.1,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,527,16,5,7,3.3,O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
CHEMBL2348218,87755,0,None,-4365,3,Human,6.1,pKd,=,6.1,Functional,Antagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrsAntagonistactivityathumanbeta2adrenoceptorexpressedinCHOK1cellsassessedasinhibitionofcimaterol-induced[3H]cAMPaccumulationincubatedfor15minspriortocimaterolinductionmeasuredafter5hrs,ChEMBL,527,16,5,7,3.3,O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1,10.1021/jm400348g
36811,1413,33,None,-3,7,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,301,7,4,4,3,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O,None
535,1413,33,None,-3,7,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,301,7,4,4,3,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O,None
937,1413,33,None,-3,7,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,301,7,4,4,3,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O,None
CHEMBL926,1413,33,None,-3,7,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,301,7,4,4,3,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O,None
DB00841,1413,33,None,-3,7,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,301,7,4,4,3,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O,None
1155,1579,43,None,2,3,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,None
3343,1579,43,None,2,3,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,None
557,1579,43,None,2,3,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,None
CHEMBL32800,1579,43,None,2,3,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,None
DB01288,1579,43,None,2,3,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,303,6,5,5,2.1,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,None
688570,186117,15,None,-1,2,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,287,6,4,4,2.4,C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1,None
CHEMBL489553,186117,15,None,-1,2,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,287,6,4,4,2.4,C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1,None
688563,211947,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,290,5,4,4,2,CC[C@@H](NC(C)C)[C@@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,None
10184665,3900,44,None,44,3,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,None
4799,3900,44,None,44,3,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,None
7353,3900,44,None,44,3,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,None
CHEMBL1198857,3900,44,None,44,3,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,None
DB09082,3900,44,None,44,3,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,None
1499,2038,40,None,-72,36,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,None
3779,2038,40,None,-72,36,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,None
536,2038,40,None,-72,36,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,None
CHEMBL434,2038,40,None,-72,36,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,None
DB01064,2038,40,None,-72,36,Human,8,pEC50,=,8,Functional,NoneNone,DrugCentral,211,4,4,4,1.1,CC(NCC(c1ccc(c(c1)O)O)O)C,None
12065,618,15,None,6,2,Human,10,pEC50,=,10,Functional,DeterminedinanintracellularcAMPaccumulationassayinCHO-K1cellsexpressingh&beta,GuidetoPharmacology,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,19875286
45483813,618,15,None,6,2,Human,10,pEC50,=,10,Functional,DeterminedinanintracellularcAMPaccumulationassayinCHO-K1cellsexpressingh&beta,GuidetoPharmacology,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,19875286
CHEMBL579394,618,15,None,6,2,Human,10,pEC50,=,10,Functional,DeterminedinanintracellularcAMPaccumulationassayinCHO-K1cellsexpressingh&beta,GuidetoPharmacology,370,6,4,5,2.7,Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O,19875286
1239,1626,45,None,-1,5,Human,10.1,pEC50,=,10.1,Functional,UnclassifiedUnclassified,GuidetoPharmacology,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,20590599
3410,1626,45,None,-1,5,Human,10.1,pEC50,=,10.1,Functional,UnclassifiedUnclassified,GuidetoPharmacology,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,20590599
3465,1626,45,None,-1,5,Human,10.1,pEC50,=,10.1,Functional,UnclassifiedUnclassified,GuidetoPharmacology,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,20590599
CHEMBL1256786,1626,45,None,-1,5,Human,10.1,pEC50,=,10.1,Functional,UnclassifiedUnclassified,GuidetoPharmacology,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,20590599
DB00983,1626,45,None,-1,5,Human,10.1,pEC50,=,10.1,Functional,UnclassifiedUnclassified,GuidetoPharmacology,344,9,4,5,2.2,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,20590599
9512,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,16640337
9887812,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,16640337
CHEMBL208427,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,16640337
DB06190,3549,32,None,-316,3,Human,5.9,pEC50,=,5.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,410,9,4,4,4.4,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O,16640337
3464,3094,24,None,-,1,Human,8.4,pEC50,=,8.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,290,5,4,4,2,CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C,20590599
4916,3094,24,None,-,1,Human,8.4,pEC50,=,8.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,290,5,4,4,2,CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C,20590599
CHEMBL160519,3094,24,None,-,1,Human,8.4,pEC50,=,8.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,290,5,4,4,2,CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C,20590599
DB01366,3094,24,None,-,1,Human,8.4,pEC50,=,8.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,290,5,4,4,2,CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C,20590599
10184665,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,20462258
4799,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,20462258
7353,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,20462258
CHEMBL1198857,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,20462258
DB09082,3900,44,None,44,3,Human,9.4,pEC50,=,9.4,Functional,UnclassifiedUnclassified,GuidetoPharmacology,485,16,4,6,4.6,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O,20462258
3466,4047,36,None,-,1,Human,9.5,pEC50,=,9.5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,20590599
37990,4047,36,None,-,1,Human,9.5,pEC50,=,9.5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,20590599
CHEMBL1243407,4047,36,None,-,1,Human,9.5,pEC50,=,9.5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,378,8,4,5,2.4,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C,20590599
2419,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,20590599
5152,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,20590599
559,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,20590599
CHEMBL1263,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,20590599
DB00938,3377,76,None,17,6,Human,9.9,pEC50,=,9.9,Functional,UnclassifiedUnclassified,GuidetoPharmacology,415,16,4,5,4.1,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O,20590599
4382,2481,0,None,-758,3,Human,5,pEC50,>,5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,396,9,4,6,2.8,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O,17293563
7445,2481,0,None,-758,3,Human,5,pEC50,>,5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,396,9,4,6,2.8,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O,17293563
9865528,2481,0,None,-758,3,Human,5,pEC50,>,5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,396,9,4,6,2.8,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O,17293563
CHEMBL2095212,2481,0,None,-758,3,Human,5,pEC50,>,5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,396,9,4,6,2.8,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O,17293563
DB08893,2481,0,None,-758,3,Human,5,pEC50,>,5,Functional,UnclassifiedUnclassified,GuidetoPharmacology,396,9,4,6,2.8,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O,17293563
443372,10110,18,None,-3,8,Human,8,pIC50,=,8,Functional,"Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.",DrugCentral,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,None
CHEMBL1160723,10110,18,None,-3,8,Human,8,pIC50,=,8,Functional,"Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.",DrugCentral,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,None
CHEMBL2062275,10110,18,None,-3,8,Human,8,pIC50,=,8,Functional,"Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.Mitogenesisinhibitionmethod:Tomeasurebeta2-ARmediatedinhibitionofmitogenesis,HEK-beta2-AR,1321N1orU87MGcellswereseededina96-wellplateatapproximately5,000cells/well.After48hours,thewellswererinsedtwiceandthemediumwasreplacedwithfreshmediumcontaining10uLofdruginsterilewater.Afteranother24hoursofincubationat37°C.,0.25uCiof[3H]-thymidinewasaddedtoeachwell.Thecellswereincubatedforanadditional2hoursat37°C.,atwhichpoint10uLof10xtrypsinwasadded,andtheresuspendedcellswereharvestedusingaTomtec96harvesterthroughglassfiberfilters.",DrugCentral,211,4,4,4,1.1,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,None
11504295,2853,35,None,1047,2,Human,10,pIC50,=,10,Functional,UnclassifiedUnclassified,GuidetoPharmacology,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,20371707
4814,2853,35,None,1047,2,Human,10,pIC50,=,10,Functional,UnclassifiedUnclassified,GuidetoPharmacology,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,20371707
7543,2853,35,None,1047,2,Human,10,pIC50,=,10,Functional,UnclassifiedUnclassified,GuidetoPharmacology,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,20371707
CHEMBL605846,2853,35,None,1047,2,Human,10,pIC50,=,10,Functional,UnclassifiedUnclassified,GuidetoPharmacology,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,20371707
DB09080,2853,35,None,1047,2,Human,10,pIC50,=,10,Functional,UnclassifiedUnclassified,GuidetoPharmacology,386,7,4,6,2.4,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C,20371707
12582,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,19245211
12582,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,20590599
12582,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,25324048
2783,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,19245211
2783,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,20590599
2783,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,25324048
CHEMBL49080,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,19245211
CHEMBL49080,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,20590599
CHEMBL49080,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,25324048
DB01407,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,19245211
DB01407,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,20590599
DB01407,931,38,None,-23,4,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,276,3,3,3,3,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,25324048